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ABSTRACT
Binge alcohol (EtOH) exposure in adolescence is a fundamental health
concern. In 2005, over 20% of teenagers between ages 15 and 17 reported
binge drinking behavior within a one month period preceding the survey (Dept. of
Health and Human Services: Substance Abuse and Mental Health Services
Administration). Binge drinking is defined as consuming enough alcohol within a
2.0 h period to bring blood alcohol concentration above 0.08%. In the adolescent
population, this type of alcohol exposure tends to be repeated. In adults, alcohol
abuse has been correlated with increased incidence of mood disorders and these
disorders are characterized by dysregulation of the hypothalamo-pituitary-adrenal
(HPA) axis, a three tiered biological system that mediates physiological stress
response. Corticotrophin releasing hormone (CRH) and arginine vasopressin
(AVP) localized in the paraventricular nucleus (PVN) of the hypothalamus are the
major neuropeptides involved in modulating HPA axis responses to stress.
Corticosterone (CORT) in rodents, and cortisol in humans, is a major
glucocorticoid hormone released into the circulation upon activation of the HPA
axis. Puberty is a period during which extensive maturation occurs, yet our
knowledge of the neurobiological consequences of binge EtOH exposure during
this time period is severely limited. I sought to investigate the neuroendocrine
consequences of EtOH exposure during pubertal maturation and tested the
xvi

hypothesis that EtOH exposure during puberty has long lasting detrimental
consequences for a proper maturation of the HPA axis. My data revealed that
repeated binge-pattern EtOH exposure resulted in a sex specific dysregulation of
the HPA axis in pubertal rats. This was marked by an increase in the expression
of CRH and AVP mRNA in the male, but not female, PVN. Notably, in both
sexes, both single and repeated binge EtOH exposures resulted in increased
circulating CORT levels and habituation effects. These results suggested that
repeated binge-like EtOH exposure differentially dysregulated the HPA axis in
males compared to females (Przybycien-Szymanska et al., AJP Endocrin. and
Metabol., 2010). My data further showed that the sex steroid hormone, 17βestradiol, is required for the maintenance of steady state levels of CRH and AVP
mRNA in the PVN of pubertal female rats and for the habituation effects
observed in CORT responses after repeated binge-pattern EtOH exposure. Most
striking, these results showed that in males, binge-pattern EtOH exposure during
puberty resulted in the dysregulation of adult HPA axis. This was evidenced by 1)
increased adult basal levels of CRH mRNA in the PVN and lower basal
circulating CORT levels, 2) differential patterns of CRH and AVP mRNA
expression in the PVN after subsequent EtOH exposures in adulthood, 3)
enhanced circulating CORT increase after single or repeated binge-like
exposures in adulthood, 4) lack of habituation in CORT response after adult
repeated binge pattern EtOH exposure (Przybycien-Szymanska et al., PLoS
One, 2011).

xvii

In addition, I investigated the molecular mechanisms involved in the
observed EtOH-induced increase in the CRH mRNA in the PVN. Increased gene
expression correlates closely with increased gene promoter activity; therefore I
tested whether EtOH affects CRH promoter activity and whether glucocorticoid
negative feedback at the promoter was dysregulated by EtOH. My data showed
that EtOH exerts a biphasic effects on the activity of the CRH promoter and these
effects are blocked by glucocorticoid receptor (GR) antagonist and deletion of
glucocorticoid response element site (a binding site for GR) on CRH promoter.
These results indicated that EtOH dysregulates functioning of the HPA axis by
interfering with normal negative glucocorticoid feedback mechanism exerted on
CRH promoter. Moreover, I showed that 17β-estradiol prevented the EtOHinduced increase in CRH promoter activity supporting a role of this hormone in
the sexually dimorphic changes of CRH mRNA in the PVN after EtOH exposure.
In conclusion, my data showed that binge-pattern EtOH exposure during
puberty has long lasting effects on the HPA axis. These effects are manifested
by alterations in PVN expression of neuropeptides involved in modulating stress
responses and glucocorticoid hormone signaling. These effects are caused by
EtOH-induced dysregulation of glucocorticoid negative feedback normally
exerted at the level of the gene promoter in the PVN and may lead to increased
risk for mood disorders in adulthood.

xviii

CHAPTER ONE
INTRODUCTION
Literature review
Binge alcohol consumption in adolescents
Alcohol abuse during adolescence is a fundamental health concern in the
United States. According to the U.S. Department of Health and Human Services,
boys on average have their first drink before age 11 and girls tend to have their
first drink before age 13. Alarming overall statistics show that by age 14, 41% of
teenagers have consumed their first drink.
Underage drinkers do not chronically abuse alcohol, they typically adopt a
“binge” pattern of alcohol consumption, defined by the National Institute on
Alcohol Abuse and Alcoholism (NIAAA) as heavy, episodic drinking in which
enough alcohol (on average 4 or 5 drinks in adult females and males,
respectively) is consumed to bring the blood alcohol concentration above 0.08 %
limit within that 2.0 h time period (White, Kraus et al. 2006). According to the
Department of Health and Human Services survey performed in 2005, 2.0% of
12-13 year-old, 8.0% of 14-15 year-old, 19.7% of 16-17 year-old, and 51% of 1820 year-old adolescents reported this pattern of drinking within a month
preceding the survey. Overall, these statistics indicate that a significant
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2
percentage of the young population consumes heavy doses of alcohol during
adolescence.

Brain development during adolescence
The onset of adult reproductive functions, also known as puberty, is
marked by many endocrinological, neurological and anatomical changes in both
males and females. During this time period, changes in hormone levels
accompany gonad maturation and acquisition of secondary sex characteristics.
In addition to sexual maturation, the late pubertal period, also known as
adolescence, is a period during which extensive brain maturation continues to
occur. Even though it is relatively vague, very often adolescence is a term
describing a time period of maturation between puberty and adulthood. This
phase is marked by emotional, cognitive and personality development and is
characterized by increased associations with groups of peers, increased risk
taking behavior, lack of behavioral inhibition, and mood swings. These
personality changes are a result of extensive brain maturation occurring during
this time and characterized by changes in cortical gray matter (Lenroot and
Giedd 2006), increased neurogenesis in some brain areas (Rankin, Partlow et al.
2003; Raymond, Kucherepa et al. 2006; Ahmed, Zehr et al. 2008), increased
dendritic pruning in other brain regions (Woo, Pucak et al. 1997; Zehr, Todd et al.
2006), changes in corpus collosum thickness (Luders, Thompson et al.; Luders,
Thompson et al. 2010) and increased synaptic connectivity (Cunningham,
Bhattacharyya et al. 2002). Adolescents may be extremely vulnerable to harmful
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effects of drugs of abuse, including alcohol because of this extensive brain
maturation occurring during this stage of development.

Fetal brain development and some of the effects of in utero alcohol exposure
The embryonic stage of life is extremely vulnerable to any types of
stressors because it is the time during which all critical systems in the fetus are
being formed. Obviously, one of the organs that develop during this time period is
the brain. Alcohol exposure during a critical developmental period, such as
embryonic or pubertal development, may result in long lasting alteration of the
systems that undergo development or maturation during these periods, Alcohol
(EtOH) exposure during fetal development has been shown to cause neuronal
dysfunction and cell death (Miki, Harris et al. 2003; Ramachandran, Watts et al.
2003; Akbar, Baick et al. 2006; Aloe 2006; Camarillo and Miranda 2008) and it
has been well described that in utero alcohol exposure can result in development
of a spectrum of disorders called Fetal Alcohol Spectrum Disorder (FASD) in the
offspring. Among other characteristics, FASD is marked by a mild or, in some
cases, severe mental retardation. This mental retardation is indicative of alcohol
exposure induced compromise in brain development that could be a result of
EtOH induced neuronal dysfunction. Some of the brain systems that are affected
by fetal EtOH exposure are cortical and striatal dopaminergic systems (Druse,
Tajuddin et al. 1990), cortical and brain stem serotonergic systems (Druse, Kuo
et al. 1991; Tajuddin and Druse 1993; Kim, Gillespie et al. 1997; Tajuddin and
Druse 1999), brain stem adrenergic systems (Choi, Lee et al. 2008) and the

4
hypothalamo-pituitary-adrenal (HPA) axis (Taylor, Branch et al. 1981; Taylor,
Nelson et al. 1984; Tajuddin and Druse 1999; Hofmann, Ellis et al. 2007; Lee,
Choi et al. 2008). For example, in utero EtOH exposure decreased serotonin
levels and the density of its receptors in the brain stem and in the motor and
somatosensory cortices (Druse, Kuo et al. 1991; Tajuddin and Druse 1993).
EtOH exposure also decreased dopamine levels, dopamine uptake sites and the
number of dopamine receptors in the striatum (Druse, Tajuddin et al. 1990).
Abnormal formation of either of these systems, dopaminergic, serotonergic or
adrenergic, increases the risk for developing substance dependence, mental
retardation, or mood disturbances in the offspring.
Mood disturbances are the end result of the dysregulation of the
homeostatic balance between different players of the HPA axis. Functioning of
the HPA axis is severely compromised by fetal EtOH exposure. It has been
shown that in utero EtOH exposure resulted in the hyperactivity of the HPA axis
responses in the young and adult offspring (Ogilvie and Rivier 1997; Kim,
Giberson et al. 1999). In post natal day (PND) 21 offspring, for example, this
hypersensitivity was marked by an enhanced increase in foot shock induced
elevation in plasma adrenocorticotrophic hormone (ACTH) levels and an
increase in basal (non-stress) corticotrophin releasing hormone (CRH)
messenger ribonucleic acid (mRNA) levels (Lee, Imaki et al. 1990; Ogilvie and
Rivier 1997). Interestingly, the effects of in utero EtOH exposure were observed
specifically if EtOH exposure occurred during the second week of gestation (Lee,
Imaki et al. 1990). The second week of rat pregnancy coincides with the
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development of the rat hypothalamic CRH system (Altman and Bayer 1986),
therefore, EtOH exposure in utero may result in permanent dysregulation of the
system. Notably, the hyper-sensitivity of the HPA axis after fetal EtOH exposure
was maintained until adulthood. In multiple studies, it has been shown that in
rats exposed to EtOH in utero, a stressor induced increase in ACTH release was
enhanced in adulthood (Weinberg 1988; Kang, Cole et al. 2004; Lee, Choi et al.
2008). In addition, CRH hetero nuclear (hn) RNA was increased after stressor in
adult rats pre-exposed to EtOH in utero as compared to control rats (Lee, Choi et
al. 2008). Together, these data suggest that alcohol exposure during a critical
developmental period, such as embryonic or pubertal development, may result in
long lasting alteration of the systems that undergo development or maturation
during these periods, however, long lasting effects of EtOH exposure during
puberty have not been extensively investigated.

The hypothalamo-pituitary-adrenal (HPA) axis
The hypothalamo-pituitary adrenal (HPA) axis is a three part endocrine
system responsible for coordinating stress responses. In a healthy system, upon
stressful stimulus, parvocellular cells of the PVN (pPVN) located in the
hypothalamus synthesize and secrete corticotrophin-releasing hormone (CRH)
and arginine vasopressin (AVP). CRH and AVP then activate CRH 1 receptors
(CRH-R1) and vasopressin 1B (V1B) receptors, respectively, in the anterior
pituitary gland and act synergistically to stimulate the anterior pituitary gland to
produce adrenocorticotrophic hormone (ACTH) (Aguilera, Harwood et al. 1983;
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Rivier, Rivier et al. 1996; Papadimitriou and Priftis 2009) . CRH and AVP
expressing neurons in the PVN that project to the median eminence and
stimulate ACTH secretion from the anterior pituitary gland play a pivotal role in
orchestrating central and endocrine signals reaching the brain during stressful
events, therefore, proper functioning of these neurons is critical for maintaining
homeostasis after stress. After CRH and AVP stimulation, corticotrope cells of
the pituitary release ACTH into systemic circulation and then ACTH acts in
endocrine fashion on the adrenal gland to produce and release glucocorticoids,
cortisol in humans and corticosterone (CORT) in rodents (Papadimitriou and
Priftis 2009) . Glucocorticoids can then exert negative feedback on both the
hypothalamus and pituitary gland to decrease the neuropeptides and ACTH
release, respectively, allowing for homeostatic state to be re-established (Erkut,
Pool et al. 1998; Malkoski and Dorin 1999; Figueiredo, Bodie et al. 2003;
Ostrander, Ulrich-Lai et al. 2006; Yamamori, Iwasaki et al. 2007; Papadimitriou
and Priftis 2009; van der Laan, de Kloet et al. 2009).

Paraventricular nucleus of the hypothalamus (PVN). Outputs and Inputs.
The paraventricular nucleus of the hypothalamus (PVN) is a diverse group
of cell bodies localized in the hypothalamus adjacent to the third ventricle. In the
adult rat brain it is localized between 0.8 mm and 2.12 mm posterior to Bregma,
8.0 mm below the top of the brain (Smith, Gardiner et al. 2008) (Paxinos and
Watson, Rat Brain Atlas, 5th edition). Among other neuropeptides and
neurotransmitters, parvocellular cells of the PVN (pPVN) contain CRH and
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arginine vasopressin (AVP) hormones and magnocellular cells of the PVN
(mPVN) are known to produce AVP (Hou-Yu, Lamme et al. 1986; Ogilvie, Lee et
al. 1998; Schulkin, Gold et al. 1998; Robertson 2001; Cole and Sawchenko 2002;
Isgor, Shieh et al. 2003). Cells expressing CRH and AVP that are located in
specific portions of the pPVN project to the median eminence where they secrete
CRH and AVP into portal circulation by which these neuropeptides reach pituitary
gland (Aguilera, Harwood et al. 1983; Rivier, Rivier et al. 1996; Hrabovszky, Deli
et al. 2007). In addition to modulating stress reactivity, the PVN is involved in
regulation of other critical body functions. For example, the PVN is known to
send its glutamatergic projections to lateral hypothalamus (Hatton, Cobbett et al.
1985), medial preoptic area (Kocsis, Kiss et al. 2003) and supraoptic nucleus
(SON) (Csaki, Kocsis et al. 2002), therefore influencing reproduction and water
homeostasis. It also sends projection to medial amygdala (MeA) (Meurisse,
Chaillou et al. 2009) and ventral tegmental area (VTA) (Rodaros, Caruana et al.
2007), therefore helps in coordinating emotional responses and appetitive
behavior after stress.
The PVN does not function by itself. It receives a vast array of inputs from
the central nervous system (CNS) therefore playing a pivotal role in coordinating
homeostatic balance in the body. For example, PVN receives autonomic nervous
system noradrenergic and adrenergic inputs from the brain stem, including such
brain stem regions as ventral medulla, vagal complex and locus coreleus
(Sawchenko and Swanson 1982; Woulfe, Hrycyshyn et al. 1988; Sawchenko and
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Bohn 1989), therefore coordinating functions of the autonomic nervous system
and the HPA axis.
The serotonergic system also extensively influences functions of the HPA
axis. For example, it has been shown that long term (14 day) treatment with
selective serotonin reuptake inhibitor, Fluoxetine, reversed conditioned stress
response procedure induced increase in anxiety-like behavior (Zhang, Raap et
al. 2000) The interaction between the serotonin system and the HPA axis may
be occurring at the level of the PVN. Serotonergic axons terminate on CRH
containing neurons within pPVN. Notably, serotonergic innervation to the pPVN
has been shown to be greater than to other diencephalic regions and the
innervation to the pPVN was more prominent than to the mPVN (Liposits, Phelix
et al. 1987). Serotonin inputs have a stimulatory effect on the HPA axis as
systemic administration of the serotonin precursor (5-hydroxytryptophan, 5-HTP)
and serotonin reuptake inhibitor increased CRH mRNA expression in the PVN,
increased ACTH precursor, pro-opiomelanocortin (POMC) mRNA in the anterior
pituitary gland and increased plasma ACTH levels as compared to control
animals (Jorgensen, Knigge et al. 2002). Also, activation of serotonin receptor 1A
and 2A localized in the PVN increased basal plasma CORT levels and increase
c-Fos activity in the PVN (Mikkelsen, Hay-Schmidt et al. 2004).
PVN is highly regulated by gamma amminobutiric acid (GABA) and
glutamate projections of the limbic structures. For example, MeA sends
GABAergic projections that terminate on the GABA receptor containing GABA
inter-neurons located near the PVN indirectly stimulating the PVN activity
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(Herman, Mueller et al. 2004). Infralimbic cortex can inhibit PVN activity, whereas
hippocampus and anterior cingulate/prelimbic cortex projections to the PVN can
stimulate the activity of the HPA axis (Herman, Tasker et al. 2002; Herman,
Ostrander et al. 2005). Together, these data indicate that functioning of the HPA
axis can be affected by various CNS systems including autonomic nervous
system, serotonergic system, and limbic system. The HPA axis can in turn
influence other functions in the body including reproduction; water balance, and
memory therefore normal functioning of the HPA axis is critical for the health of
the individual.

Pituitary gland and its functions
The pituitary gland is a small endocrine organ protruding from the ventral
side of the hypothalamus. It is connected to the hypothalamus via the median
eminence from which the pituitary stalk originates. The pituitary gland plays a
critical role in coordinating water balance, reproduction, energy metabolism,
growth and stress responses, therefore it is called a “master endocrine gland”.
The pituitary galnd consists of two major lobes, anterior (adenohypophysis) and
posterior (neurohypophysis) lobe. The posterior pituitary gland stores and
releases AVP (also called. antiduretic hormone or ADH) that is produced in the
supraoptic nucleus (SON) and mPVN and oxytocin hormone produced in the
mPVN and SON. The anterior pituitary gland, on the other hand, is under a tight
regulation of parvocellular cells of the hypothalamus and releasing factors
produced in these neurons. The releasing factors produced in various
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hypothalamic nuclei include, thyroid releasing hormone (TRH) that stimulates
production of thyroid stimulating hormone (TSH) from the pituitary gland, growth
hormone releasing hormone (GHRH) stimulating production and release of
growth hormone (GH), prolactin releasing hormone stimulating prolactin release
from the gland, and CRH and AVP that stimulate the production and release of
ACTH. In addition, anterior pituitary releases luteinizing hormone (LH) and follicle
stimulating hormone (FSH) that are under a tight regulation of gonadortophin
releasing hormone (GnRH) (Gibo, Hokama et al. 1993; Dasen and Rosenfeld
1999) tightly regulating reproductive functions of both males and females.
As mentioned previously, ACTH release from the anterior pituitary gland is
under a tight regulation by CRH and AVP neuropeptides produced in the pPVN.
CRH released from the pPVN acts on the anterior pituitary gland corticotropes
via activating CRH 1 receptors (CRH R1) and stimulating ACTH production
(Aguilera, Harwood et al. 1983; Makino, Schulkin et al. 1995; Rivier, Rivier et al.
1996; Green, Figueroa et al. 2000; Rivier, Grigoriadis et al. 2003). AVP,
synergistically with CRH, stimulates the production of ACTH by acting at the
pituitary gland corticotropes expressing AVP 1b receptors (AVP 1b) (Ostrowski,
Lolait et al. 1992; Lolait, O'Carroll et al. 1995; Aguilera and Rabadan-Diehl 2000).
Proper functioning of these hypothalamic neurons is critical for the normal
functioning of the anterior pituitary gland corticotropes as they influence
glucocorticoid release from the adrenal cortex and coordinate stress responses.
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Adrenals and their functions
Adrenal glands are the two separate endocrine glands. Each adrenal
gland is located on top of each kidney. Each gland contains two distinct divisions,
adrenal cortex, and medulla, both responsible for producing different types of
hormones. The core of the adrenal gland, medulla, surrounded by the cortex,
contains chromaffin cells producing catecholamines, adrenaline (also called
epinephrine) and noradrenalin (also called norepinephrine). Epinephrine and
norepinephrine are major players in the ‘fight-or-flight” responses of the
autonomic nervous system during extreme stress. The major inputs to the
medulla are sympathetic nervous system inputs originating from the thoracic
spinal cord (Bacon and Smith 1988; Cao and Morrison 2001). Upon release,
epinephrine and norepinephrine act on the heart, gastrointestinal tract and the
brain to prepare the body for immediate response to stress, “fight or flight”
response.
The adrenal cortex, on the other hand, is devoted to slower endocrine
responses exerted by production of steroid hormones such as major stress
steroid hormones glucocorticoids (cortisol in primates and corticosterone (CORT)
in rodents) and aldosterone. In primates, adrenal cortex is also a source of
androgens such as testosterone (T) and dehydroepiandrosterone (DHEA). The
adrenal cortex is subdivided into three zones, zona glomerulosa, zona fasciculata
and zona reticularis, each responsible for production of different hormones
(Kater, Biglieri et al. 1982; Nishikawa and Strott 1984; Kater, Irony et al. 1990;
Rosol, Yarrington et al. 2001; Rainey, Carr et al. 2002; Young, Murphy et al.
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2003). The outer-most layer, zona glomerulosa, contains cells that produce
aldosterone which is responsible for maintaining blood pressure (Kater, Biglieri et
al. 1982). The inner layer, zona fasciculata, contains cells that are responsible for
producing glucocorticoids, in response to the ACTH stimulation during stress
(Nishikawa and Strott 1984; Kater, Irony et al. 1990). Inner-most layer of the
cortex, zona reticularis, produces androgens, such as DHEA (Rainey, Carr et al.
2002).
Glucocorticoids released from the adrenal glands act on variety of organs
in the body in order to help to maintain homeostatic balance during and after
stress. in the brain, glucocorticoids act on different brain regions, including
amygdala, hippocampus, suprachiasmatic nucleus (SCN) and the PVN (Clark
and Kemppainen 1994; Roy, Mittal et al. 2002; Sage, Maurel et al. 2002; Liu,
Unmehopa et al. 2006; Morsink, Steenbergen et al. 2006; Little, Croft et al.
2008). By modulating functions of these brain regions, glucocorticoids can affect
emotion, memory, circadian rhythms, and their own release, therefore, chronic or
extremely high elevation of these hormones may have detrimental consequences
for the homeostatic balance in the body.

Glucocorticoid mediated negative feedback in the PVN
Glucocorticoid hormones released from the adrenals exert negative
feedback at the level of the PVN and pituitary gland in order to bring itheir own
release from the adrenals back to basal levels and return the HPA axis to its
homeostatic state. They do that by decreasing the production and release of the
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CRH and AVP from the PVN (Makino, Schulkin et al. 1995; Makino, Smith et al.
1995; Erkut, Pool et al. 1998; Malkoski and Dorin 1999) and ACTH release from
the anterior pituitary gland (Clark and Kemppainen 1994). This negative
feedback allows for a homeostatic state to be maintained after stress and any
dysregulation of this feedback may result in developing mood disorders.
In the PVN, glucocorticoids directly affect the transcriptional activity of the
CRH gene. Glucocorticoids activate glucocorticoid receptors (GR) which belong
to a classical steroid receptor superfamily (ligand activated transcription factors).
Upon activation by glucocorticoid, GR undergo dimerization, translocate to the
nucleus and directly affect gene transcription (Goujon, Laye et al. 1997; Schulkin,
Gold et al. 1998; Sapolsky, Romero et al. 2000; Morsink, Steenbergen et al.
2006). In the PVN, glucocorticoids acting through GR are known to decrease
CRH gene transcription through signaling at the negative glucocorticoid response
element (nGRE) located between -249 and -278 nucleotides upstream from the
transcription initiation site of the CRH promoter and thorough interactions with
cAMP response element (CRE) site of the CRH promoter located -224 upstream
from the transcription initiation site. The CRE site binding of phosphorylated
cAMP response element binding protein (pCREB) is required for an increase in
CRH promoter activity and gene transcription (Van, Spengler et al. 1990;
Malkoski and Dorin 1999; King, Smith et al. 2002; Yamamori, Iwasaki et al. 2007;
Liu, Kamitakahara et al. 2008; van der Laan, de Kloet et al. 2009). Overall,
glucocorticoids acting via GRs decrease CRH promoter activity in the PVN

14
therefore, they decrease transcriptional activity of the promoter and decrease
CRH gene expression keeping the HPA axis in homeostatic state.

Role of arginine vasopressin (AVP) in the regulation of the HPA axis
In addition to CRH, arginine vasopressin (AVP) is another neuropeptide
critical for mediating stress and anxiety responses. First discovered as antiduretic
hormone (ADH), AVP is synthesized in the supraoptic nucleus (SON), PVN, bed
nucleus of stria terminalis (BSTN), amygdala and suprachiasmatic nucleus
(SCN). Neurons that synthesize AVP in the pPVN project to the median
eminence and facilitate the synergistic actions of AVP and CRH following
stressful stimuli through enhancing ACTH and glucocorticoid release (Aguilera,
Harwood et al. 1983; Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Scott and
Dinan 1998; Papadimitriou and Priftis 2009). The role of AVP in regulation of the
HPA axis is substantiated by the following data 1) chronic social stress changes
the expression of AVP mRNA in the amygdala of adult rats (Albeck, McKittrick et
al. 1997); 2) rats bred for high anxiety traits exhibit high levels of AVP expression
in the PVN and higher level of vasopressin release compared to rats bred for low
anxiety traits (Wigger, Sanchez et al. 2004); 3) mice lacking the vasopressin 1a
(V1a) receptor exhibit reduced anxiety responses (Bielsky, Hu et al. 2004). In
addition to stress regulation of the AVP expression, it has been shown that the
transcriptional activity in hypothalamic neurons expressing AVP can be
stimulated by acute alcohol (EtOH) administration demonstrated by increased
amount of AVP hetero nuclear ribonucleic acid (hnRNA) in this brain region
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(Ogilvie, Lee et al. 1997). Together these studies indicate that, in addition to
corticotrophin releasing hormone (CRH), AVP is an important modulator of
normal HPA axis function and that these function can be disrupted by EtOH
exposure.

Pubertal maturation of the HPA axis
The HPA axis is one of the systems that undergo extensive plasticity
during pubertal development (Romeo, Lee et al. 2004; Romeo, Bellani et al.
2006; Romeo and McEwen 2006; McCormick and Mathews 2007; Evuarherhe,
Leggett et al. 2009; Evuarherhe, Leggett et al. 2009; Laroche, Gasbarro et al.
2009). Corticosterone (CORT) and CRH and AVP levels, are markedly different
in response to both acute and chronic stressors in pre-pubertal (juvenile) and
pubertal animals as compared with adult animals (Jankord, Solomon et al.;
Romeo, Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen
2006{Laroche, 2009 #190; McCormick and Mathews 2007; Evuarherhe, Leggett
et al. 2009; Evuarherhe, Leggett et al. 2009). Most striking is the observation that
CORT and ACTH levels take much longer to return to baseline in juvenile
compared to adult animals when subjected to a variety of stressful stimuli
(Vazquez and Akil 1993; Romeo, Bellani et al. 2006). Further, juveniles have
higher overall stress reactivity (Romeo, Bellani et al. 2006) and chronic stress
during puberty has been shown to result in an exaggerated stress-induced CORT
response in adulthood (Jankord, Solomon et al.; Isgor, Cecchi et al. 2003). In
addition, even a very mild form of stress, such as shipping, during puberty
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contributes to reduced sexual behaviors in adulthood as pubertal male and
female mice shipped during their 6th week of age (puberty) exhibited suppressed
sexual behaviors and lower plasma CORT levels at 12 weeks of age (adulthood)
as compared to mice shipped during 12th week of age (Laroche, Gasbarro et al.
2009).
Changing gonadal steroid hormone levels differentially regulate the HPA
axis during puberty vs. adulthood. It has been shown, for example, that
ovariectomized pre-pubertal female rats (PND 28) replaced with estradiol (E2)
have suppressed stress responses (as measured by lower plasma CORT levels)
after 30 min restraint stress compared with ovariectomized adult female rats
replaced with E2 and subjected to the same stressor (Evuarherhe, Leggett et al.
2009), In males gonadectomized before puberty (PND 28), testosterone (T)
treatment did not change adult circulating CORT levels but T decreased plasma
CORT levels in animals that were gonadectomized in adulthood (11 week of
age). Also, following 10 min noise stress in these same castrated during puberty
males, testosterone (T) did not change the responsiveness of the HPA axis but T
suppressed stress response in animals that were gonadectomized in adulthood
(as measured by changes in CORT levels after stress) (Evuarherhe, Leggett et
al. 2009). Further, Viau et al. have shown that 60 day old females had highest
basal and stress induced plasma ACTH and CORT levels when compared to 30
day old females, 60 day old and 30 day old males. 60 day old males, on the other
hand, had the lowest basal and stress induced plasma ACTH and CORT levels
when compared to 30 day old males, 60 day old and 30 day old females
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indicating that changes in the responsiveness of the HPA axis that occur over
pubertal maturation are correlated with changing sex steroid hormone levels
(Viau, Bingham et al. 2005). Together these data indicate that during pubertal
maturation, the HPA axis undergoes extensive organization and is vulnerable to
any types of stressors. Stress and EtOH exposure during puberty may have long
lasting behavioral consequences in adulthood resulting from long lasting
alterations of the HPA axis.

Dysregulation of the HPA axis and mood disorders
Dysregulation of the normal glucocorticoid negative feedback and
functioning of the HPA axis is a hallmark of different types of mood disorders,
including but not limited to post-traumatic stress disorder (PTSD), depression
and anxiety (Ikin, Creamer et al.; Pervanidou and Chrousos; Wood, Walker et al.;
Smith, Davidson et al. 1989; Scott and Dinan 1998; Newport, Heim et al. 2003;
Steimer, Python et al. 2007). For example, in depressed patients, intravenous
infusion of CRH resulted in blunted ACTH release but normal cortisol release
(Holsboer, Lauer et al. 1995; Arborelius, Owens et al. 1999). Patients with PTSD
tend to have elevated cerebrospinal fluid CRH levels and blunted ACTH
responses to CRH challenge as compared to healthy individuals (Smith,
Davidson et al. 1989; Arborelius, Owens et al. 1999). These data indicate
dysregulation of the CRH-ACTH signaling in mood disorders. Various other
human and animal studies indicated involvement of both the CRH and AVP
systems in different types of mood disorders and individual differences in the
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susceptibility towards developing these types of disorders (Wood, Walker et al.;
Jensen, Keller et al. 1997; Keck, Welt et al. 2003; Yamamoto, Morinobu et al.
2009); however, other systems influencing functioning of the HPA axis also play
a role in developing mood disorders
Serotonergic and noradrenergic systems send their inputs to the PVN and
have been implicated in major depressive and anxiety disorders (Eison 1990;
Blier 2001). For example, enhanced serotonin transporter binding protein levels
in the thalamus, insula and striatum were observed in patients with major
depressive disorder or during the depressive stage of bipolar disorder (Cannon,
Ichise et al. 2007). Serotonin 1A receptor function in patients with depression is
reduced and this may be linked with reduction in the receptor binding potential in
the cortex and raphe nucleus (Drevets, Thase et al. 2007). Selective serotonin
reuptake inhibitors (SSRI) have been used in treatment of depression and
generalized anxiety disorders as abnormality in serotonin receptor 1A, 1C and 2
functions have been implicated in these types of disorders (Baldwin and Rudge
1995; Gorman and Kent 1999). Lastly, serotonin neurons are known to inhibit
norepinephrine neurons, therefore SSRI can affect the noradrenergic system as
well (Blier 2001) and both of these systems affect functioning of the HPA axis.
These data show that other neurotransmitter systems that converge on the HPA
axis may be involved in mood disorders, however, at the end, mood disorders
are characterized by dysregulation of the proper negative feedback of the HPA
axis.

19
Sex differences in the HPA axis reactivity to stressors
There are gender differences in susceptibility of men and women to mood
disorders with females being at a higher risk for these types of disorders
(Zilberman, Tavares et al. 2003; Becker, Monteggia et al. 2007). Multiple studies
have show that in adult animals there are sex differences in the responsiveness
of the HPA axis to stress and alcohol administration. For example, there are sex
differences in 30 min restraint stress induced CORT release with young (PND
20) females having lower plasma CORT levels and adult females (PND 80)
having higher plasma CORT levels compared to males (Sencar-Cupovic and
Milkovic 1976; Evuarherhe, Leggett et al. 2009). Also, after acute EtOH injection
(3 g/kg) adult females had higher plasma ACTH and CORT increase compared
to adult males (Rivier 1993; Ogilvie and Rivier 1996; Ogilvie and Rivier 1997),
These data clearly show that there are sex differences in the responsiveness of
the HPA axis to stressors at the levels of the ACTH and CORT.
There are also sex differences in adult basal CRH and AVP mRNA levels
in the PVN as well as CRH and AVP mRNA levels in adult males and females
after stress and EtOH exposure. For example, adult intact and adrenalectomized
(PND 80) females have lower basal CRH and AVP mRNA in the PVN compared
to age matched males (Patchev, Hayashi et al. 1999). In females, contrary to
males, there are no changes in the expression of AVP mRNA 3.0 h after acute
EtOH injection either in the pPVN or magnocellular (m) PVN (Ogilvie and Rivier
1997) . Contrary to female data, in adult males, acute EtOH administration
increases the expression of AVP mRNA in the pPVN after 3.0 h but fails to
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change the expression of CRH heteronuclear (hn) RNA after 20 min in the same
region (Rivier and Lee 1996). Together, these data clearly show that there are
sex differences in the responsiveness of the HPA axis to stressors and to EtOH
exposure at the level of the PVN, but the mechanisms involved in these
differences are not well known.
Steroid hormones have been shown to modulate the stress
responsiveness of the HPA axis in males and in females. For example, in
females, there was a greater plasma CORT increase after stress and alcohol
administration as compared to males (Sencar-Cupovic and Milkovic 1976; Rivier
1993; Ogilvie and Rivier 1997; Evuarherhe, Leggett et al. 2009; Weiser and
Handa 2009). T is known to play inhibitory role on stress induced functions of the
HPA axis marked by decreased ACTH and CORT increase when compared to
females and increased basal plasma CORT levels in gonadectomized males as
compared to intact males (Ogilvie and Rivier 1997; Viau, Chu et al. 1999;
Williamson and Viau 2008; Evuarherhe, Leggett et al. 2009).
T and its metabolites, such as 3β-diol and dihydrotestosterone (DHT), also
differently modulate the HPA axis activity at the level of hypothalamus (De Vries,
Wang et al. 1994; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau, Lee et al.
2003; Scordalakes and Rissman 2004; Lund, Hinds et al. 2006; Pak, Chung et al.
2007; Williamson and Viau 2008; Handa, Weiser et al. 2009; Pak, Chung et al.
2009). These effects can be mediated through estrogen receptor beta (ER β),
main ER fond in the PVN (Isgor, Cecchi et al. 2003; Miller, Suzuki et al. 2004;
Lund, Rovis et al. 2005; Suzuki and Handa 2005; Pak, Chung et al. 2007; Handa,
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Weiser et al. 2009) and through androgen receptor (AR) present in the PVN and
in other hypothalamic regions modulating PVN activity (Viau and Meaney 1996;
Lund, Hinds et al. 2006). For example, in bed nucleus of stria terminalis (BST) of
gonadectomized adult rats, DHT and E2 increase AVP mRNA as compared to
gonadectomized rats not replaced with hormones. In juvenile rats, on the other
hand, E2 and 3β-diol, but not DHT, increase AVP mRNA expression in BST but
only E2 increased AVP mRNA expression in medial amygdala (MeA) (Pak,
Chung et al. 2009). In addition, 3β-diol is known to activate the AVP promoter
activity in a neuronal cell line (Pak, Chung et al. 2007; Pak, Chung et al. 2009).
Together these data indicate that sex steroid hormones modulate the HPA axis
activity at different levels of the HPA axis functioning.

Chronic stress and hypo-activity of the HPA axis
Chronic stress induces habituation of the HPA axis. Several studies
have shown that chronic stressor induced a lesser activation of the HPA axis as
compared to acute stressor induced activation of the axis (Figueiredo, Bodie et
al. 2003; Girotti, Pace et al. 2006; Ostrander, Ulrich-Lai et al. 2006; Ostrander,
Ulrich-Lai et al. 2009). For example, acute cat exposure for 1.0 h (acute stress)
resulted in a significant rise in plasma ACTH and CORT levels just after the
cessation of the stressor as compared to no-stress control rats, however, daily
1.0 h exposures for 7 or 14 days (chronic homotypic stress) resulted in ACTH
and CORT levels that were not significantly different when compared to control,
not stressed, animals. CRH mRNA in the PVN, on the other hand, was
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significantly elevated after both acute and chronic stressors (Figueiredo, Bodie et
al. 2003). In addition, chronic variable stress (twice daily exposure to various
stressors (1.0 h restraint, 1.0 h restraint in cold temp, 1.0 h shaker stress, 20 min
warm water forced swim, or 5.0 min cold water stress) plus occasional overnight
stressor (overnight social isolation or overnight social crowding stress) for seven
consecutive days) resulted in lower plasma ACTH responses to the new
environment challenge 4.0 and 7.0 days after chronic variable stress paradigm.
The same was true when plasma CORT levels were measured, however, the
CRH mRNA in the PVN was elevated if novel environments challenge was
administered 16.0 h after cessation of chronic variable stress and was not
different after 4.0 or 7.0 days (Ostrander, Ulrich-Lai et al. 2006). These data
suggest that chronic stress; either homo- or heterotypic, results in a habituation
of the HPA axis responsiveness after cessation of the stressor or after exposure
to a novel stressor. The mismatch between CRH mRNA levels and plasma
hormone measurements further indicate that chronic stress in adulthood
dysregulates normal functioning of the HPA axis and this may be linked to mood
disturbances.

Alcohol abuse and relationship to mood disorders
Alcohol exposure is closely linked with a dysregulation of adult and
adolescent stress system. For example, alcohol abuse in adulthood is correlated
with a higher incidence of clinically diagnosed anxiety disorders and in
adolescent and adult populations, alcohol consumption is correlated with
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increased suicide risk (Pompili, Serafini et al.; Zilberman, Tavares et al. 2003;
Makhija and Sher 2007). Notably, women tend to be more sensitive to the effects
of alcohol and have a higher incidence of clinically diagnosed anxiety disorders
compared to men (Zilberman, Tavares et al. 2003; Becker, Monteggia et al.
2007). In corroboration with human studies, it has been shown in experimental
animals that EtOH exposure changes animal’s anxiety responses as well. In
adolescent rats, for example, EtOH exposure increased anxiety-like behaviors
without affecting performance in the retention based passive avoidance or novel
object exploration tasks, performance which is indicative of memory retention
abilities (Popovic, Caballero-Bleda et al. 2004). The link between increased risk
of mood disorders in human population and increased anxiety-like behaviors in
animals is substantiated by data showing EtOH induced alterations in
neuropeptides involved in modulating HPA axis, CRH and AVP in the
paraventricular nucleus of the hypothalamus (PVN), main brain region involved in
coordinating stress responses in mammals (Allen, Rivier et al.; Rivier, Bruhn et
al. 1984; Ogilvie and Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997;
Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Ogilvie,
Lee et al. 1998; Li, Kang et al. 2005). Together these data indicate that EtOH
exposure dysregulates proper functions of the HPA axis which dysregulation is
linked with developing mood disorders.
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Alcohol exposure during puberty and its long lasting effects
During puberty, EtOH exposure induces brain damage due to
inflammation and has long lasting effects on a variety of CNS structures,
including the mesolimbic dopaminergic and glutaminergic system (Pascual, Boix
et al. 2009), hippocampus, and cerebellum (Pascual, Blanco et al. 2007). Such
changes in the CNS are often manifested by altered adult behaviour patterns
(Maldonado-Devincci, Badanich et al.; Slawecki, Thorsell et al. 2004; Pascual,
Blanco et al. 2007; Pascual, Boix et al. 2009). For example, Pascual et al.
showed that 2 weeks of intermittent EtOH administration (single ip injection of
3.0 g/kg EtOH for two consecutive days, followed by 2 day rest, then followed
again by 2 days of EtOH injections) caused an increase in voluntary EtOH
consumption in adult rats (Pascual, Boix et al. 2009). In a different study, they
also showed that this intermittent pattern of EtOH administration induced long
lasting deficits in learning ability, as discerned by a decreased number of correct
choices in conditional discrimination learning task, and a reduced ability to adapt
to a challenging environment in adulthood in a narrow beam task (Pascual,
Blanco et al. 2007). These data indicate that the developing adolescent brain is
extremely vulnerable to EtOH-induced toxicity and that effects of EtOH exposure
during puberty can be observed in adulthood.
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Summary
Binge alcohol abuse during adolescence is a fundamental heath concern
in the United States. Adolescence is a period during which extensive brain
maturation continues to occur, therefore, this high dose EtOH exposure during
this period can have detrimental effects on proper brain maturation. It has been
shown that EtOH exposure during puberty can cause brain damage and that
EtOH exposure during this phase of life has long lasting effects on a variety of
CNS structures. These effects can be manifested by changes in adult
behavioural responses.
One of the systems that undergo extensive plasticity during pubertal
development is the HPA axis responsible for coordinating stress responses.
Dysregulation of the proper responses of this system, i.e. abnormal brain
expression of neuropeptides involved in modulating stress responses, CRH and
AVP and disrupted glucocorticoid signaling at the level of the PVN, results in
development of different types of mood disorders including anxiety, depression
and PTSD. In adulthood, alcohol abuse has been shown to be correlated with a
higher incidence of clinically diagnosed anxiety disorders and increased suicide
risk with women tending to be more sensitive to the effects of alcohol and have
higher incidence of clinically diagnosed anxiety disorders compared to men.
Even though the HPA axis changes during adolescence, consequences of binge
pattern of EtOH exposure during this time period on the development of the HPA
axis have not been investigated and have to be addressed in further research.
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Next Step in Alcohol Research: Consequences of adolescent binge alcohol
exposure and mechanisms involved.
It is well established that the HPA axis undergoes extensive maturation
during adolescent period (Romeo and McEwen 2006; McCormick and Mathews
2007; Evuarherhe, Leggett et al. 2009; Evuarherhe, Leggett et al. 2009).
Previous reports have indicated that adult CRH and AVP expressing neurons in
the PVN are modulated by EtOH exposure (Rivier, Bruhn et al. 1984; Ogilvie and
Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Ogilvie, Lee et al.
1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Ogilvie, Lee et al. 1998;
Li, Kang et al. 2005) and that there are sex differences in the responsiveness of
adult HPA axis to stress and EtOH exposure (Sencar-Cupovic and Milkovic 1976;
Rivier 1993; Ogilvie and Rivier 1996; Ogilvie and Rivier 1997; Patchev, Hayashi
et al. 1999), In addition, it has been shown that pubertal binge like EtOH
exposure increased anxiety-like behaviors during this critical developmental time
period (Popovic, Caballero-Bleda et al. 2004). The long lasting consequences of
binge EtOH exposure on the development of the HPA axis have not been
investigated. The overall goal of these studies was to extend previous findings
performed in pubertal and adult animal models of EtOH exposure by elucidating
1) short term effects of binge EtOH exposure during peri-pubertal period on the
expression of CRH and AVP mRNA in the PVN and plasma CORT levels, 2)
molecular mechanisms involved in EtOH effects and observed sex differences in
the responsiveness of the HPA axis to EtOH exposure and 3) long lasting
neuroendocrine consequences of binge EtOH exposure during this critical time
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period on functioning of adult HPA axis as it has been shown that alcohol
consumption during adolescence is a fundamental heath concern and can have
detrimental effects on proper HPA axis maturation.

Hypothesis and Aims
One way to establish long lasting effects of binge EtOH exposure on
functioning of adult HPA axis is to measure CRH and AVP mRNA expression in
the PVN and circulating CORT levels in adult animals pre-exposed to binge
EtOH paradigm during peri-pubertal development but before we can establish
these long lasting effects of pubertal binge EtOH exposure, we have to verify if
binge EtOH exposure during peri-puberty alters CRH and AVP mRNA expression
in the PVN and what are possible mechanisms for these changes. In addition,
based on the previous adult data, I also have to investigate whether there are
sex differences in the responsiveness of adolescent HPA axis to EtOH exposure
and if yes, what are possible mechanisms for these differences. If I see changes
in pubertal HPA axis functioning after binge EtOH exposure, I can establish if
these changes result in long lasting perturbations of the HPA axis. Based on
previous data, I hypothesized that binge alcohol exposure during peri-pubertal
development results in a long lasting dysregulation of adult HPA axis caused by
permanent changes in the pubertal expression of the CRH and AVP mRNA
expression in the PVN which results from EtOH induced dysregulation of the
glucocorticoid negative feedback at the level of the hypothalamus (Fig. 1).
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Fig 1. Schematic representation of the proposed hypothesis. A. Normal functioning of
the HPA axis. Increased glucocorticoid (CORT) level exerts negative feedback to
decrease production and release of CRH and AVP from the hypothalamus. I hypothesize
that binge alcohol exposure during pubertal development results in a long lasting
dysregulation of adult HPA axis caused by permanent changes in the pubertal
expression of the CRH and AVP mRNA in the PVN which results from EtOH induced
dysregulation of the glucocorticoid negative feedback at the level of the hypothalamus
(B).
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The following Specific Aims were established in other to test this hypothesis:
Aim 1. Short term effects of binge EtOH exposure during peri-puberty.
It is well established that adult EtOH exposure alters gene expression of
CRH and AVP in the PVN and that there are sex differences in the
responsiveness of adult HPA axis to EtOH exposures (Rivier 1993; Ogilvie and
Rivier 1996; Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Ogilvie and Rivier
1997; Li, Kang et al. 2005). However, the effects of EtOH exposure during
puberty on the central regulators of the HPA axis, CRH and AVP remain
unknown. In this aim I answered following questions:
1) Does binge EtOH exposure during peri-puberty change the PVN
expression of stress regulated neuropeptides, CRH and AVP during this time
period?
2) Are there sex differences in the responsiveness of peri-pubertal HPA
axis to binge EtOH exposure?
3) If there are sex differences in the responsiveness of pubertal HPA axis
to binge EtOH exposure, is 17β-estradiol responsible for these sex differences?
In order to answer these questions, peri-pubertal male and female rats
were subjected to binge EtOH exposure paradigm 1.0 h after the last EtOH
treatment, animals were sacrificed and blood and brains were collected. Plasma
was isolated from the blood and used for measurements of blood EtOH
concentrations (BAC) and hormone levels. Brains were rapidly frozen, specific
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nuclei were microdisected and RNA was isolated. Quantitative real time reverse
transcription-polymerase chain reaction (qRT-PCR) was used to measure
changes in the mRNA expression in these brain nuclei. See Chapter 2 Results
section and Chapter 7, General Methods section, for detailed description of
experimental design and specific methods used for each specific experiment
performed in this aim.
In summary, my data showed that repeated binge, but not acute binge,
EtOH exposure in peri-puberty increased the PVN expression of CRH and AVP
mRNA but this effect was observed only in males. EtOH exposure had no effects
on the CRH and AVP mRNA expression in peri-pubertal females indicating clear
sex difference in the responsiveness of pubertal HPA axis to binge EtOH
exposure. Further, the data showed that 17β-estradiol (E2) is partially responsible
for observed sex differences but it is not the only factor involved.
Aim 2. Molecular mechanism involved in EtOH effects in the PVN and
observed sex differences in the CRH expression after EtOH exposure.
Binge EtOH exposure increased CRH mRNA levels in the PVN and
plasma CORT levels in peri-pubertal male rats (Przybycien-Szymanska, Rao et
al. 2009) which is indicative of disrupted negative feedback that should be
exerted by glucocorticoids at the level of the PVN in an undisturbed situation. In
addition, in studies with ovariectomized females, I have shown that E2 is partially
responsible for observed sex differences in the responsiveness of the HPA axis
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to EtOH exposures (Chapter 4); however, the molecular mechanisms behind
these EtOH effects remain unknown. In this aim I answered following questions:
1) Does EtOH treatment directly regulate the activity of the CRH
promoter?
2) Does EtOH interfere with the glucocorticoid negative feedback that
should be normally exerted at the CRH promoter?
3) What specific sites on the CRH promoter are involved in EtOH effects?
4) Does 17β-estradiol (E2) treatment affect EtOH induced changes in the
activity of the CRH promoter?
In order to answer these questions, cells derived from rat PVN (IVB cell
line) were seeded and then transiently transfected with the wild type (WT) or
mutated CRH promoter. 24.0 h after transient transfections, cells were treated
with EtOH and after appropriate treatment time, dual luciferase reporter assay
was performed in order to measure changes in the promoter-luciferase activity
due to EtOH treatments. In addition, cells were treated with the same EtOH
treatment paradigms in the presence of 10 nM E2 and this was done in order to
investigate the role of E2 in sex specific effects of EtOH. See Chapters 3 and 4
Results section and Chapter 7, General Methods section, for detailed description
of experimental design and specific methods used for each specific experiment
performed in this aim.
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In summary, data presented in Chapter 3 showed that 12.5 and 100 mM
EtOH treatment exerts biphasic effects on the activity of the CRH promoter with
an initial decrease in the activity of the promoter at 0.5 h time point followed by
an increase in the activity at 2.0 h. Interestingly, at the 2.0 h time point even dose
as low as 12.5 mM induced an increase in CRH promoter activity. This effect was
blocked when cells were treated with EtOH in the presence of glucocorticoid
receptor (GR) antagonist and when portions of the negative glucocorticoid
response element (nGRE) site and the cAMP response element (CRE) site of the
CRH promoter were deleted. In addition, data presented in Chapter 4 showed
that in the presence of E2, EtOH did not change CRH promoter activity
supporting the role if E2 in mediating sexually dimorphic effects of EtOH.
Together, these data indicated that EtOH exerts direct effects on the activity of
the CRH promoter resulting in changes in CRH gene expression by interfering
with GR signaling at the level of the CRH promoter and that EtOH interaction with
E2 is partially responsible for observed sex differences.
Aim 3. Long lasting consequences of binge EtOH exposure during peripubertal development on functioning of adult HPA axis.
Previous data showed that pubertal EtOH exposure has long lasting
behavioral consequences marked by increased EtOH preference and impaired
learning in adult animals (Pascual, Blanco et al. 2007; Pascual, Boix et al. 2009).
I have shown that binge EtOH exposure in peri-pubertal male rats increased PVN
expression of CRH and AVP mRNA (Przybycien-Szymanska, Rao et al. 2009)
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and that EtOH induced dysregulation of normal negative GR feedback at the
level of the CRH promoter in the PVN cells is involved in these effects (Chapter
3). One main question that remains unanswered is whether these changes
observed in peri-puberty are long lasting and result in dysregulation of
functioning of adult HPA axis. In this aim, I answered the following questions:
1) Do changes observed during peri-puberty in the CRH and AVP mRNA
persists into adulthood?
2) Are adult animals prę-exposed to binge EtOH during peri-puberty more
sensitive to subsequent single EtOH exposure in adulthood?
3) Do adult animals pre-exposed to binge EtOH during peri-puberty
habituate to subsequent binge EtOH exposure in adulthood.
In order to answer these questions, peri-pubertal male rats were
treated either with saline or binge EtOH exposure and then allowed to reach
adulthood without any disturbances. In adulthood, these same animals were
further subdivided into saline, acute EtOH and binge EtOH treatment groups (see
Table 3 and General Methods of Chapter 7 for a detailed description) On the last
day of adult treatments, 1.0 h after the last EtOH exposure, animals were
sacrificed and blood and brains were collected. Plasma was isolated and used
for BAC and hormone measurements. Brains were rapidly frozen, sectioned on a
freezing microtome and PVN and SON were microdisected. Total mRNA was
isolated and then qRT-PCR was performed to measure changes in the gene
expression in these nuclei in all treatment groups. See Chapter 5 Results section
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and Chapter 7, General Methods section, for detailed description of experimental
design and specific methods used for each specific experiment performed in this
aim.
Data collected in these experiments showed that binge EtOH exposure
during peri-puberty resulted in long lasting changes in functioning of adult HPA
axis marked by increased basal expression of CRH mRNA in the PVN and lower
basal plasma CORT levels as compared to adult EtOH naïve rats. In addition,
these data showed that binge EtOH exposure during peri-puberty increased
sensitivity of adults to subsequent EtOH exposures as marked by enhanced
increase in plasma CORT levels after adult acute and binge EtOH exposure as
compared to adult EtOH naïve rats. In addition, at the level of the PVN, binge
EtOH exposure during peri-puberty caused a different pattern of the CRH and
AVP mRNA responses as compared to these animals that did not binge during
puberty. Together, these data clearly show that binge EtOH exposure did not
cause habituation of the HPA axis to subsequent binge EtOH exposure in
adulthood but, on the contrary, it increased the sensitivity of the HPA axis to adult
EtOH exposures. This indicates that binge EtOH exposure in adolescence may
potentially lead to increased risk for developing mood disorders in adulthood

CHAPTER TWO
BINGE-PATTERN ALCOHOL EXPOSURE DURING PUBERTY INDUCES
SEXUALLY DIMORPHIC CHANGES IN GENES REGULATING THE HPA AXIS
(PRZYBYCIEN-SZYMANSKA ET AL, AM J PHYSIOL. ENDOCRINOL METAB 298; E-320-E328, 2010)

Introduction
Alcohol abuse during adolescence is a growing fundamental heath
concern in the United States. According to the US Department of Health and
Human Services, boys on average have had their first drink before age 11, and
girls before age 13; with the overall statistics showing that 41% of teenagers
have had their first drink by age 14. Underage drinkers typically adopt a “binge”
pattern of alcohol consumption, defined by the National Institute on Alcohol
Abuse and Alcoholism as heavy, episodic drinking in which enough alcohol is
consumed in one sitting to bring the blood alcohol concentration (BAC) >0.08
g/100 g (White, Kraus et al. 2006). During adolescence, significant neural
remodeling occurs as evidenced by changes in cortical gray matter (Giedd,
Blumenthal et al. 1999; Paus, Zijdenbos et al. 1999; Lenroot and Giedd 2006),
neurogenesis (Raymond, Kucherepa et al. 2006), and increased synaptic
connectivity (Cunningham, Bohn et al. 1990; Woo, Pucak et al. 1997;
Cunningham, Bhattacharyya et al. 2002; Sisk and Zehr 2005), raising the
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possibility that alcohol consumption during this critical period can lead to longterm neurobiological and behavioral defects.
One neurological system that undergoes extensive plasticity during
pubertal development is the hypothalamo-pituitary-adrenal (HPA) axis (Romeo
2003; Romeo, Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen
2006). Under normal physiological conditions, an acute psychological or physical
stressor activates the HPA axis. Hypothalamic corticotrophin-releasing hormone
(CRH) stimulates adrenocorticotrophic hormone (ACTH) release from the
anterior pituitary, which, in turn, causes the release of adrenal glucocorticoids.
This sequence of events sets up a negative feedback system whereby increased
circulating glucocorticoid levels serve to inhibit the additional release of
hypothalamic CRH. Importantly, alcohol consumption can alter the expression of
genes involved in mediating the stress response of the HPA axis. For instance,
Rivier and Lee (Rivier and Lee 1996) demonstrated that acute ethanol (EtOH)
administration to adult rats increased the transcriptional activity of hypothalamic
CRH and arginine vasopressin (AVP) neurons, as measured by increased CRH
and AVP heteronuclear (hn) RNA following a single dose of EtOH. In addition,
the release of ACTH from the pituitary gland in response to EtOH was blocked
when CRH and AVP antagonists were used concomitantly (Rivier and Lee 1996).
These results show that acute EtOH exposure activates the HPA axis and the
effects of EtOH are likely mediated by both CRH and AVP.
AVP is a multifunctional neuropeptide critical for mediating both stress and
anxiety responses (Wigger, Sanchez et al. 2004; Egashira, Tanoue et al. 2007).
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First discovered as antidiuretic hormone, AVP is synthesized in the
paraventricular nucleus (PVN), supraoptic nucleus (SON), bed nucleus of stria
terminalis (BST), amygdala (AMY), and suprachiasmatic nucleus (SCN).
Neurons that synthesize AVP in the parvocellular division PVN project to the
median eminence and facilitate the synergistic actions of AVP and CRH following
stressful stimuli by enhancing ACTH and glucocorticoid release
(Dickstein, DeBold et al. 1996). Several lines of evidence suggest that acute or
chronic alcohol exposure might lead to increased displays of anxiety behavior.
Correlative studies have demonstrated that over 50% of patients with alcohol
dependency also have anxiety-related or depression-related psychiatric
disorders, and these types of disorders are often associated with an abnormal
stress response. Interestingly, female alcoholics have a higher incidence of
clinically diagnosed anxiety disorders compared with male alcoholics (Zilberman,
Tavares et al. 2003; Epstein, Fischer-Elber et al. 2007), possibly because of the
inherent sex differences in the stress responses of the HPA axis (Becker,
Monteggia et al. 2007; Handa, Zoeller et al. 2007). Furthermore, repeated
episodes of acute EtOH exposure increased anxiety behaviors in peri-pubertal
animals, as measured by increased latency to explore a novel object in the
retention-based passive avoidance task (Popovic, Caballero-Bleda et al. 2004).
Direct effects of EtOH on AVP gene expression in the hypothalamus is one
possible mechanism by which EtOH could alter anxiety behaviors, and, in fact,
acute EtOH administration has been shown to increase the amount of AVP
hnRNA in adult rats (Rivier and Lee 1996). Taken together, these studies show

38
that AVP is an important modulator of normal HPA axis function that can be
disrupted by alcohol exposure.
Our current understanding of how EtOH exposure, especially a binge
pattern of EtOH exposure, affects the brain during pubertal development is very
limited. In this study, we tested the hypothesis that a binge pattern of EtOH
exposure during pubertal development stimulates the stress response by
increasing circulating levels of corticosterone (CORT) and upregulating CRH and
AVP mRNA levels in the PVN of the hypothalamus in male and female rats. Our
results showed a striking sex difference in the response to binge EtOH exposure
for most parameters measured. Overall, the results from our study confirm that a
binge pattern of EtOH exposure during puberty significantly alters the expression
of genes important or regulating the HPA axis and might lead to a higher risk of
developing anxiety disorders in adulthood.

Results
General Approach
In order to investigate effects of EtOH exposure during puberty on
stress responsiveness of the HPA axis during this time period, peri-pubertal male
and female rats were treated either with saline, acute EtOH or binge EtOH
exposure between PND 37 and 44 or remained untreated during the course of
the experiment (see Fig 2). On the last day of treatments (PND 44), 1.0 h after
the last EtOH administration, animals were sacrificed and brains and trunk blood
were collected. Plasma was isolated and used for further hormone and blood

39
alcohol concentration (BAC) measurements. Brains were rapidly frozen,
sectioned on a freezing microtome and PVN and SON were microdissected for
CRH and AVP mRNA measurements using qRT-PCR (see Chapter 7, General
Methods section for detailed description).
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Binge Exposure Paradigm During
Puberty
PND 23

Arrival

30

Handling

37

40

42

44

Untreated : Handled 8 days
Saline
: Saline 8 days
Acute EtOH: Saline (ip) 7 days + 3g/kgEtOH (ip) 1 day
Binge EtOH: 3g/kgEtOH (ip) 3 days +
Saline (ip) 2 days +
3g/kgEtOH (ip) 3 days

Fig 2. Binge alcohol exposure paradigm employed in these studies.
After 1 week of acclimation period and 1 week of daily handling, animals were divided
into one of 4 groups and started following treatments: 1) UNTREATED 2) SALINE
ONLY (intraperitoneal (ip) saline injection once/day for 8 days), 3) ACUTE EtOH (saline
injection once/day for 7 days; one 3g/kg EtOH injection on day of sacrifice), 4) BINGE
EtOH (EtOH injections once/day for 3 days (3g/kg), saline injection once/day for 2 days,
EtOH injection once/day for 3 days). The same paradigm was used in all studies,
regardless of the age.
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Alcohol exposure had no effect on body weights
Body weight measurements were obtained every other day during the
duration of treatments in both males and females treated either with saline, acute
EtOH or binge EtOH or that remained untreated during the course of the
experiment (see Fig 2 and General Methods section in Chapter 7 for detailed
description of binge EtOH exposure paradigm).
Repeated measured mix AVOVA revealed that neither EtOH exposure
(acute or binge) nor saline injections caused males (Fig 3A) or females (Fig 3B)
to lose weight during the duration of treatments indicating that neither EtOH nor
stress inhibited growth of animals.
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Fig 3. Effects of ethanol treatment on body weight during pubertal development (post
natal day (PND) 37-44). Mean body weights of male (A) and female (B) animals
untreated or treated with daily IP injections of saline, saline + one day EtOH (acute), or
binge EtOH paradigm.
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In these experiments, EtOH exposure paradigm resulted in average blood
alcohol concentrations of 159.42 ± 14.38 and 143.92 ± 21.45 mg/dl in males and
females (Fig 4), respectively. Acute (singe dose) EtOH exposure resulted in BAC
of 146.91 ± 8.69 and 230.4 ± 36 mg/dl in males and females (Fig 4), respectively
and in both cases the values were significantly different from BAC in untreated
and saline groups (below the limit of detection, p<0.001). These values are
consistent with the defined BAC threshold of binge drinking.
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Fig 4. Effects of EtOH treatments on blood alcohol levels in male and female rats. Blood
alcohol concentrations (BAC) 1.0 h post-injection in males (A) and females (B) treated
with saline, acute EtOH or binge EtOH. Data expressed as mean EtOH mg/dl. *
indicates statistically significant difference compared to untreated control (P < 0.05).
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Binge alcohol exposure decreased testosterone levels in males but did not
change estradiol levels in females.
To determine the effects of binge EtOH exposure during puberty on
gonadal steroid hormone levels, T and E2 were measured on the last day of
treatments (see Chapter 7, General Methods section for detailed description of
hormone measurements). In males, binge, but not acute, EtOH exposure
significantly decreased T levels in the plasma (Fig 5A; p<0.001) compared to
untreated and saline groups. T levels were 463.84 ± 43.54 pg/ml in untreated,
435.35 ± 31.13 pg/ml in saline, 391.27 ± 55.42 pg/ml in acute EtOH and 264.88 ±
58.59 pg/ml in binge EtOH groups. On the other hand, neither of the EtOH
treatments changed the E2 levels in females (Fig 5B). The values were 22.91 ±
3.74 pg/ml, 24.76 ± 4.84 pg/ml, 25.34 ± 7.11 pg/ml and 19.25 ± 2.95 pg/ml in
untreated, saline, acute EtOH and binge EtOH groups, respectively. Even though
there was no change in E2 level due to treatments, levels observed in females
indicate that pubertal transition was initiated (Andrews, Advis et al. 1980; Sisk,
Richardson et al. 2001). Since the E2 level did not increase beyond the level
required for the occurrence of the first proestrus (Andrews, Advis et al. 1980) ,
females in our experiments did not start regular cycling.
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Fig 5. Effects of EtOH treatment on gonadal steroid hormone levels. Plasma
concentrations of (A) testosterone [T] and (B) estradiol [E2] 1.0 h after IP injection of
saline, acute EtOH or binge EtOH treatments. Untreated animals received no injection.
Data expressed as T or E2 pg/ml. * indicates statistically significant difference compared
to untreated control (P < 0.05).
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Effects of acute and binge alcohol exposure on circulating CORT levels.
To determine circulating CORT levels on the last day of treatments, I
measured plasma CORT levels using RIA (see Chapter 7, General Methods
section for detailed description of hormone measurements). In males and
females, acute and binge EtOH exposure significantly increased plasma CORT
levels (Fig 6). In males, CORT levels in acute and binge EtOH groups were
88.62 ± 12.65 pg/ml and 44.83 ± 11.66 ng/ml, respectively. Those values were
significantly higher than values measured in untreated and saline groups (2.19 ±
0.58 ng/ml and 5.82 ± 1.4 ng/ml, respectively; p<0.001) (Fig 6A). However,
CORT levels between the two EtOH groups were also significantly different with
the binge group having 50% lower CORT levels compared with acute EtOH
group (P<0.05) (Fig 6A).
As in males, both acute and binge EtOH exposures significantly increased
plasma CORT levels in females (Fig 6B; p<0.001). In acute and binge EtOH
exposure groups CORT levels were 469.67 ± 11.74 ng/ml and 365.04 ± 19.63
ng/ml, respectively which were significantly different from values measured in
untreated and saline groups (0.05 ± 0.05 ng/ml and 66.89 ± 29.64 ng/ml,
respectively) (Fig 6B). As in males, binge EtOH exposure significantly decreased
CORT level compared to acute EtOH exposure (p<0.001). in addition, females
had significantly higher plasma CORT levels compared to males after EtOH
exposure (Fig 6B, p<0.001).
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Fig 6. Effects of EtOH treatments on blood corticosterone levels in male and female rats.
Plasma corticosterone (CORT) levels in males (A) and females (B) 1.0 h after IP
injection of saline, acute, or binge EtOH treatments. Untreated animals received no
injection. Data expressed as mean CORT ng/ml of blood. * indicate statistically
significant difference compared to untreated and saline controls; # indicated significant
difference compared to acute EtOH (P < 0.05).
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Binge alcohol exposure changes the expression of CRH and AVP in the PVN in
males but not in females.
In order to investigate the effects of EtOH exposure during puberty on the
expression of genes involved in stress and anxiety responses in males and
females (see Chapter 7, General Methods section for detailed description), CRH
and AVP mRNA expression was measured using qRT-PCR. No significant
differences were observed between untreated and saline control groups in either
of the sexes (Fig 7). Only binge, and not acute, EtOH exposure significantly
increased the expression of CRH (Fig 7A, p < 0.05) and AVP mRNA (Fig 7B, p <
0.05) in the male PVN. The expression of CRH and AVP mRNA in acute EtOH
exposure group was the same as in the saline group indicating that the effect
observed in the binge EtOH group is due to repeated EtOH exposure.
On the other hand, there were no significant differences among treatment
groups in the expression of CRH and AVP mRNA in the PVN of female rats (Fig
7C, D) which indicates a sex difference in responsiveness of peri-pubertal HPA
axis to EtOH exposures.
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Male

Female

Fig 7. Effects of EtOH treatments on CRH and AVP gene expression in the PVN of male
and female rats. CRH and AVP mRNA expression in the PVN of peri-pubertal male (A
and B, respectively) and female (C and D, respectively) rats treated with saline, acute, or
binge EtOH. Data expressed as mRNA copies/µg total RNA. * indicates statistically
significant difference compared to untreated control (P < 0.05).
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Alcohol exposure does not change the expression of AVP in the SON
In order to confirm that the observed changes in the expression of AVP
mRNA in PVN of male rats were not exclusively due to the reported diuretic
effect of EtOH, I measured the expression of the AVP mRNA in the SON, region
of the brain involved in controlling water balance. There were no differences in
the expression of AVP mRNA in the SON either in males (Fig 8A, p = 0.319) or in
females (Fig 8B, p = 0.652) suggesting that the change in the AVP mRNA
observed in the PVN reflected change in the population of AVP-expressing cells
responsible for mediating stress and anxiety.
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Fig 8. Effects of EtOH treatments on AVP gene expression in the SON of male and
female rats. AVP mRNA expression in SON of peri-pubertal male (A) and female (B) rats
treated with saline, acute, or binge EtOH. Data expressed as AVP mRNA copies/µg total
RNA.
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Discussion
Our current understanding of how alcohol consumption affects the
developing postnatal brain is severely limited. To date, specific molecular and
neuroendocrine markers that are activated by alcohol during puberty have not
been identified. Elucidating the neurobiological targets of alcohol resulting from a
binge pattern of consumption during adolescence is critical for understanding the
long-term behavioral consequences and potential development of mental health
disorders. Therefore, the goal of this study was to investigate the effects of
binge-pattern EtOH exposure during puberty on the expression of specific
neuroendocrine factors that mediate stress and anxiety, including CRH and AVP.
My data reveal the novel findings that peri-pubertal binge-pattern, but not acute,
EtOH exposure increased the expression of CRH and AVP mRNA in the PVN of
peri-pubertal male rats, yet had no effect in peri-pubertal females (Fig 9). Data
presented here indicate that the effects of alcohol on the HPA axis are sexspecific and dependent on repeated high-dose exposures. Moreover, CORT
levels were increased significantly in response to both acute and binge EtOH
exposure paradigms (Fig 9), suggesting that EtOH is a potent activator of the
HPA axis during pubertal development. Notably, there was no sex difference in
the CORT response to EtOH, and, under binge-pattern exposure conditions, the
animals appeared to habituate to the effects of the stressor. Last, we have shown
that binge-pattern EtOH exposure decreased sex steroid hormone levels in male,
but not female, rats and that the observed effects of EtOH on AVP gene
expression were unlikely because of the diuretic effects of EtOH but, instead,
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probably specific for the population of AVP-expressing neurons that regulate
stress and anxiety.
Acute and binge-pattern EtOH exposure increased plasma CORT levels in
our study, confirming previous reports that EtOH is a potent activator of the
stress response in adults. Ogilvie and Rivier (1997) showed that acute EtOH
administration increased CORT levels which peaked at 15 min. post EtOH
injection and were sustained until 1.0 h after the injection (Ogilvie and Rivier
1997). However, I showed that plasma CORT levels in the binge EtOH groups
were significantly lower compared to the acute EtOH exposure groups,
suggesting that the HPA axis habituated to the stressful stimuli of multiple doses
of EtOH. Also, females had higher plasma CORT levels after EtOH exposure
compared with males, indicating that females were more sensitive to EtOH
administration than males. These data are in agreement with multiple studies
demonstrating that there are gender differences in responsiveness to alcohol,
with females tending to achieve higher CORT levels compared with males given
the same dose of EtOH (Rivier 1993; Ogilvie and Rivier 1996).
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SUMMARY: Effects of binge alcohol exposure in puberty
Males (PND 37-44):
-

Repeated binge EtOH exposure INCREASED CRH and AVP mRNA in the PVN

-

Both acute and repeated binge EtOH exposures INCREASED plasma CORT
levels, habituation effect after repeated binge EtOH exposure present

Females (PND 37-44)
-

NO CHANGES in the CRH and AVP mRNA in the PVN dure to treatmnets

-

Both acute and repeated binge EtOH exposures INCREASED plasma CORT
levels, habituation effect after repeated binge EtOH exposure present

EtOH

A

EtOH

B

PVN

PVN
No change

↑ CRH, AVP

CRH, AVP

Anterior pituitary gland
ACTH
Adrenal cortex

Anterior pituitary gland

_
ACTH
Adrenal cortex

↑ CORT
Body organs

_

↑ CORT
Body organs

Fig 9. Summary of results described in Chapter 2. In males (A) binge EtOH exposure ↑
CRH and AVP mRNA in the PVN and ↑ plasma CORT levels. In females (B), binge
EtOH exposure did not induce changes in the CRH and AVP mRNA in the PVN but ↑
plasma CORT levels. These data indicate that glucocorticoid (CORT) negative feedback
is dysregulated in both males and females but mechanisms behind these effects are
different.
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Acute EtOH consumption, chronic EtOH consumption, and withdrawal
from EtOH dependency have all been associated with dysregulation of the HPA
axis in adults at multiple levels including hypothalamic CRH and AVP systems.
CRH and AVP neurons in the PVN are required for some of the effects of EtOH
(Rivier, Bruhn et al. 1984; Hoffman and Dave 1991; Rivier 1993; Ogilvie and
Rivier 1996; Rivier and Lee 1996; Rivier, Rivier et al. 1996; Ogilvie, Lee et al.
1997; Ogilvie, Lee et al. 1997; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998;
Silva, Paula-Barbosa et al. 2002; Li, Kang et al. 2005). For instance, studies in
adult rats have shown that acute alcohol administration increased circulating
levels of ACTH (Rivier, Bruhn et al. 1984). This effect was dependent on the
synergistic action of CRH and AVP, since pharmacological antagonism of the
CRH and AVP receptors abolished the response (Rivier, Rivier et al. 1984;
Rivier, Rivier et al. 1984; Ogilvie, Lee et al. 1997). Similarly, chronic alcohol
treatment resulted in a 33% decrease in the number of AVP-expressing neurons
in the SCN (Madeira, Andrade et al. 1997) and altered the diurnal rhythm in
circulating glucocorticoids (Tabakoff, Jafee et al. 1978). AVP neurons in the SCN
convey circadian information to the PVN and other extrahypothalamic brain
nuclei. Moreover, the circadian expression of AVP in the SCN modulates the
diurnal rhythm of circulating glucocorticoids (Isobe and Isobe 1998). Our data
showing that EtOH administration alters CRH and AVP mRNA in peri-pubertal
male rats are consistent with the observations in adult animals. Notably, in our
study, a single dose of acute EtOH failed to increase CRH and AVP mRNA in the
PVN despite inducing a dramatic increase in circulating CORT levels. These data

57
suggest that the EtOH-induced upregulation of these genes occurs as a result of
repeated EtOH exposure, as would be achieved with a binge pattern of alcohol
consumption. It remains to be determined whether there are long-lasting
behavioral or physiological deficiencies associated with these changes in gene
expression. Nevertheless, there is a growing body of evidence to suggest that
neurite remodeling, neurogenesis, and synaptic connectivity are prominent
developmental events during puberty (Sisk and Zehr 2005). Accordingly, it is
logical to assume that repeated and excessive alcohol use during this critical
stage of development could lead to permanent alterations in the morphological
and/or neurochemical circuitry that might be organized during this time. These
changes could, in turn, have negative consequences on normal adult behavior
patterns, since brain morphology and neurochemistry are intimately linked with
behavior.
The neuropeptide AVP is a compelling candidate for mediating the
underlying neuroendocrine basis of the sexually dimorphic effects of alcohol.
First, central release of AVP from the PVN, BST, and AMY mediates a broad
range of social behaviors and participates in modulation of the stress response.
In both males and females, AVP augments the stress response by acting
synergistically with CRH, which can be altered by a variety of factors, including
gonadal steroid hormones and alcohol (Handa, Corbier et al. 1985; McCarthy,
McDonald et al. 1996; Albeck, McKittrick et al. 1997; Erkut, Pool et al. 1998;
Engelmann, Wotjak et al. 2000; Blanchard, Griebel et al. 2005; Ring, Malberg et
al. 2006). Moreover, AVP and the AVP receptors are differentially regulated by
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gonadal steroid hormones in a sex- and age-dependent manner (Sladek,
Swenson et al. 2000; Bale, Davis et al. 2001; Quadros, Pfau et al. 2002; Yue,
Mutsuga et al. 2006; Pak, Chung et al. 2009). For example, AVP expression in
the BST is greater in males than females (Miller, Vician et al. 1989), and this sex
difference is abolished by castration and restored with testosterone replacement,
an effect that is accomplished mainly by testosterone-derived 17β-estradiol (Han
and De Vries 2003). To date, little is known about the maturation of the central
AVP system, including the temporal, sex-specific, and hormonal influences that
occur during pubertal development. Previously, we showed that AVP mRNA
expression in the BST and AMY was differentially regulated in pre- and postpubertal animals (Pak, Chung et al. 2009). Here, we have demonstrated
prominent sex-dependent effects of binge-pattern EtOH administration on AVP
mRNA levels during the pubertal transition. Our study showed that, in males,
there was a significant increase in AVP mRNA following binge-pattern, but not
acute, EtOH administration. Conversely, there were no effects on AVP in females
using the same binge-pattern paradigm. It is important to note that, although the
binge-pattern EtOH treatments significantly reduced testosterone levels, there
was no effect on estradiol levels, suggesting that the EtOH effects on gonadal
steroid hormones alone are not sufficient to explain these sex differences.
Developmental changes in HPA axis reactivity have been well
documented. Most striking is the observation that CORT and ACTH levels take
much longer to return to baseline in juvenile compared with adult animals
subjected to a variety of stressful stimuli (Vazquez and Akil 1993; Romeo, Bellani
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et al. 2006). It is well known that males and females achieve sexual maturity at
different rates with respect to reproductive function, but whether there are sex
differences in the rate of HPA axis maturation during puberty is unknown. The
majority of studies investigating the maturation of the HPA axis during pubertal
development have focused strictly on comparisons between the pre- and postpubertal states, but not at time points in between (Romeo, Bellani et al. 2006).
However, one study in human adolescents showed that there were sex
differences in the cortisol response to a CRH challenge (Stroud, Papandonatos
et al. 2004). In general, girls achieved peak cortisol levels later and had a slower
return to baseline following a CRH challenge compared with boys (Stroud,
Papandonatos et al. 2004), a difference that persisted throughout all Tanner
stages of development. These data suggest that sex differences in HPA axis
reactivity might not necessarily be because of a differential timing in HPA axis
maturation between males and females but rather because of inherent
differences that are perhaps organized before pubertal onset. Recent evidence
from Evuarherhe and colleagues (Evuarherhe, Leggett et al. 2009; Evuarherhe,
Leggett et al. 2009) support this possibility. In their study, 17β-estradiol inhibited
the CORT-induced response to restraint stress in pre-pubertal female rats but
enhanced the response post-pubertal. Importantly, the adult response to restraint
stress in the presence of 17 β -estradiol was still enhanced regardless of whether
the animals were ovariectomized before, or following, puberty. These data
indicate that the maturation of the HPA axis in females might be programmed
before pubertal onset and that it is independent of circulating gonadal steroid
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hormones during pubertal development. At this time, there are no empirical data
to suggest that the HPA axis matures at different rates in males compared with
females, and, in fact, the evidence available from humans would predict that they
likely mature at similar rates. However, we cannot rule out the possibility that the
differences we observed might be because of discrepancies in the relative state
of HPA axis maturation between males and females. Nevertheless, our data
demonstrate a clear distinction between the effects of repeated EtOH exposure
during the pubertal transition that might lend some insight into the time course for
the development of the HPA axis between males and females. Furthermore, our
data have demonstrated that repeated EtOH exposure during the pubertal
transition results in a dysregulation of the HPA axis akin to that of a chronic
stressor in adults.
In this study, both males and females began receiving injection treatments
on day 37, which were completed on day 44, falling within the defined peripubertal period for both males and females (30–45 days of age; (Laviola, Adriani
et al. 2002)). In general, female rats undergo pubertal onset (as measured by
vaginal introitus) at 32–35 days of age, with regular estrous cyclicity and mature
ova first occurring between 43 and 47 days of age (Sisk, Richardson et al. 2001;
Sisk and Zehr 2005). Unlike females, in which puberty is defined as the 1st day
of vaginal introitus, males do not have a reliable external benchmark that defines
pubertal onset, since the commonly used external marker of preputial separation
is dependent upon increased testosterone levels. The binge pattern alcohol
exposure paradigm employed in our experiments did not inhibit feeding behavior
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or normal growth patterns that occur during pubertal development. Moreover, it
allowed us to distinguish the pharmacological effects of EtOH from the effects of
other nonspecific stressors, such as handling and injections. This binge EtOH
exposure paradigm has been previously shown to be reliable for testing the
effects of alcohol using an exposure pattern that is typical for adolescents
(Lauing, Himes et al. 2008). In addition, it has been show that the intraperitoneal
injection of EtOH, employed in our paradigm, does not result in significantly
different blood alcohol concentrations compared with oral gavage in adolescent
Wistar rats (Walker and Ehlers 2009).
Although it was not possible to separate the parvocellular and
magnocellular divisions of the PVN in our tissue punch sample preparations, we
are confident that the EtOH-induced changes in AVP expression accurately
reflect changes in the AVP-expressing neurons associated with regulation of the
HPA axis, and not in those responsible for osmoregulation for the following
reasons. First, we showed that there were no changes in the expression of the
AVP mRNA in the SON, a region where AVP is primarily responsible for
regulating fluid homeostasis. Second, there was no effect of EtOH in the acutetreated group, and, since fluid homeostasis is an immediate and not cumulative
physiological response, any diuretic effect of EtOH would have been observed in
the acutely treated groups. Third, if the effects of EtOH on AVP expression were
because of an osmoregulatory effect, we would have expected to see a
significant increase in the females, as well as the males. Finally, our data are in
agreement with previous studies showing that there were no changes in AVP

62
expression in the magnocellular division of the PVN 3.0 h after an acute EtOH
administration (Ogilvie, Lee et al. 1997).
Alcohol is a potent neurotoxic agent that induces widespread cell death in
the developing brain (Silva, Paula-Barbosa et al. 2002; Chu, Tong et al. 2007).
Exciting new data have revealed that AVP has an important neuroprotective role
in the PVN. Chen and colleagues (Chen, Volpi et al. 2008; Chen, Liu et al. 2009)
have shown that AVP prevented apoptosis in H32 cells, a cell line derived from
the PVN, following serum deprivation. These effects were mediated by mitogenactivated protein kinase activated Bad phosphorylation and by protein kinase Cα
and -β. These data raise the possibility that the physiological role of increased
AVP following binge EtOH exposure in males is, in part, to provide cellular
protection against repeated EtOH toxicity. In females, on the other hand, 17_estradiol is known to be neuroprotective in addition to playing roles in modulating
reproductive functions and anxiety responses (Cardona-Gomez, Mendez et al.
2001; Garcia-Segura, Azcoitia et al. 2001; Cunningham, Bhattacharyya et al.
2002; Huppenbauer, Tanzer et al. 2005; Bodo and Rissman 2006; DonCarlos,
Azcoitia et al. 2009). Our study showed that there was no increase in AVP mRNA
after binge EtOH exposure in females, possibly because there are different
mechanisms for neuroprotection in males compared with females.
Taken together, we have identified specific neuroendocrine targets of
EtOH in the adolescent hypothalamus following a binge pattern of EtOH
exposure. Furthermore, we have demonstrated that the effects of EtOH
administration on genes critical for the developing HPA axis are sex specific.
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Sexually dimorphic patterns of addictive behavior emerge during adolescence
and often persist in adulthood. Patterns of alcohol use during this developmental
time period can also lead to permanent changes in brain function that often
manifest in adulthood as psychological disorders, such as depression and
anxiety. Overall, these data have identified potential genes involved in increased
anxiety responses after EtOH exposure and might lead to a better understanding
of the mechanisms involved in increased prevalence of anxiety disorders in
females compared with males.

CHAPTER THREE

ALCOHOL DYSREGULATES CORTICOTROPHIN-RELEASING-HORMONE
(CRH) PROMOTER ACTIVITY BY INTERFERING WITH THE NEGATIVE
GLUCOCORTICOID RESPONSE ELEMENT (NGRE) SITE OF THE
PROMOTER

Introduction
Alcohol is a potent activator of the hypothalamo-pituitary adrenal (HPA)
axis, as manifested by immediate increases in circulating glucocorticoids
following exposure (Rivier, Bruhn et al. 1984; Rivier 1993; Ogilvie and Rivier
1996; Ogilvie and Rivier 1997; Ogilvie, Lee et al. 1998; Przybycien-Szymanska,
Rao et al. 2010). Moreover, alcoholics are significantly more likely to have
diagnosed mood disorders implicating alcohol as a potential endocrine disrupter
of the HPA axis (Pompili, Serafini et al.; Zilberman, Tavares et al. 2003).
Although the effects of alcohol on HPA function have been well described, our
understanding of the molecular mechanisms regulating alcohol effects on the
HPA axis remain poorly defined. Corticotrophin-releasing hormone (CRH)expressing neurons located in the paraventricular nucleus of the hypothalamus
(PVN) play a pivotal role in orchestrating the central stress response and proper
functioning of these neurons is critical for maintaining a homeostatic state
64
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following a stressful event. The HPA axis is a three-tiered biological system that
begins at the highest level with CRH release from the PVN potentiating the
release of adrenocorticotrophin hormone (ACTH) from the anterior pituitary
gland. ACTH acts, in turn, on the adrenal glands to increase theproduction and
release of glucocorticoid hormones (Papadimitriou and Priftis 2009).
Glucocorticoids (CORT) can then exert negative feedback on both the
hypothalamus and pituitary gland to decrease CRH and ACTH release,
respectively, allowing for a homeostatic state to be re-established (Figueiredo,
Bodie et al. 2003; Ostrander, Ulrich-Lai et al. 2006; Papadimitriou and Priftis
2009).
We previously demonstrated that binge-pattern alcohol exposure during
pubertal development increased both circulating plasma CORT levels and CRH
mRNA expression in the PVN (Przybycien-Szymanska, Rao et al. 2009),
suggesting that alcohol exposure disrupted normal glucocorticoid negative
feedback pathways. Glucocorticoid negative feedback is mediated, in part, by
the activation of glucocorticoid receptors (GR), which belong to the superfamily of
nuclear steroid receptors. Upon activation by glucocorticoids, GRs undergo
dimerization, translocate to the nucleus, and modulate gene transcription
(Goujon, Laye et al. 1997; Schulkin, Gold et al. 1998; Sapolsky, Romero et al.
2000; Morsink, Steenbergen et al. 2006). In the PVN, GRs are known to
decrease CRH gene transcription through signaling at the negative glucocorticoid
response element (nGRE), located between -249 and -278 nucleotides upstream
from the transcription start site of the CRH promoter (Fig 10). Overall,
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glucorticoids acting through GRs decrease CRH promoter activity thereby,
decreasing transcriptional activity of the promoter and decreasing CRH gene
expression.
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Fig. 10 Schematic model describing normal CRH promoter regulatopn. In the absence of
EtOH when activated GRs interact with nGRE to recruit specific coregulators (not
depicted in this diagram), they also prevent signaling at the CRE site of the CRH
promoter by CREB thereby decreasing the activity of this promoter and its gene
transcription. These interactions between the nGRE and CRE sites are required for
glucocorticoid mediated decrease in CRH promoter activity.
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Based on our previous observations that binge-pattern EtOH exposure in
pubertal rats increased CRH gene expression in the PVN (PrzybycienSzymanska, Rao et al. 2009), we tested the hypothesis that ethanol (EtOH)
increases CRH gene expression by directly interfering with glucocorticoid
negative feedback at the level of the CRH promoter. The overall goals of this
study were to determine if 1) EtOH directly modulates CRH promoter activity and
2), to identify a putative site of action for EtOH on the CRH promoter. Overall, our
results showed that EtOH differentially modulated CRH promoter activity in a
time-dependent manner. Further, these effects were mediated, in part, through
the nGRE site on the CRH promoter. Taken together, our data provide strong
evidence that EtOH exposure directly disrupts GR:CRH signaling which, if occurs
during adolescence, may be detrimental for proper maturation of the HPA axis.

Results
General approach
In order to investigate molecular mechanisms involved in EtOH effects in
the PVN, CRH promoter activity was measured in PVN derived neuronal cell line
(IVB) after various EtOH treatments. The CRH promoter-luciferase construct was
transfected into the cells and 24.0 h after transfections cells were subjected to
different EtOH treatments. First, time course experiments using 12.5 and 100
mM dose of EtOH were performed in the wild type and mutated CRH promoter in
order to investigate temporal regulation of CRH promoter activity by EtOH and
direct sites on the CRH promoter involved in EtOH effects. Second, possible
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EtOH interactions with GR signaling were investigated in cells pre-treated with
GR antagonist and then treated with 100 mM EtOH for 0.5, 1.0, 2.0, or 4.0 h.
After each specific EtOH treatment regiment, CRH promoter activity was
measured using dual luciferase reporter assay. Also, GR expression in IVB cells
after EtOH treatments was measured using qRT-PCR.

100 mM EtOH treatment did not induce cell death.
We used a MTT assay to determine whether our highest dose of EtOH
treatment (100 mM) induced cell death in our IVB cell line. The results showed
that EtOH treatment had a significant effect on cell viability (F(4,10) = 3.495,
p=0.049, N = 3, Fig. 11). Contrary to what would be expected, EtOH did not
decrease cell viability at any time point measured, rather, it increased
mitochondrial activity at 4.0 h time point.
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Fig 11. Effects of 100 mM EtOH treatment on cell viability in a neuronal cell line.
Mitochondrial activity was measured in IVB cell line after 0.5, 1.0, 2.0 and 4.0 h of 100
mM EtOH treatment. Data expressed as % change of mitochondrial activity relative to
vehicle (10% FBS media) treated controls. Dissimilar letters indicate statistically
significant difference. More specifically a is different from b but is not different from other
a (P < 0.05)
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EtOH treatment altered CRH promoter activity in a time- dependent manner.
To determine whether EtOH alters CRH promoter activity, we used an in
vitro reporter gene assay and added EtOH directly to the cell culture media (rat
PVN-derived cell line (IVB). Our results showed that treatment with 100 mM
EtOH had a biphasic effect on CRH promoter activity (F(4,28) = 15.331, p<0.001,
N = 6, Fig 12A). Notably, EtOH significantly decreased CRH promoter activity
after 0.5 h (p=0.002), whereas EtOH significantly increased the promoter activity
after 2.0 h (p=0.043). We then treated the cells with EtOH in the presence of a
glucocorticoid receptor antagonist (RU486) in order to ascertain whether EtOH
interacted with glucorcorticoid negative feedback mechanisms that influences
CRH promoter activity. Treatment with RU486 alone significantly decreased
baseline promoter activity. Importantly however, RU486 completely abolished the
EtOH-induced increase in CRH promoter activity observed after 2.0 h of EtOH
treatment, suggesting that EtOH might interact with glucocorticoid receptors to
alter CRH promoter activity. Interestingly, treatment with RU486 did not seem to
affect the EtOH-induced decrease in CRH promoter activity observed after 0.5 h
of EtOH treatment (Fig. 12B).
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Fig 12. Effects of EtOH treatment (A) and RU486 pre-treatment (B) on CRH promoter
activity in a neuronal cell line. CRH-luciferase activity was measured in IVB cell line after
treatment with 100 mM EtOH for 0.5, 1.0, 2.0 or 4.0 h or media alone (A, n=6) and after
16.0 h pretreatment with 100nM RU486 and 100 mM ETOH/100 nM RU486 cotreatment for 0.5, 1.0, 2.0 or 4.0 h (B, n=3). Data expressed as % change in luciferase
activity of vehicle treated WT control. Dissimilar letters indicate statistically significant
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difference between groups. For example, a is significantly different from b, c, d and d b;
b is different from a, c, ac, and so on (P < 0.05).

EtOH treatment did not have an effect on GR mRNA expression in IVB cells
It is possible that EtOH directly affects GR expression, thereby altering
CRH promoter activity. In order to test this we measured GR mRNA expression
in IVB cells following treatment with 100 mM EtOH for 0.5 or 2.0 h using qRTPCR. Our data revealed that there were no changes in GR mRNA expression in
IVB cells relative to baseline (F(4,47)=0.1.889, p=0.128) at any time point tested
(p=0.435 and p=0.082 for 0.5 and 2.0 h, respectively) (Fig 13).
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Fig 13. Effects of 0.5 h or 2.0 h EtOH treatment on the GR mRNA expression in IVB cell
line. GR mRNA expression in IVB cell was measured after treatment with 100 mM EtOH
for 0.5 or 2.0 h or vehicle. Data expressed as fold change in GR mRNA expression
calculated according to the standard ∆∆ct method.
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EtOH increased CRH promoter activity at 2.0 h time point at all concentrations
tested
The results obtained from initial experiments in Figure 12 demonstrated
that EtOH alters CRH promoter activity. The concentration used in those
experiments (100 mM) was based on previously published studies that used
EtOH treatment in a cell culture model system however, the physiological
relevance of this high concentration is questionable given that the blood alcohol
level corresponding to the legal limit for driving (0.08%) is equivalent to about 25
mM (Pickering, Wicher et al.; Blevins, Mirshahi et al. 1997; McAlhany, Miranda et
al. 1999; Li, Kang et al. 2005; Druse, Tajuddin et al. 2006; Lee, Tajuddin et al.
2009). Therefore, we tested CRH promoter activity in the presence of varying
concentrations of EtOH in order to establish the minimal effective dose. The
highest concentration of EtOH (100 mM) increased CRH promoter activity to the
same degree following 2.0 h of EtOH treatment as observed in the previous time
course experiments (Figs. 12A and 14). Surprisingly however, EtOH significantly
increased CRH promoter activity at all of the lower concentrations we tested
compared to vehicle treated control (F(4,45) = 2.665, p=0.044, N = 6, Fig 14).
Also, there was no dose response observed, suggesting that lowest 12.5 mM
concentration of EtOH is sufficient to elicit a maximal response of CRH promoter
activity. Thus, for all subsequent studies the 12.5 mM concentration of EtOH was
used in order to be consistent with concentrations that were more physiologically
relevant.
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Fig 14. Effects of 2.0 h EtOH treatment with different concentrations of EtOH on CRH
promoter activity. CRH-luciferase activity was measured in IVB cell line after treatment
with 12.5, 25.0, 50.0 and 100 mM EtOH for 2.0 h or media alone. Data expressed as %
change in luciferase activity from vehicle treated control. Dissimilar letters indicate
statistically significant difference between treatment groups. More specifically, a is
significantly different from b (P < 0.05).
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Validation of CRH promoter deletion mutants with forskolin treatment.
To verify specific sites of EtOH action at the level of the CRH promoter,
we sequentially deleted GR binding sites that are found within nGRE (see
diagram in Fig 15 and Chapter 7 General Methods section for detailed
description of methods used). In addition, we deleted a cAMP response element
(CRE) site which is required for increasing CRH promoter activity (Liu,
Kamitakahara et al. 2008). The CRE site has been implicated in EtOH effects at
the CRH promoter in studies that showed that 25 mM EtOH treatment exerted a
biphasic effect on the CRH promoter (a decrees at 0.5 h and an increase at 2.0 h
) and that the forskolin induced increase in CRH promoter activity was decreased
by EtOH treatment (Li, Kang et al. 2005).
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Fig 15. Schematic representation of the CRH promoter deletions used in these
experiments. Diagrams depict specific portions of the nGRE site deleted within this site
that is located between -249 and -278 bp upstream from the transcription imitation site
(arrow) on the CRH promoter and the CRE site deletion that is located -217 bp upstream
from the transcription site.
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Initially, in order to test validity of these mutants generated, cells
transfected with the WT or mutated CRH promoter were treated with 25 mM
forskolin for 6.0 h and the promoter activity was measured using dual luciferase
assay (see Chapter 7 General Methods section for detailed description of
methods used). Forskolin is a potent activator of the CRH promoter by increasing
cAMP levels and affecting signaling at the CRE site. As expected, forskolin
treatment significantly increased CRH promoter activity in all CRH promoter
constructs used except for the construct in which the CRE regulatory site was
deleted (N = 3, Fig. 16). These data indicate that the CRH promoter
manipulations did not render the promoter inactive and the constructs were
responding to forskolin stimulation as expected.
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Fig 16. Effects of Forskolin treatment on WT and mutated CRH promoter activity.
Luciferase activity was measured in IVB cell line after treatment with 25 µM Forskolin for
6.0h (blue) or vehicle (black) in WT CRH promoter or in a promoter lacking above
described regulatory sites. Data expressed as % change in luciferase activity of vehicle
treated control. Dissimilar letters indicate statistically significant difference between
groups. For example, a is significantly different from b, c, d, and e and so on (P < 0.05).
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Basal activity of the CRH promoter was changed after specific deletions.
One-way ANOVA indicated that the mutations had a significant effect on
basal (after vehicle treatment) CRH promoter activity (F(5, 39) = 28.118, p <
0.001, N = 6, Fig 16 black bars). Deletion of GR binding site 1 and 2 (CRH∆GR1
and CRH∆GR2) significantly increased basal CRH promoter activity (p<0.001,
Fig 15 black bars) and CRE site deletion (CRH∆CRE) significantly decreased
basal CRH promoter activity (Fig. 16 black bars, p = 0.023) as compared to
vehicle treated promoter constructs.

Deletion of GR binding sites within nGRE abolished alcohol induced increase in
CRH promoter activity at 2.0 h time point but did not prevent EtOH-induced
decrease at 0.5 h
In order to investigate possible mechanisms involved in EtOH induced
changes in CRH promoter activity, time course experiments with all the CRH
deletion mutants described above were performed (see Chapter 7 General
Methods section for detailed description of methods used). For the summary of
results see Table 1.
Similar to the 100 mM dose, 12.5 mM EtOH treatment induced biphasic
effects on the WT CRH promoter activity. These effects were altered in various
CRH promoter mutants. More specifically, one way AVOVA revealed an effect of
this EtOH treatment on CRH promoter activity (F(4,36)=7.619, p<0.001) and post
hoc tests showed that at 0.5 h there was a significant decrease (p<0.001) and at
2.0 h there was a significant increase (p=0.023) in CRH promoter activity due to
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12.5 mM EtOH treatment as compared to vehicle treated controls (Fig.17A). The
same effects were evident with 100 mM EtOH treatment. These results indicate
that regardless of the dose tested, EtOH exerted biphasic effects on CRH
promoter activity.
GR 1 and 2 deletions did not alter EtOH induced decreases in promoter
activity but abolished an increase at 2.0 h. Notably, in these mutants EtOH
treatment for 4.0 h increased the promoter activity. In the CRH∆GR1 mutant, one
way ANOVA showed an effect of EtOH treatment (F(4,31)=8.144, p<0.001) and
post hoc analysis showed that at 0.5 and 1.0 h time point there was a significant
decrease in promoter activity (p=0.003 and 0.004, respectively, Fig 17B), an
increase in CRH promoter activity was abolished at a 2.0 h time point but it was
present at 4.0 h after 12.5 mM EtOH treatment (p=0.015). A similar trend was
observed in the CRH∆GR2 mutant. One way ANOVA showed an effect of EtOH
treatment (F(4,30)=4.826, p<0..001) and post hoc tests revealed that at 1.0 h
post EtOH treatment there was a significant decrease in the promoter activity
(Fig 17C, p=0.024). An increase was abolished at 2.0 h but present at 4.0 h time
point (Fig 17C, p=0.002) as compared to vehicle treated control.
A different pattern of responses was observed in the CRH∆GR3 mutant.
Even though one way ANOVA showed an effect of EtOH treatment on the CRH
promoter (F(4,37)=3.465, p=0.017), in this mutant, EtOH induced changes in
CRH promoter activity relative to the vehicle treated group were abolished (Fig.
17E). In this mutant, CRH promoter activity was significantly increased at the 4.0
h time point as compare to the 0.5 and 2.0 h time point (p=0.018 and p=0.023,
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respectively). These data indicate that even though the CRH∆GR3 mutant still
exhibits dynamic changes after EtOH treatment, EtOH induced decrease and
increase in CRH promoter activity relative to vehicle treatment were abolished.
These data show that this site is important for EtOH modulation of the CRH
promoter, especially for a decrease in the promoter activity.
The time course data in a CRH∆GR1/2 mutant further supports the role of
the GR binding site 3 in an EtOH induced decrease in CRH promoter activity. In
this mutant, having only GR binding site 3 site of the nGRE intact, a decrease in
CRH promoter activity was still present (Fig. 17D). One way ANOVA revealed
that 12.5 mM EtOH treatment had a significant effect on CRH promoter activity in
this mutant (F(4,29)=3.108, p=0.03). Post hoc analysis showed that at 0.5 h post
EtOH treatment CRH promoter activity was significantly decreased as compared
to vehicle treated control (p=0.01). An increase in the promoter activity in this
mutant was completely abolished.
Interestingly, even though basal promoter activity was significantly
decreased, in the CRH∆CRE mutant, a slight decrease in the promoter activity
was still observed at the 0.5 h time point (Fig 17F). One way ANOVA showed
that EtOH exerted a significant effect on CRH promoter activity in this mutant
(F(4.19)=2.897, p=0.05). Post hoc analysis showed that EtOH significantly
decreased the promoter activity at 0.5 h time point (p=0.046) but completely
abolished an increase in the promoter activity at the later time points.
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Fig 17. Effects of EtOH treatment on WT and mutated CRH promoter reactivity.
Luciferase activity was measured in IVB cell line after treatment with 12.5 mM EtOH for
0.5, 1.0, 2.0 or 4.0 h or vehicle in A) WT CRH promoter, B) promoter lacking GR binding
site 1 (CRH∆GR1), C) GR binding site 2 (CRH∆GR2), D) GR binding site 1 and 2
(CRH∆GR1/2); E) GR binding site 3 (CRH∆GR3), or F) CRE site (CRH∆CRE). Data
expressed as % change in luciferase activity from vehicle treated control. Dissimilar
letters indicate statistically significant difference between groups. More specifically a is
significantly different from b and c; ab is the not different from a or b but is different from
c and so on (P < 0.05).
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SUMMARY: Effects of alcohol on CRH promoter activity in vitro
-

12.5 and 100 mM EtOH ↓ CRH promoter activity at 0.5 h

-

12.5 and 100 mM EtOH ↑ CRH promoter activity at 2.0 h

-

An increase in the promoter activity due to EtOH is dependant on the nGRE and
CRE sites

CRH
Promoter
Construct

Basal
activity of
the
promoter
(vehicle)
relative to
WT
promoter
activity
(100%)

Promoter
activity at
0.5 h
relative to
basal
promoter
activity

Promoter
activity at
1.0 h
relative to
basal
promoter
activity

Promoter
activity at
2.0 h
relative to
basal
promoter
activity

Promoter
activity at
0.4 h
relative to
basal
promoter
activity

WT CRH

100%

↓

-

↑

-

CRH∆GR1

↓

↓
↓

-

CRH∆GR2

↑
↑

-

↑
↑

CRH∆GR3
CRH∆GR1/2

-

-

-

-

-

CRH∆CRE

↓

-

-

-

-

↓
↓

Table 1. Summary of EtOH induced effects in different CRH promoter constructs,
Arrows indicate relative relationships in the promoter activity as compared to vehicle
treated construct, red = increase and green = decrease. Basal activity of different
mutants is compared to activity of the WT vehicle treated CRH promoter.
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Discussion
The goal of this study was to investigate in vitro the molecular
mechanisms involved in alcohol induced increase in the CRH gene expression
observed previously in the PVN of male rats. We tested the hypothesis that
alcohol increases CRH mRNA expression in the PVN by directly interfering with
negative glucocorticoid feedback at the level of the CRH promoter. Our data
clearly show that in vitro EtOH treatment directly influences CRH promoter
activity and that an increase in the promoter activity observed at 2.0 h is
mediated via EtOH-GR signaling interaction at the nGRE site and its possible
interactions with the signaling at the CRE site of the CRH promoter.
When activated GRs interact with nGRE to recruit specific coregulators,
they also prevent signaling at the CRE site of the CRH promoter by CREB,
decreasing the activity of this promoter and its transcription. It has been shown
that interaction between the nGRE and CRE sites is required for normal
glucocorticoid mediated decrease in CRH promoter activity (King, Smith et al.
2002), Fig 17A). Based on my data, I propose that in the presence of EtOH, GRCRH DNA interaction at the nGRE site is blocked allowing for free access of
phosphorylated CREB (pCREB) to the CRE site and activation of CRH promoter
(Fig 17B) which will then result in increased gene transcription and CRH mRNA
expression that has been previously observed in vivo (Rivier and Lee 1996;
Ogilvie, Lee et al. 1997; Ogilvie, Lee et al. 1998; Li, Kang et al. 2005; PrzybycienSzymanska, Rao et al. 2009).
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cAMP

A

CREB

GR GR

5’

3’
CRH gene

CRH promoter
nGRE CRE

cAMP

B

GR GR

EtOH

p CREB

5’

3’
CRH gene

CRH promoter
nGRE CRE

Fig. 18. Schematic model describing EtOH effects on the CRH promoter. A. In the
absence of EtOH when activated GRs interact with nGRE to recruit specific coregulators
(not depicted in this diagram), they also prevent signaling at the CRE site of the CRH
promoter by CREB thereby decreasing the activity of this promoter and its gene
transcription. These interactions between the nGRE and CRE sites are required for
glucocorticoid mediated decrease in CRH promoter activity. It is possible that at 0.5 h
EtOH treatment this mechanism is enhanced through yet un identypied mechanisms. B.
If EtOH treatment is prolonged, GR-CRH DNA interaction at the nGRE site is blocked
allowing for free access of phosphorylated CREB (pCREB) to the CRE site and
activation of the CRH promoter witch will then result in increased gene transcription.
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This conclusion is substantiated but the following data: 1) EtOH directly
modulated CRH promoter activity in PVN derived neuronal cell line; 2) GR
antagonist (RU486) abolished EtOH induced increase in CRH promoter activity
observed at 2.0 h and 3) deletion of either of the specific GR binding sites within
the nGRE site prevented EtOH induced increase in the promoter activity. These
data support my hypothesis that alcohol modulates CRH mRNA expression in
the PVN by directly interfering with negative glucocorticoid feedback exerted at
the level of the CRH promoter. A direct effect of EtOH at the CRH promoter is
further substantiated by data showing no changes in GR expression upon EtOH
treatment in IVB cells.
This conclusion is consistent with previous in vivo reports showing that
chronic EtOH treatment and withdrawal modulated GRE-DNA binding in rat
cortex and hippocampus. Chronic alcohol diet (15 days) decreased GRE- DNA
binding in the cortex and hippocampus as measured by chromatin
immunoprecipitation assay (ChIP) but 24.0 h withdrawal returned GRE-DNA
binding levels back to basal levels only in hippocampus; in the cortex GRE-DNA
binding levels remained decreased (Roy, Mittal et al. 2002). Our in vitro data
show that deletion of portions of nGRE site on the CRH promoter and GR
antagonist treatment abolished EtOH induced changes in the promoter activity.
Based on these data, it is likely that alcohol affects GR protein binding at the
GRE site of the CRH promoter but additional experiments verifying GRE-DNA
binding of GR at the CRH promoter in the presence and absence of EtOH need
to be performed in order to further verify this hypothesis.
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Contrary to the results obtained by Roy, et al., we did not observe any
EtOH-mediated changes in GR mRNA expression. One possibility is that GR
protein levels change with chronic, as opposed to acute, EtOH treatment,
although Spencer and McEwan (1990) also noted that there were no changes in
cytosolic fractions of mineralocorticoid receptor (MR) or GR following chronic
EtOH treatment in the brains of adult rats (Spencer and McEwen 1990). By
contrast, Little at al., (2008) showed that chronic EtOH treatment (28 week, liquid
diet) and 2 week withdrawal increased nuclear GR protein but did not change the
cytosolic GR protein levels in the prefrontal cortex of male C57BL mice (Little,
Croft et al. 2008). In our study we measured GR mRNA and not protein due to
the short time course of EtOH treatment, but the above cited studies raise the
possibility that EtOH might directly target nuclear GR protein for degradation or
alter translational processing of GR mRNA.
There are several other possibilities that might explain our divergent
results. First, it is possible that the reason why there were no changes in the GR
is because we used an immortalized cell line instead of primary cells. Second, in
previous reports investigators looked at the protein levels when we measured
mRNA expression. Therefore, it is possible that EtOH could affect protein stability
instead of transcriptional activity of the gene. Further experiments need to be
performed in primary neurons or in neuronal cell lines to verify if changes in the
GR expression in the PVN or in PVN derived cell lines play a role in EtOH
induced increase in CRH promoter activity and increase in CRH mRNA after
binge EtOH exposure.

90
Deletion of either GR binding site of the nGRE regulatory region of the
CRH promoter abolished EtOH induced increase in CRH promoter activity at a
2.0 h time point, Notably, in CRH∆GR1 and CRH∆GR2 mutants an increase in
CRH promoter activity was present at 4.0 h time point post EtOH treatment
indicating that when only one of the two GR binding sites is present, EtOH can
still activate the promoter but it takes longer for it to do so. Deletion of both sites
abolished the EtOH induced increase in the promoter activity completely
indicating that these sites are important for EtOH effects. Deletion of the GR
binding site 3 abolished EtOH induced increase in the promoter activity at 2.0 h
as well and this effect was still not present at the 4.0 h time point. Together,
these data indicate that at least two GR binding sites (GR 1 or 2 plus GR 3) are
required for EtOH induced increase in promoter activity. Further studies need to
be performed in order to elucidate more closely interactions between these GR
binding sites on the CRH promoter that are involved in EtOH induced effects.
Nevertheless, these data clearly show that EtOH disrupts normal glucocorticoid
negative feedback exerted at the promoter level.
Deletion of the CRE site eliminated EtOH induced increase in the
promoter activity at 2.0 h time point but it also decreased basal CRH promoter
activity and prevented forskolin induced activation of the promoter activity but did
not abolish EtOH induced decrease in CRH promoter activity at 0.5 h.. Previous
reports showed that in a rat glioma hybrid NG108-15 cell line, alcohol decreased
forskolin induced increase in CRH promoter activity (Li, Kang et al. 2005) making
it likely that the CRE site of the promoter is responsible for alcohol effects on the
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CRH promoter. It is well known that cAMP signaling, CREB binding and
coactivator recruitment to the CRH promoter is required for transcriptional
activation of the CRH (Liu, Kamitakahara et al. 2008). Therefore, it is not
surprising that when the CRE site is deleted, the CRH promoter cannot be
activated, even in the presence of the potent cAMP stimulator, forskolin.
Interaction of CRE site signaling with the effects exerted at the nGRE site were
not investigated in the Li et al., study, but since nGRE and its interaction with the
CRE site in the presence of glucocorticoids is required for inhibition of CRH
promoter activity (Malkoski and Dorin 1999; King, Smith et al. 2002), it is likely
that alcohol interferes with GR signaling at the level of the nGRE site of the CRH
promoter and the interaction between nGRE site and the signaling at the CRE
site is required for alcohol effects.
These data suggest that the observed EtOH-induced decrease in CRH
promoter activity does not involve the GR binding site 1 or 2 or the CRE site but
requires GR binding site 3. This further supports my conclusion that EtOH
interferes with GR signaling at the nGRE site to dysregulate the promoter activity.
Based on my data, it appears that at an early time point (0.5 h), normal negative
feedback exerted by glucocorticoids is still present and longer EtOH treatment
time is required for EtOH induced dysregulation of this feedback and an increase
in the promoter activity. Notably, these data indicate GR binding site 3 as being
extremely important for this negative feedback. EtOH-induced decrease in the
promoter activity was completely abolished only when this site was deleted.
These data are consistent with our previous in vivo data showing that
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longer/repeated EtOH exposure, i.e. binge EtOH exposure, is required for EtOH
induced dysregulation of the HPA axis. Together, data presented herein clearly
show that EtOH effects are mediated through nGRE site-EtOH interactions at the
level of the CRH promoter and longer periods of EtOH treatments are required
for dysregulation of normal glucocorticoid negative feedback.
One may argue that an increase in CRH promoter activity at 2.0 h is a
result of compensatory mechanisms being activated in the cells due to alcohol
induced cell death at that may have occurred at 0.5 h when a decrease in
promoter activity was observed. This explanation is highly unlikely due to
following reasons: 1) there was no decrease in cell viability at 0.5 h as measured
by MTT assay and 2) an increase in the promoter activity at 2.0 h time point
exceeded basal levels of the activity of the promoter which would be highly
unlikely to happen if cell death was occurring
100 mM EtOH treatment did not induce cell death at any time point tested,
instead, it increased mitochondrial activity at 4.0 h as measured by MTT
toxicology assay in which increased absorbance indicates increased
mitochondrial dehydrogenases activity. This result could be potentially an effect
of increased mitochondrial activity due to EtOH-induced oxidative stress in cells.
This conclusion is substantiated by previous reports showing a time course of
events in primary cortical neurons after EtOH exposure (Ramachandran, Watts
et al. 2003). In this report researchers showed that 5 min after 4.0 mg/ml EtOH
treatment, there is an increase in the amount of reactive oxygen species,
followed by an increase in mitochondrial 4-hydroxynonenal (HNE) at 1.0 h,
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followed by an increase in cytochrome c release at 2.0 h and increase in caspase
3 activation at 12.0 h. This sequence of events results in DNA fragmentation and
decrease in cell number that starts at 12.0 h of EtOH exposure (Ramachandran,
Watts et al. 2003). This proposed time line suggests that an increased
mitochondrial activity at 4.0 h in our system could be a result of an initiation of
oxidative stress induced cell death but it was too early for cell death to occur. If
alcohol treatment was longer than 4.0 h, we could possibly observe a decrease
in cell viability which would indicate cell death. Nevertheless, cell death was not
observed at any time point in our studies and could not explain the observed
decrease in CRH promoter activity at 0.5 h time point.
Overall, results presented in this study show that in a neuronal cell line
derived from the PVN, alcohol increases CRH promoter activity by interfering
with GR signaling at the nGRE site of the promoter. This may explain a potential
mechanism by which EtOH treatment in vivo increases the CRH mRNA levels in
the PVN. Although further investigation is required to assess alcohol effects on
upstream molecular targets that result in increased promoter activity. These data
for the first time identify neuronal GR- CRH DNA system as a direct target for
alcohol influence in the PVN.

CHAPTER FOUR

ROLE OF ESTRADIOL IN THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA)
AXIS RESPONSIVENESS OF PERI-PUBERTAL FEMALE RATS TO BINGE
ALCOHOL EXPOSURE

Introduction
Alcohol abuse during adolescence is a fundamental heath concern in the
United States. According to the U.S. Department of Health and Human Services,
41% of teenagers have had their first drink by the age of 14. Underage drinkers
typically adopt a “binge” pattern of alcohol consumption, defined by the National
Institute on Alcohol Abuse and Alcoholism (NIAAA) as heavy, episodic drinking in
which enough alcohol is consumed to bring the blood alcohol concentration
above 0.08 % limit within that 2.0h period (White, Kraus et al. 2006). According to
the Department of Health and Human Services survey performed in 2005, 2.0%
of 12-13 year-old, 8.0% of 14-15 year-old, 19.7% of 16-17 year-old and 51% 1820 year-old adolescents reported this pattern of drinking within a month
proceeding the survey. Overall, these statistics indicate that a significant
percentage of the adolescent population consumes heavy doses of alcohol
during this critical period of brain development which is called adolescence and is
94
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marked by dendrite pruning, prefrontal cortex development, increases in white
matter and formation of new neuronal connections (Woo, Pucak et al. 1997;
Giedd, Blumenthal et al. 1999; Paus, Zijdenbos et al. 1999; Cunningham,
Bhattacharyya et al. 2002; Sisk and Zehr 2005; Lenroot and Giedd 2006;
Raymond, Kucherepa et al. 2006)
One system that undergoes extensive maturation during adolescence is
the hypothalamo-pituitary-adrenal (HPA) axis (Romeo, Lee et al. 2004; Romeo,
Bellani et al. 2006; Romeo and McEwen 2006; McCormick and Mathews 2007;
Evuarherhe, Leggett et al. 2009; Evuarherhe, Leggett et al. 2009). Under normal
physiological conditions, an acute stressor activates the HPA axis. Hypothalamic
corticotrophin-releasing hormone (CRH) stimulates adrenocorticotrophic
hormone (ACTH) release from the anterior pituitary which in turn, causes the
release of adrenal glucocorticoids, cortisol in humans and corticosterone (CORT)
in rodents. Arginine vasopressin (AVP) released from the parvocellular portion of
the paraventricular nucleus of the hypothalamus (PVN) and is known to act
synergistically with CRH to augment the release of ACTH and CORT and
mediate stress and anxiety responses (Dickstein, DeBold et al. 1996; Wigger,
Sanchez et al. 2004; Egashira, Tanoue et al. 2007). This sequence of events
sets up a negative feedback system whereby increased circulating glucocorticoid
levels serve to inhibit the additional release of hypothalamic CRH and AVP by
inhibiting the activity of the promoter (Van, Spengler et al. 1990; Iwasaki, Oiso et
al. 1997; Malkoski and Dorin 1999; Kim, Summer et al. 2001).
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Several lines of evidence suggest that acute or chronic alcohol exposure
might lead to increased displays of anxiety behavior. Correlative studies have
demonstrated that over 50% of patients with alcohol dependency also have
anxiety-related or depression-related psychiatric disorders (Conway, Compton et
al. 2006), and these types of disorders are often associated with an abnormal
stress response. Interestingly, women alcoholics have a higher incidence of
clinically diagnosed anxiety disorders compared to men alcoholics (Zilberman,
Tavares et al. 2003; Epstein, Fischer-Elber et al. 2007), possibly due to the
inherent sex differences in the stress responses of the HPA axis (Becker,
Monteggia et al. 2007; Handa, Zoeller et al. 2007).
Pubertal binge-alcohol exposure can alter the expression of both the CRH
and the AVP mRNA in the PVN, a main region involved in modulating stress
reposes. We have shown previously that in peri-pubertal male rats, binge, but
not acute EtOH exposure increased the expression of the CRH and AVP mRNA
in the PVN but this effect was not observed in female peri-pubertal rats
(Przybycien-Szymanska, Rao et al. 2009). In addition, in adult rats, even single
exposure to alcohol at the dose of 3g/kg, significantly increased PVN expression
of CRH and AVP mRNA but as observed in peri-pubertal rats, this effects was
evident only in males. Together, these data clearly indicate that there is a sex
difference in the responsiveness of the HPA axis to alcohol exposures and this
sex difference becomes apparent during peri-pubertal development but the
mechanisms behind these inherent sex differences in the responsive of female
HPA axis to alcohol exposure remain unknown.
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In this study, the role of 17β-estradiol (E2) in the responsiveness of peripubertal females to binge pattern EtOH exposure as well as the role of E2 to
alcohol effects in vitro were investigated. I hypothesized that 1) in ovariectomized
females E2 replacement will prevent alcohol induced changes in the CRH and
AVP mRNA levels in the PVN that will be evident in Ch-treated group and 2) that
in a cell culture, E2 treatment will prevent an increase in the CRH promoter
activity observed previously in the CRH promoter after alcohol treatment. We
showed here that 1) in E2–treated females, binge EtOH exposure did not cause
changes in the CRH and AVP mRNA in the PVN and that the increase in
circulating CORT level after binge EtOH exposure was lower compared to an
increase in plasma CORT levels after acute EtOH exposure (habituation effects),
2) in Ch-treated females, binge EtOH exposure decreased the CRH and AVP
mRNA levels in the PVN and prevented habituation effect after binge EtOH
exposure and 3) that in a neuronal cell line E2 treatment prevented EtOH induced
increase in CRH promoter activity.

Results
General Approach
In order to investigate a role of estradiol (E2) in sex differences observed
after EtOH exposure during puberty on stress responsiveness of the HPA axis
during this time period, peri-pubertal ovariectomized on PND 26 female rats that
were replaced either with Cholesterol (Ch) or 17β-estradiol (E2) were treated
either with saline, acute EtOH or binge EtOH exposure between PND 37 and 44
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(see Fig 2 and Table 2 for binge EtOH exposure paradigm Fig 2 and
experimental design Table 2). On the last day of treatments (PND 44), 1.0 h after
the last EtOH administration, animals were sacrificed and brains and trunk blood
were collected. Plasma was isolated and used for further hormone and BAC
measurements. Brains were rapidly frozen, sectioned on a freezing microtome
and PVN and SON were microdissected for CRH and AVP mRNA
measurements using qRT-PCR.
In addition, the effect of E2 on EtOH induced changes in CRH promoter
activity was investigated in a neuronal cell line (IVB) derived from the PVN. Cells
were transfected with CRH promoter-luciferase construct and 8.0 h after
transfections, cells were pre-treated with 10 nM E2 for 16.0 h. After 16.0 h pretreatment period, cells were incubated with 10 nM E2 and 100 mM EtOH for 2.0 h
and then CRH promoter activity was measured using dual luciferase assay (see
Chapter 7, General Methods section for detailed description of methods used in
this chapter).

Body weight differences and E2 levels after alcohol treatments in ovariectomized
Ch- or E2 – treated female rats
On PND 26, females were bilaterally ovariectomized and replaced with
silastic capsules containing either 17β-estradiol (E2) or cholesterol (Ch). On PND
37, both E2-treated and Ch-treated animals were randomly assigned to either 1)
saline-treated (N = 8/group), 2) acute EtOH treated (N=8/group) or 3) binge EtOH
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treated (N = 8/group, 3g/kg/day) groups (see Table 2 and Chapter 7 General
Methods section for detailed description).
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Experimental design 1
PND 26

PND 37-44
Saline (n=8)

OVX + Chol (n=24)

Acute EtOH (n=8)
Binge EtOH (n=8)
Saline (n=8)

OVX + 17βEstradiol (n=24)

Acute EtOH (n=8)
Binge EtOH (n=8)

Saline = 8 days ip 0.9% saline
Acute EtOH = 7 days ip saline + 1 day 3g/kg EtOH
Binge EtOH = 3 days ip 3g/kg EtOH + 2 days saline + 3 days ip 3g/kg EtOH

Table 2. Schematic representation of treatment groups used. Pre-pubertal females
(PND 26) were bilaterally ovariectomized and replaced with 1.0 mm silastic capsules
containing cholesterol (Ch) or 17β-estradiol (E2). Starting on PND 37, animals received
one of the three treatments; saline, acute EtOH or binge EtOH.
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Body weight measurements were obtained every other day during the
duration of treatments. Repeated measures mixed ANOVA revealed that there
was no main effect of EtOH treatment on body weight gain (F(2,44) = 0.252;
p=0.388) but that there was a main effect of age (F(1,44)= 9.9. p = 0.003). In
addition, there were no between subject interactions on weight gain in these
groups (F(2,44)=0.267, p=0.767). On the other hand, there was hormone by age
interaction on weight gain between groups (F(1,45)=33.362, p<0.001). These
data show that within E2–treated group, animals gained weight slower compared
to animals within Ch-treated group (Fig. 19), Even though E2 treatment had an
effect on body weight gain, EtOH did not cause animals to lose weight. As
expected, in Ch-treated females lack of E2 in the system resulted in increased
body mass as compared to E2–treated females (Fig 19B) indicating that
implantation of E2 containing capsules was effective in our animals and raised
plasma E2 levels.
As reported by Dr. Pau from Oregon National Primate Research
Center/Oregon Health Science University Endocrine Technology and Support
Laboratory, E2 levels in E2–replaced ovariectomized females were 65 ± 7.3 pg/ml
and there were no differences in plasma E2 levels between different EtOH
treatment groups (F(2.20)=2.929, p=0.077). These data, together with body
weight data, indicate that E2 replacement via silastic capsules was effective in
these experiments and raised plasma E2 levels to expected values.

102
E2/saline
E2/acute

200

E2/binge
Chl/saline
Ch/acute
Ch/binge

Body weight (g)

160

120

80

40
200

Ch
E2

d
d
Body weight (g)

160

c
b
120

a

e, f

0

2

g
f, g

f

e

80

40

4
Treatment Days

6

8

Fig 19. Effects of ethanol treatment on body weight of ovariectomized females replaced
either with Ch or E2 during pubertal development. Representative mean body weights of
animals in all treatments groups (A) and combined treatments groups within Ch and E2
females (B) treated with daily IP injections of saline, saline + one day EtOH (acute), or
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binge EtOH paradigm. Dissimilar letter indicate statistically significant difference. More
specifically a is different from b, c, d, e, f, fg, and g; ef is different from a, b, c, d, and g
(p<0.05).

Blood alcohol concentrations (BAC) in Ch- or E2 – treated ovariectomized
females.
1.0 h after the last EtOH treatment, BAC were measured using commercially
available kit (Pointe Scientific) (see Chapter 7 General Methods section for
details). Two-way ANOVA showed that there was no main effect of hormone
treatment (F(2,38) = 1.595; p=0.516) and that there was a main effect of EtOH
treatment (F(2,38) = 60.368, p <0.001) on BAC in these experiments. There was
no interaction between these two factors (F(4,38 = 1.678; p = 0.175). On
average, EtOH exposure resulted in BAC of 257.09 ± 19.97 mg/dl and 275.77 ±
22.94 (Fig 20) in E2–treated and Ch-treated females, respectively. More
specifically, acute (singe dose) EtOH exposure resulted in BAC of 252.25 ±
36.57 and 244.65 ± 28.85 in E2– and Ch-treated females, respectively and in
both cases the values were significantly different from BAC in saline group
(below the limit of detection, p<0.001). Binge EtOH exposure resulted in BAC of
221.94 ± 17.52 and 306.89 ± 33.84 in E2– and Ch-treated females, respectively
and they both were significantly higher compared to BAC in saline treaded
controls (below the limit of detection, p<0.001, Fig 20). These values are
consistent with the defined BAC threshold of binge drinking.
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Fig 20. Effects of EtOH treatments on blood alcohol levels in ovariectomized female
rats. Blood alcohol concentrations (BAC) 1.0 h post-injection in ovariectomized females
replaced either with Ch or E2 and then treated with saline, acute EtOH or binge EtOH.
Data expressed as mean alcohol mg/dl. Dissimilar letter indicate statistically significant
difference between groups. More specifically a is significantly different from b (P < 0.05).
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Plasma ACTH and CORT levels after alcohol exposure in Ch- or E2 – treated
ovariectomized (OVX) females rats
In order to investigate the effects of E2 replacement on the effects of EtOH
exposure during peri-puberty on circulating ACTH and CORT levels in OVX
females, both plasma ACTH and CORT levels were measured using RIA (see
Chapter 7 General Methods section for details). Overall two-way ANOVA
revealed that there was a main effect of hormone treatment (F(1,35) = 10.563;
p=0.003) and a main effect of EtOH treatment (F(2,35) = 24.219; p<0.001) on the
plasma ACTH levels and that there was no interaction between the two factors
(Fig 21A; F(2,35) = 3.154, p = 0.055). In Ch-treated females, both acute
(p<0.001) and binge (p=0.002) EtOH exposures significantly increased plasma
ACTH levels as compared to saline treated controls and there was no difference
between plasma ACTH levels in acute EtOH group as compared to binge EtOH
group (Fig 21A, p=0.735). Plasma ACTH levels in E2–treated group showed a
different pattern of responses to EtOH exposure. Notably, there was a significant
increase in plasma ACTH levels after acute EtOH exposure (p<0.001) and no
changes after binge EtOH exposure (Fig 21A, p=0.15) as compared to saline
treated controls (Fig 21A). These data indicate a habituation effect that is absent
in Ch-treated group. Plasma ACTH levels in binge EtOH group were not different
as compared to saline treated group within this hormone treatment (p=0.159).
Analysis of plasma CORT levels revealed that there was no main effect of
hormone treatment (F(2,36) = 0.318; p=0.73) and that there was a main effect of
EtOH treatment (F(2,36) = 27.834; p<0.001) on the plasma CORT levels. There
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was no interaction between the two factors (Fig 21B; F(4, 36) = 2.235, p = 0.084)
(Fig 21B). In Ch-treated females, both acute (p<0.001) and binge (p<0.001)
EtOH exposures significantly increased plasma CORT levels as compared to
saline treated controls and there was no difference between plasma CORT levels
in acute EtOH group as compared to binge EtOH group (p=547). Plasma CORT
levels in E2–treated group showed a different pattern of responses to EtOH
exposure. There was a significant increase in plasma CORT levels after acute
EtOH exposure (p=0.007) and no changes after binge EtOH exposure (p=0.567)
as compared to saline treated controls (Fig 21B). These data further indicate that
the habituation effect that is absent in Ch-treated group is present in E2–treated
females. Lastly, as expected, based on studies performed in intact animals and
based on known influence of E2 on stress axis in females (Sencar-Cupovic and
Milkovic 1976; Rivier 1993; Weiser and Handa 2009; Przybycien-Szymanska,
Rao et al. 2010), basal (saline induced) plasma CORT levels were higher in E2 treated females as compared to Ch-treated females (Fig 21B, p=0.032).
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Fig 21. Effects of EtOH treatments on blood ACTH and CORT levels in ovariectomized
female rats replaced with Ch or E2. Plasma ACTH (A) and CORT (B) levels in
ovariectomized females replaced either with Ch or E2 1.0 h after IP injection of saline,
acute, or binge EtOH treatments.. Data expressed as mean ACTH and CORT ng/ml of
blood. Dissimilar letters indicate statistically significant difference among groups. More
specifically a is significantly different from b and c but nor from a, and b is different from
a and c but not b and so on (P < 0.05).
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CRH and AVP mRNA expression in the PVN after alcohol treatments in CH- or
E2–treated ovariectomized (OVX) females.
In order to investigate the effects of E2 replacement on the effects of EtOH
exposure during peri-puberty on the expression of genes involved in stress and
anxiety responses in OVX females, CRH and AVP mRNA were measured using
qRT-PCR (see Chapter 7 General Methods section for details). Two-way ANOVA
revealed that there was no main effect of hormone treatment on the expression
of CRH mRNA (F(1,40) = 0.0575; p=0.812) (Fig 22A) or AVP mRNA
(F(1,40)=1.008; p=0.321) (Fig 22B) in the PVN and that there was a main effect
of EtOH treatment on the CRH mRNA expression (F(2,40) = 5.397, p = 0.008).
There was no interactions between these two factors on the CRH mRNA
expression (F(2,40)=1.622; p=0.21) or on the AVP mRNA expression
(F(2,40)=2.008; p=0.148) in the PVN in peri-pubertal females. Post hoc analysis
of the CRH and AVP mRNA expression in the PVN of Ch-treated females
showed that binge EtOH exposure significantly decrease the CRH mRNA (Fig
22A, p=0.03) and AVP mRNA (Fig 22B, p=0.028) expression in these treatment
groups but there were no differences within E2 -treated females.
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Fig 22. Effects of EtOH treatments on CRH and AVP gene expression in the PVN of
ovariectomized female rats replaced with Ch or E2. CRH (A) and AVP (B) mRNA
expression in the PVN of peri-pubertal females replaced either with Ch or E2 1.0 h after
treatment with either saline, acute, or binge EtOH. Data expressed as mRNA copies/µg
total RNA. Dissimilar letters indicate statistically significant difference between groups.
For example, a is significantly different from b but not ab and so on (P < 0.05).
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CRH and AVP mRNA expression in the SON after alcohol treatments in Ch- or
E2–traded ovariectomized (OVX) females.
We have shown previously that in peri-pubertal male and female rats
(Przybycien-Szymanska, Rao et al. 2009), EtOH does not change the AVP
mRNA expression in the SON, a main region responsible for osmoregelation
which indicated that the effects observed in all previous studies in the PVN were
not due to diuretic effects of EtOH on the AVP containing neurons. In this study I
also measured the AVP mRNA expression in the SON in order to verify the HPA
axis specificity of EtOH effects using qRT-PCR. Contrary to what we observed in
intact animals, there were changes associated with EtOH treated in the AVP
mRNA expression in the SON. Two-way ANOVA revealed that there was a main
effect of EtOH treatment (F(2,39)=4.696, p=0.015) and no main effects of
hormone replacement (F(1,39)=1.434, p=0.238) on the AVP mRNA expression in
the SON and that there was an interaction between the two factors analyzed
(F(2,39)=4.075, p=0.005) (Fig. 23). Post-hoc tests showed that in E2–treated
females, there were no changes in the AVP mRNA expression (p=0.907);
however, in the Ch-treated group binge EtOH treatment significantly decreased
the AVP mRNA levels as compared to saline controls (p<0.001) and acute EtOH
group (p = 0.003). There were no differences between saline and acute EtOH
groups within Ch-treated females (Fig. 23, p=0.747).
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Fig 23. Effects of ethanol treatments on AVP gene expression in the SON in
ovariectomized female rats. AVP mRNA expression in SON of peri-pubertal Ch- or E2 treated female rats treated with saline, acute, or binge EtOH. Data expressed as mRNA
copies/µg total RNA. Dissimilar letters indicate statistically significant difference. More
specifically a is significantly different from b and c but not from ca (P < 0.05).
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17β-Estradiol treatment in vitro abolished EtOH induced changes in CRH
promoter activity
In order to investigate possible interactions of EtOH with E2 on the activity
of the CRH promoter, I treated IVB cells transfected with CRH promoterluciferase construct with 100 mM EtOH or 100 mM EtOH plus 10 nM E2 and
measured luciferase activity (see Chapter 7 General Methods section for details).
Statistical analysis revealed that EtOH significantly increased the CRH promoter
activity as compared to vehicle treated controls (Fig 24, p=0.016) but in the
presence of E2 this EtOH effect was abolished (Fig 24, p=0.539). These data
indicate that the presence of E2 moduulates EtOH induced effects exerted on
CRH promoter.
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Fig 24. Effects of EtOH treatment on CRH promoter activity in a neuronal cell line after
E2 treatment. CRH promoter-luciferase activity was measured in IVB cell line in cells
transfected with CRH promoter-luciferase construct after treatment with 100 mM EtOH
for 2.0 h in media alone or in the presence of 10 nM E2. Data expressed as % change in
luciferase activity of vehicle treated control. * indicates statistically significant different
compared to vehicle treated control (P < 0.05)
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Discussion
We have shown previously that binge alcohol exposure during peripuberty induced sexually dimorphic changes in the PVN expression of CRH and
AVP mRNA but the pattern of alcohol induced changes in plasma CORT levels
was the same in females as in males (Przybycien-Szymanska, Rao et al. 2009).
These data indicated sex specific dysregulation of peri-pubertal HPA axis. To
date, mechanisms behind these effects have not been described. The goals of
this study were to investigate 1) the effects of binge EtOH exposure in
ovariectomized peri-pubertal females and a role of E2 replacement in modulating
these effects and 2) effects of EtOH treatment in a presence of estradiol on the
CRH promoter activity. These results showed for the first time that 1) in Chtreated ovariectomized females, binge EtOH exposure significantly decreased
CRH and AVP mRNA in the PVN and both acute and binge EtOH exposures
significantly increased circulating CORT levels, 2) that in E2 -treated
ovariectomized females, alcohol did not induce changes in the CRH and AVP
mRNA in the PVN and only acute EtOH exposure significantly increased plasma
CORT levels in this group. In vitro data presented herein showed that estradiol
treatment prevented EtOH induced increase in CRH promoter activity at the 2.0 h
time. These data indicate that E2-EtOH interaction are potentially responsible for
sex differences in responsiveness of the HPA axis to alcohol administration as in
the presence of estradiol in vivo and in vitro these effects of alcohol were
abolished (see Fig 25 for the summary of major findings)
.
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SUMMARY: Effetc of binge EtOH exposure in ovariectomized females
Ch-treated females (PND 37-44)
-

BINGE EtOH ↓ CRH and AVP mRNA in the PVN

-

Both binge and acute EtOH ↑ plasma CORT levels, no habituation

E2-treated females (PND 37-44)
-

NO CHANGES in the CRH and AVP mRNA after EtOH treatmnets

-

Both binge and acute EtOH treatments ↑ CORT levels, habituation effect present

EtOH

A

EtOH

B

PVN

PVN
No change

↓ CRH, AVP

CRH, AVP

Anterior pituitary gland
ACTH
Adrenal cortex

Anterior pituitary gland

_
ACTH
Adrenal cortex

↑ CORT
Body organs
No steroid hormones present

_

↑ CORT
Body organs
In the presence of estradiol

Fig 25. Summary of results described in Chapter 4. In OVX Ch-treated females (A)
binge EtOH exposure ↓ CRH and AVP mRNA in the PVN and ↑ plasma CORT levels. In
OVX estradiol replaced females (B), binge EtOH exposure did not induce changes in
the CRH and AVP mRNA in the PVN but ↑ plasma CORT levels. These data indicate
that the presence of estradiol is required for the maintenance of steady sate levels of the
CRH and AVP mRNA in the PVN after EtOH exposures.
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In this study, both acute and binge EtOH exposure increased circulating
ACTH and CORT levels in Ch-treated ovariectomized females, however, in E2 treated females only acute EtOH exposure significantly increased plasma ACTH
and CORT levels. Notably, in these females ACTH and CORT levels were similar
between saline and binge alcohol treated groups indicating a clear habituation
effects after repeated EtOH exposure. These data are consistent with our
previous reports in intact peri-pubertal male and female rats in which we showed
that there was a habituation effect after repeated EtOH administrations marked
by lower increase in plasma CORT levels after binge EtOH treatment compared
to plasma CORT levels after acute EtOH exposure (Przybycien-Szymanska, Rao
et al. 2009). Data presented in this report indicate that the presence of estradiol
is required for habituation effects because in Ch-treated females there was no
difference between plasma ACTH and CORT levels between the two alcohol
treated groups.
In addition to the role of E2 in the habitation effect after binge EtOH
exposure, these data support previous finding describing the role of E2 in
increased sensitivity to stressful stimuli in female animals. Plasma CORT levels
after saline administration were higher in E2 -treated females compared to Chtreated females. This is consistent with previous reports showing greater plasma
CORT increase after stress and alcohol administration in females compared to
males (Sencar-Cupovic and Milkovic 1976; Rivier 1993; Ogilvie and Rivier 1997;
Evuarherhe, Leggett et al. 2009; Weiser and Handa 2009). Our previous
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experiments showed that CORT levels in intact peri-pubertal males and females
were not different between saline treated groups as compared to untreated rats,
however saline injection could be considered to be a mild stressor inducing a
small increase in circulating CORT levels and these effects were significantly
greater in females compared to males. These data indicate and further support
findings showing increased sensitivity to stress in females and a role of E2 in this
increased sensitivity.
Contrary to what was observed in peri-pubertal (Przybycien-Szymanska,
Rao et al. 2009) and adult animals (Rivier 1993; Ogilvie and Rivier 1996; Ogilvie
and Rivier 1997), E2 failed to induce a greater increase in CORT levels after
EtOH administration in E2 -treated females as compared to Ch-treated group.
This could be explained by lack of other sex steroid hormones that would inhibit
the HPA axis. One such hormone, testosterone (T), is known to play inhibitory
role on stress induced functions of the HPA axis marked by decreased ACTH
and CORT increase when compared to females and increased basal CORT
levels in gonadectomized males (Ogilvie and Rivier 1997; Viau, Chu et al. 1999;
Williamson and Viau 2008; Evuarherhe, Leggett et al. 2009). The fact that
plasma ACTH and CORT levels were not different after EtOH administration
between CH- and E2 -treated females could be explained by the fact that there
was no HPA axis inhibition.
A most striking finding of these experiments is that E2 replacement
abolished alcohol induced changes in the CRH and AVP mRNA in the PVN
which is consistent with previous data showing no changes in the expression of
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these neuropeptides in the PVN of peri-pubertal (Przybycien-Szymanska, Rao et
al. 2009) and adult female rats (Ogilvie and Rivier 1997). These data indicate a
role of E2 in lack of EtOH induced changes in the CRH and AVP mRNA
expression in the PVN, however, it is not clear what is the role this lack of EtOH
effects on the CRH and AVP mRNA in the PVN in females and what causes an
increase in these genes in the PVN of intact males observed in previous studies
(Rivier, Bruhn et al. 1984; Ogilvie and Rivier 1996; Rivier and Lee 1996; Ogilvie,
Lee et al. 1997; Ogilvie and Rivier 1997; Przybycien-Szymanska, Rao et al.
2009). Notably, in Ch-treated females lack of E2 alone did not increase CRH and
AVP mRNA in the PVN, therefore E2 cannot be the only factor involved in
sexually dimorphic effects of EtOH. Notably, in Ch-treated females, I observed a
decrease in the CRH and AVP mRNA in the PVN which indicates that some
other factor, not present in gonadectomized females, is responsible for EtOH
induced increase in the CRH and AVP mRNA in male PVN.
It has been shown that in addition to E2, T and its metabolites such as 3βdiol and dihydrotestosterone (DHT), differently modulate the HPA axis activity
(De Vries, Wang et al. 1994; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau,
Lee et al. 2003; Scordalakes and Rissman 2004; Lund, Hinds et al. 2006; Pak,
Chung et al. 2007; Williamson and Viau 2008; Handa, Weiser et al. 2009; Pak,
Chung et al. 2009) and that this effect can be mediated through estrogen
receptor beta (ER β), the main ER found in the PVN (Isgor, Cecchi et al. 2003;
Miller, Suzuki et al. 2004; Lund, Rovis et al. 2005; Suzuki and Handa 2005; Pak,
Chung et al. 2007; Handa, Weiser et al. 2009) or through androgen receptor
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signaling present in the PVN and in other hypothalamic regions (Viau and
Meaney 1996; Lund, Hinds et al. 2006). For example, in bed nucleus of stria
terminalis (BST) of gonadectomized adult rats, DHT and E2 increased AVP
mRNA as compared to gonadectomized rats not replaced with any hormones.
The same is true in medial nucleus of amygdala (MeA) (De Vries, Wang et al.
1994; Pak, Chung et al. 2009). In juvenile rats, on the other hand, E2 and 3β-diol,
but not DHT, increase AVP mRNA expression in BST but only E2 increased AVP
mRNA expression in MeA (Pak, Chung et al. 2009). 3β-diol is known to activate
the AVP promoter activity in a neuronal cell line (Pak, Chung et al. 2007; Pak,
Chung et al. 2009). In addition to inhibiting ACTH and CORT release, T can also
inhibit the HPA axis at the level of the hypothalamus were it has been found to
decrease restraint induced changes in the CRH expression (Patchev and
Almeida 1996; Viau and Meaney 1996; Viau, Chu et al. 1999; Viau, Lee et al.
2003; Williamson and Viau 2008). In our Ch-treated animals, lack of any sex
steroid hormones could be partially responsible for a decrease in the CRH and
AVP mRNA in the PVN due to EtOH but more studies need to be performed in
order to elucidate exactly what factors are required for EtOH induced increase in
the CRH and AVP mRNA in the PVN.
Another possibility behind EtOH induced decrease in the CRH and AVP
mRNA in the PVN of ovariectomized Ch-treated females, further supporting the
role of E2, is that these females lack E2 mediated neuroprotection. E2 has been
shown in multiple studies to exert neuroprotective effects after a neuronal insult
(Li, Siegel et al.; Pietranera, Bellini et al.; Garcia-Segura, Wozniak et al. 1999;
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Azcoitia, Sierra et al. 2001; McCullough, Blizzard et al. 2003; Sierra, Azcoitia et
al. 2003; Saleh, Connell et al. 2005; Veiga, Azcoitia et al. 2005). There is an
increase in aromatase, an enzyme involved in conversion of T to E2, activity after
ischemic stroke and other brain insults (Garcia-Segura, Wozniak et al. 1999;
Saleh, Connell et al. 2005; Veiga, Azcoitia et al. 2005) . These findings indicate
that a decrease in the CRH and AVP mRNA in the PVN could be explained by
lack of neuroprotection against neurotoxic effects of EtOH; however, this still
does not explain the reason why we see an increase in the expression of these
neuropeptides in the PVN of intact males. It is possible that in peri-pubertal
males an AVP increase in the PVN plays a neuroprotective role as these bingeEtOH exposed pubertal males have low levels of circulating E2. AVP has been
shown to be protective against apoptotic cell death in a neuronal cell line (Chen,
Volpi et al. 2008; Chen, Liu et al. 2009) therefore it is likely to speculate that in
males an upregulation of AVP plays a neuroprotective role. This explanation,
however, still does not explain an increase in the CRH mRNA.
The role of E2 in modulation of the HPA axis at the level of the
hypothalamus is further supported by our in vitro data showing no EtOH induced
increase in CRH promoter activity in the presence of E2. . These data are
consistent with previous reports showing a close relationship between gonadal
and adrenal hormones in regulation of the HPA and hypothalamo-pituitarygonadal (HPG) axis, respectively. For example, E2 and ERβ play a stimulatory
role on the HPA axis activity. This enhancing effect is marked by increased CRH
promoter activity after cotransfection of different ERβ isoforms and increased
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AVP mRNA in the PVN, and enhanced increase in plasma ACTH and CORT
after stress in the presence of E2 (De Vries, Wang et al. 1994; Ogilvie and Rivier
1997; Miller, Suzuki et al. 2004; Weiser and Handa 2009). Adrenal hormones can
in turn modulate the expression of ER β as adrenodectomy decreased ERβ
mRNA expression in the PVN of adult rats and this effects was fully reversed with
CORT replacement (Isgor, Cecchi et al. 2003). Consistent with in vivo data
showing no EtOH induced changes in the CRH mRNA expression in the PVN in
intact females or in ovariectomized females replaced with E2, in a neuronal cell
line, E2 treatment prevented EtOH induced stimulation of CRH promoter activity.
These data indicate that there is close cooperation between EtOH and E2
signaling and this interaction is involved in sex specific effects of EtOH exposure.
In this study binge EtOH exposure, did not change the AVP mRNA
expression in the SON in E2 -treated group but it significantly decreased SON
expression of this neuropeptides in Ch-treated group. Our data collected in E2 treated ovariectomized females are consistent with previous reports showing no
effects of EtOH treatments in the SON of normal rats (Ogilvie, Lee et al. 1997), or
in magnocellular division of the PVN (Ogilvie and Rivier 1997). Notably, in Chtreated group we observed a significant decrease in the AVP mRNA expression
in the SON and this effect could be explained in two ways. First, data showing a
decrease AVP in the SON is consistent with diuretic effects of alcohol on the
AVP as the AVP is mostly known as antidiuretic hormone (ADH). This
explanation is highly unlikely because we did not observe changes in the AVP
mRNA expression in the SON in E2-treated females and in intact peri-pubertal
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male and female rats (Przybycien-Szymanska, Rao et al. 2009). If this decrease
was due to diuretic effects of EtOH, we would see it in other studies as well.
Second, based on previous reports, I can speculate that EtOH could induce cell
death in the PVN which would result in decreased expression of AVP mRNA in
the SON. This explanation is consistent with previous reports showing that the
AVP mRNA in the SON was decreased following alcohol exposure but only in
rats bearing PVN lesions (Ogilvie, Lee et al. 1997) and AVP is neuroprotective in
a PVN derived neuronal cell line (H32) (Chen, Volpi et al. 2008; Chen, Liu et al.
2009). In these experiments, addition of the AVP into the media was found to
protect against serum starvation induced cell death (Chen, Volpi et al. 2008;
Chen, Liu et al. 2009). EtOH induced cell death in the PVN could be responsible
for a decrease in the AVP mRNA in the PVN in Ch-treated females. If that was
the case, the decrease in the AVP mRNA in the SON could be explained by the
cooperation between these two nuclei. Functions of the PVN and SON and their
responses to EtOH have been shown to be linked (Ogilvie, Lee et al. 1997) . The
cooperation between both magnocellular and parvocellular AVP systems needs
to be further investigated in order to support this hypothesis even though this
explanation at this moment seems to be most likely.
Lastly, we showed that E2 -treated females had significantly lower body
weights and gained weight slower as compared to Ch-treated females but EtOH
treatment had no effects on body weight. These findings are consistent with
known anorexigenic effects of E2, as lack of this hormone in humans, for
example during menopausal transition in women, tends to increase body weights
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(Cagnacci, Zanin et al. 2007). In addition, body weight data in EtOH treated
groups showed the binge alcohol exposure paradigm employed in our
experiments did not inhibit the growth of animals. This is consistent with our
previous data which showed no differences in body weights due to EtOH
treatment (Przybycien-Szymanska, Rao et al. 2009). In addition this binge EtOH
exposure paradigm has been shown to be reliable for testing the effects of EtOH
using an exposure pattern that is typical for adolescents (Lauing, Himes et al.
2008). Lastly, it has been show that the IP injection of EtOH, employed in our
paradigm, does not seem to result in significantly different BAC compared to oral
gavage in adolescent Wistar rats (Walker and Ehlers 2009).
Taken together, our data show for the first time that E2 plays a critical role
in mediating sexually dimorphic effects of EtOH and that these effects of E2 may
be exerted at the level of the CRH promoter. Further studies need to be
performed in order to investigate mechanisms involved in increase in the CRH
and AVP mRNA in the PVN of intact peri-pubertal male rats after binge EtOH
exposure as the absence of E2 does not explain this increase. In addition, we
need to establish whether the presence of E2 in the system makes females
protected or more sensitive to the effects of E2 as compared to males, If they are
more sensitive, this increase in sensitivity to E2l effects may lead females who
binged during adolescence to exhibit even grater risk for developing mood
disorders in adulthood as compared to males.

CHAPTER FIVE

BINGE-PATTERN ALCOHOL EXPOSURE DURING PUBERTY
INDUCES LONG-TERM CHANGES IN HPA AXIS REACTIVITY. (PRZYBYCIENSZYMANSKA MM ET AL., PLOS ONE APRIL 2011)

Introduction
Alcohol abuse, especially binge-pattern alcohol abuse, is highly prevalent
among adolescents. According to the Substance Abuse and Mental Health
Services Administration, 36% of youths ages 18 to 20 reported at least one
binge-drinking episode during the past 30 days, defined by National Institute on
Alcohol Abuse and Alcoholism (NIAAA) as consuming four or five drinks within a
two hour period that causes a rapid increase in blood alcohol concentration
(BAC) to the level of 0.08 g % or greater. Our previous studies demonstrated that
binge-pattern EtOH exposure in adolescent rats negatively affected the HPA axis
by dysregulating normal negative feedback pathways, however whether these
neurobiological changes were transient or persistent remained unclear
(Przybycien-Szymanska, Rao et al. 2009). Thus, a central focus of this study
was to determine the long-term neurobiological consequences of adolescent
binge-pattern alcohol exposure on adult HPA axis reactivity. The HPA axis is
xtremely plastic during pubertal development, suggesting that early alcohol
124
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abuse could permanently disrupt the normal maturational process of the
HPAaxis. Alcohol is a physiological stressor and potent activator of the HPA axis
(Rivier and Lee 1996; Ogilvie, Lee et al. 1997; Li, Kang et al. 2005; PrzybycienSzymanska, Rao et al. 2009). Acute psychological or physical stressors activate
parvocellular neurons in the hypothalamic paraventricular nucleus (pPVN) to
release corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP)
into the portal system of the anterior pituitary gland, which, upon stimulation,
releases adrenocorticotrophic hormone (ACTH). ACTH then acts on the adrenal
cortex to release glucocorticoids, cortisol in humans and corticosterone (CORT)
in rodents, into the systemic circulation setting up a negative feedback loop by
which CORT acts on the hypothalamus and pituitary gland to decrease further
release of CRH, AVP, and ACTH. During pubertal development, the brain and
HPA axis undergo extensive maturational processing, characterized by altered
HPA axis reactivity, increased synaptic connections, and differential
responsiveness to the effects of gonadal steroid hormones (Sisk and Zehr 2005;
Romeo, Bellani et al. 2006; McCormick and Mathews 2007; Evuarherhe, Leggett
et al. 2009; Evuarherhe, Leggett et al. 2009). These studies indicate that the
successful shaping of mature HPA function that occurs during pubertal
development may be extremely vulnerable to the detrimental effects of alcohol.
We have previously shown that binge-pattern EtOH exposure in peripubertal male rats increased the expression of CRH and AVP mRNA in the PVN
during this time period (Przybycien-Szymanska, Rao et al. 2009), however the
long lasting effects of this pattern of EtOH exposure during puberty on the PVN
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and the HPA axis as a whole remain unknown. In this study we tested the
hypothesis that binge-pattern EtOH exposure during puberty has long lasting
effects on the reactivity of the adult HPA axis. The overall goals of this study
were to 1) determine how binge-pattern EtOH exposure during puberty affects
central expression of adult CRH and AVP, as well as circulating CORT levels,
and 2) determine whether adults pre-exposed to EtOH during puberty were more
sensitive to subsequent EtOH exposures in adulthood. Overall, our results
showed that peri-pubertal binge-pattern EtOH exposure induced a striking long
lasting alteration of many HPA axis parameters. Our data provide strong
evidence that binge-pattern EtOH exposure during pubertal maturation has longterm detrimental effects for the healthy development of the HPA axis.

Results
General Approach
In order to investigate the long lasting effects of binge EtOH exposure
during puberty on functioning of adult HPA axis, peri-pubertal male rats (PND 3744) were exposed to saline (EtOH naïve) or binge EtOH exposure paradigm
(EtOH pre-exposed) and then allowed to grow up undisturbed until adulthood.
Starting on PND 68 (early adulthood), male rats were treated with following
regiments 1) saline only, 2) acute EtOH exposure or 3) binge EtOH exposure for
8 consecutive days (see Fig 2 and Table 3 for detailed description of binge EtOH
exposure paradigm and experimental deign). On the last day of adult treatments
(PND 75), 1.0 h after saline or EtOH administration, animals were sacrificed and
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he brains and trunk blood were collected. Plasma was separated and used for
further BAC and hormone measurement. Brains were rapidly frozen, then
sectioned on a freezing microtome and the PVN and SON were microdissected
to perform CRH and AVP mRNA measurements using qRT-PCR (see Chapter 7
General Methods section for detailed description of methods used)

Effects of binge EtOH exposure on body mass and growth rate.
In order to investigate the long lasting effects of binge EtOH exposure
during puberty, pubertal and then adult male rats were treated according to our
binge EtOH exposure paradigm (Fig 2 and Table 3). Animals at PND 37 were
randomly assigned to either 1) saline-treated (N = 30) or 2) binge EtOH treated
(N = 30, 3g/kg/day) groups and then allowed to grow till adulthood. On PND 68
(early adulthood) each group was divided into following treatment groups (Table
3): 1) saline only control groups (N=10); 2) acute EtOH groups (N=10) and 3)
binge EtOH groups (N=10).
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Experimental Design 2

Puberty (PND37-44)

Adult (PND 68-75)

Saline (n=10)
EtOH naïve
Saline (n = 30)

Acute EtOH (n=10)
Binge EtOH (n=10)
Saline (n=10)

EtOH pre-exposed
Binge EtOH (n = 30)

Acute EtOH (n=10)
Binge EtOH (n=10)

Table 3. Experimental design 2. During pubertal development animals were divided in
two treatment groups, saline (ip injection of saline once a day for 8 days) or binge EtOH
treatment (3 days of ip injections of 3g/kg EtOH, followed by 2 days of saline and again
by 3 days of EtOH injections). After pubertal treatments animals were undisturbed for a
month and then in adulthood each pubertal treatment group was divided into 3
subsequent treatment groups; 1) saline, 2) acute EtOH (7 days of saline followed by 1
day of 3g/kg EtOH injections), or 3) binge EtOH .
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Body weights were measured every other day during the duration of both
pubertal and adult treatments to determine whether pubertal binge pattern EtOH
exposure altered normal growth patterns. Growth curves for each treatment
group (Fig. 26A), and combined groups based on EtOH exposure during puberty
(Fig. 26B), show that there was a significant weight difference between animals
exposed to binge pattern EtOH starting from the fifth day of pubertal treatment
(Fig 26B, p<0.01). The weight difference increased by the last day of treatment
during puberty and persisted during the time when animals were undisturbed and
throughout the adult treatment regiment (Fig 25B, p<0.001). Animals did not lose
weight at any point, despite the fact that the animals that received binge EtOH
treatment had significantly lower body weights compared to saline-treated
controls. Interestingly, subsequent binge EtOH exposure in adulthood did not
further alter the growth pattern of adult animals (Fig 26).
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Fig 26. Effects of ethanol treatment on body weight during puberty and adulthood. Mean
body weights of male animals untreated treated with daily IP injections of saline, saline +
one day EtOH (acute), or binge EtOH paradigm. (A) represents body weights in all
groups separately and (B) shown combined body weight based on pubertal treatment
(saline or binge EtOH exposure). Data presented as mean body weight (g). * represents
statistically significant difference as compared to saline treated group on a given
treatment day (p<0.05).
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BAC following adult acute and binge EtOH exposure.
BACs were measured on the final day of adult treatment 60 min following
the injections. There were no statistically significant differences in BAC between
either acute (205.1±21.8; 221.8 ±19.1 for EtOH naïve and EtOH pre-exposed
groups, respectively) or binge EtOH treated groups (172.9 ±27.0; 208.2 ±28.2 for
EtOH naïve and EtOH pre-exposed groups, respectively) (Fig 27). BAC in
animals treated with saline were below the limit of detection for the assay.
Interestingly, prior EtOH exposure (i.e. EtOH pre-exposed binge group) had no
effect on adult BAC after either acute or binge EtOH treatments. The values
observed in EtOH-treated groups are consistent with the defined BAC threshold
for binge drinking (80 mg/dl) and showed that all EtOH-treated groups were
intoxicated to the same degree.
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Fig 27. Adult blood alcohol concentrations (BAC) following EtOH treatment. BAC 1.0 h
post-injection in adult animals pre-treated during peri-puberty with either saline (EtOH
Naïve) or binge EtOH paradigm (ETOH pre-exposed) then treated with saline, acute
EtOH or binge EtOH as adults. Data expressed as mean EtOH mg/dl. Dissimilar letters
indicate statistically significant difference between groups. More specifically a is
significantly different from b (P < 0.05).
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Binge-pattern EtOH exposure during peri-puberty significantly altered adult
CORT levels.
Circulating CORT levels were measured by RIA to determine whether
binge EtOH exposure during puberty affected responsiveness of the HPA axis to
subsequent EtOH exposures in adulthood. All measurements were taken in adult
animals and they were classified as either EtOH pre-exposed or EtOH naïve.
Three different measures of adult HPA reactivity, as ascertained from plasma
CORT levels, were compared: 1) basal pre-stress, 2) sensitivity to a single EtOH
exposure (acute stress), and 3) sensitivity to repeated EtOH exposure (binge –
repeated stress). Two-factor ANOVA was used to assess main effects of
pubertal and adult treatments and interactions between these two factors. Every
parameter measured was significantly different between animals that were EtOH
pre-exposed compared with those that only received saline during puberty (EtOH
naïve). There was a statistically significant main effect of EtOH treatment during
adulthood (F(2,51) = 71.218, p<0.001), no significant main effect of treatment
during puberty (F(1,51 ) = 3.305, p = 0.075 and a there was a significant
interaction between pubertal and adult treatment (F(2, 51) = 4.458, p = 0.016).
Overall, our data revealed that the pattern of plasma CORT responses were
significantly different depending on whether the animals were pre-exposed to
EtOH (Fig. 28). Notably, basal levels of plasma CORT were significantly lower in
animals that had previously been exposed to EtOH during pubertal development
compared with EtOH naïve animals (t(17) = 3.23, p = 0.005, Fig. 28, open bars).
Second, plasma CORT levels in animals that were pre-exposed to EtOH during
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puberty were significantly higher following adult treatment with a single (acute)
(t(18) = -2.247, p = 0.037) or binge-pattern EtOH (t(15) = -2.218, p = 0.042) (Fig.
28, hatched and solid bars), suggesting that the adult animals were more
sensitive, or that the HPA axis was potentially more responsive, to the stressful
effects of EtOH. Animals that did not have prior EtOH exposure also had
significantly elevated CORT levels following EtOH treatment in adulthood (F(2,
27) = 34.105, p <0.001), but as mentioned above, it was significantly lower than
the animals that were pre-exposed. Finally, animals that were pre-exposed to
EtOH during puberty failed to habituate to the binge-treatment paradigm as
indicated by their equivalently higher plasma CORT levels following a
subsequent acute or binge EtOH treatment (p = 0.358, Fig. 28). By stark
contrast, animals that received saline during puberty (EtOH naïve) did show a
habituation effect to the repeated binge EtOH treatment (p = 0.003), which is
consistent with our previous reports in peri-pubertal animals.
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Fig 28. Effects of pubertal binge EtOH pre-treatments on plasma CORT levels in EtOH
exposed adult animals. Plasma corticosterone (CORT) levels 1.0 h post-injection in adult
animals pre-treated with either saline (EtOH Naïve) or binge EtOH paradigm (EtOH preexposed) during peri-puberty and then treated with saline, acute EtOH or binge EtOH
paradigm in adulthood. Data expressed as mean CORT ng/ml of blood. Dissimilar letters
indicate statistically significant difference. More specifically a is significantly different
from b, c, d, e and be; e is different from a, b, c, d, but not from be and so on (P < 0.05).
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Binge-pattern EtOH exposure during puberty significantly altered responsiveness
of adult CRH and AVP mRNA in the PVN to subsequent EtOH exposure.
Next, we measured CRH and AVP mRNA in the PVN using quantitative
RT-PCR to determine the long-term effects of pubertal binge EtOH exposure on
adult HPA axis reactivity. CRH and AVP mRNA were used as endpoints to
ascertain three different measures of adult HPA axis status: 1) basal pre-stress,
2) sensitivity to a single EtOH exposure (acute stress), and 3) sensitivity to
repeated EtOH exposure (binge – repeated stress). Two-way AVOVA showed
that there was a main effect of EtOH treatment during puberty on adult CRH
mRNA expression (F(1, 42) = 8.641, p = 0.005), as well as a main effect of
pubertal treatment (F(1, 44) = 4.876, p = 0.032) and adult treatment (F(2, 44) =
5.835, p = 0.006) for AVP mRNA expression in the PVN (Fig 29 and 30). Similar
to the results obtained with plasma CORT levels, the patterns of gene expression
for CRH and AVP were significantly different depending on whether the animals
were pre-exposed to EtOH or EtOH naïve.
Basal pre-stress levels of CRH mRNA was significantly higher in animals
that were exposed to EtOH during puberty compared with those that received
saline (EtOH naïve) (t(14) = -2.175, p = 0.047) (Fig. 29, open bars). A single
(acute) dose of EtOH significantly increased CRH mRNA levels (t(14) = -2.363, p
= 0.033) in animals that were pre-exposed to EtOH during adolescence, yet had
no effect in animals that were EtOH naïve (Fig. 29, hatched bars). Conversely,
binge-pattern EtOH exposure significantly increased CRH mRNA levels in EtOH
pre-exposed animals compared to EtOH naive, however the levels were not
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statistically different from the baseline levels of EtOH pre-exposed animals (Fig.
29, solid bars).
Pre-exposure to EtOH during puberty had no effect on baseline levels of
adult AVP mRNA (t(15) = -1.342, p = 0.199, Fig. 30, open bars). However
compared to baseline, a single (acute) dose significantly decreased AVP mRNA
levels in EtOH naïve animals (t(15) = -2.214, p = 0.043), but had no significant
effect compared to baseline in animals pre-exposed to EtOH (Fig. 30, hatched
bars). Binge-pattern EtOH exposure significantly decreased AVP mRNA levels
compared to baseline in both groups, however the levels were only different from
acute EtOH treatment in the pre-exposed group (Fig. 30, solid bars).
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Fig 29. Effects of pubertal binge EtOH pre-treatments on CRH gene expression in the
PVN of EtOH exposed adult rats. CRH mRNA expression in adult animals pre-treated
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peripuberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data
expressed as mRNA copies/µg total RNA. Dissimilar letters indicate statistically
significant difference between groups. For example, a is significantly different from b and
c but is not significantly different from ab, c is different from a, b and ab (P < 0.05).
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Fig 30. Effects of pubertal binge EtOH pre-treatments on AVP gene expression in the
PVN of EtOH exposed adult rats. AVP mRNA expression in adult animals pre-treated
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peripuberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data
expressed as mRNA copies/µg total RNA. Dissimilar letters indicate statistically
significant difference. More specifically a is significantly different from b and bc; b is
different from a but not bc (P < 0.05).
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Binge EtOH exposure during puberty does not change the expression of the AVP
mRNA in adult SON.
To confirm that the observed changes in the expression of the AVP mRNA
in PVN after EtOH treatments were not due to the reported diuretic effects of
alcohol, we measured AVP mRNA expression in the supraoptic nucleus of the
hypothalamus (SON), a region responsible for maintaining water homeostasis.
Two way AVOVA showed no main effects of either pubertal (F(1, 48) = 0.65, p =
0.424) or adult (F(2, 48) = 1.72, p = 0.19) treatment and no significant
interactions between treatments during puberty and during adulthood (F(2,48) =
1.359, p = 0.267) (Fig 31).
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Fig 31. Effects of pubertal binge EtOH pre-treatments on AVP gene expression in the
SON of EtOH exposed adult rats. AVP mRNA expression in adult animals pre-treated
with either saline (EtOH naïve) or binge EtOH paradigm (EtOH pre-exposed) during peripuberty and then treated with saline, acute EtOH or binge EtOH in adulthood. Data
expressed as AVP mRNA copies/µg total RNA.
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Discussion
The goals of this study were to 1) identify the long lasting effects of binge
EtOH exposure during pubertal development on the maturation of the HPA axis
by measuring circulating CORT, and hypothalamic neuropeptides (CRH and
AVP), previously identified to be susceptible to EtOH effects and 2) determine
whether binge-pattern EtOH exposure during puberty renders the adult HPA axis
more sensitive, or responsive, to subsequent EtOH exposure. The most striking
finding of our study was that exposure to binge-pattern EtOH during puberty
resulted in a permanent dysregulation of the adult HPA axis, which is consistent
with our hypothesis and is substantiated by the following data. First, adult
animals that were previously exposed to binge-pattern EtOH during puberty had
significantly lower circulating basal CORT levels, yet increased basal CRH
mRNA expression in the PVN. We previously showed that peri-pubertal animals
exposed to binge-pattern EtOH had significantly elevated levels of CRH and AVP
mRNA in the PVN (Przybycien-Szymanska, Rao et al. 2009) and the present
data demonstrate that those observed elevated CRH levels are maintained well
into adulthood. Second, binge EtOH exposure during puberty sensitized the
adult HPA axis to subsequent stressful stimuli (acute EtOH exposure), evident by
a marked increase in adult levels of CRH mRNA in the PVN and higher
circulating CORT levels compared to controls following a single exposure to
EtOH. Finally, the stress response to EtOH exposure was significantly
exacerbated and there was no habituation effect following repeated doses of
EtOH in adults that were previously exposed to binge-pattern EtOH during
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pubertal development, which is contrary to the effects observed in adult EtOH
naïve animals. Collectively, present results underscore the heightened reactivity
of the adult HPA axis in animals previously exposed to alcohol during
adolescence and suggest that EtOH might interfere with the normal development
of the HPA axis. See Fig 32 for summary of major finding in Chapter 5.
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SUMMARY; The effects of pubertal; binge EtOH exposure on adult HPA axis reactivity
EtOH naïve males (PND 68-74)
-

NO CHANGES in CRH mRNA levels in the PVN after EtOH exposures

-

Acute and binge EtOH exposures ↑ plasma CORT levels, habituation effect
present

EtOH pre-exposed males (PND 68-74)
-

Acute EtOH ↑ CRH and AVP mRNA in the PVN (as compared to EtOH naïve)

-

In EtOH pre-exposed during puberty animals there was ↓ basal plasma CORT
levels (as compared to EtOH naïve)

-

EtOH pre-exposed rats had ENHANCED ↑ in plasma CORT after subsequent
acute and binge EtOH, No habituation
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Fig 32. Summary of results described in Chapter 5. In EtOH-naive (A) binge EtOH
exposure did not change CRH and AVP mRNA in the PVN and ↑ plasma CORT levels.
In EtOH pre-exposed during puberty animals (B), binge EtOH exposure increased the
CRH and AVP mRNA in the PVN and enhanced an increase in plasma CORT levels
after acute and binge EtOH exposures. These data indicate that binge EtOH exposure
during puberty induces long lasting changes in functioning of the HPA axis.

EtOH is a potent activator of the stress response as indicated by
increased plasma CORT levels after both acute and binge treatments, however
repeated doses over several days (i.e. binge-pattern) leads to an habituation
effect (Przybycien-Szymanska, Rao et al. 2009). This same pattern has been
observed with other types of psychological and physiological stressor (acute vs.
chronic stress) in adult animals. Adult animals exhibit a high increase in CORT
levels after exposure to a single predator stress however, after chronic homotypic
stress this response is diminished (Figueiredo, Bodie et al. 2003). Herein, we
have shown that animals exposed to acute or binge EtOH only during adulthood
had increased plasma CORT levels and, as observed in pubertal animals, this
effect was diminished following a binge-pattern of EtOH exposure indicating
habituation of the HPA axis to the repeated homotypic stressor. By contrast,
adult animals that received prior EtOH exposure during puberty not only had
higher plasma CORT levels, but the habituation effect was not observed. These
data indicate that after binge EtOH exposure during puberty, the HPA axis is not
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only more sensitive to subsequent EtOH exposures but also that its normal ability
to habituate to repeated stressors is compromised.
These data are consistent with other studies that show adult EtOH
exposure alters the expression of CRH and AVP in the PVN (Rivier and Lee
1996; Ogilvie, Lee et al. 1997; Silva, Madeira et al. 2002; Silva, Paula-Barbosa et
al. 2002). For instance, adult rats treated with a single 3g/kg EtOH dose had
increased CRH and AVP mRNA in the PVN, whereas chronic dietary EtOH
treatment reduced the number of AVP immunoreactive neurons in that same
brain region (Silva, Madeira et al. 2002). Notably, the decreased AVP
immunoreactivity was maintained 4 months after EtOH withdrawal in animals that
received chronic dietary EtOH treatment, highlighting the potential for EtOH to
exert a permanent effect on specific regulatory parameters of the HPA axis. We
have shown previously that binge-pattern, but not acute, EtOH exposure during
puberty increased both CRH and AVP mRNA in the PVN (PrzybycienSzymanska, Rao et al. 2009). Contrary to what has been observed in other
studies in adult EtOH naïve animals, (Ogilvie, Lee et al. 1997; Ogilvie, Lee et al.
1997; Ogilvie, Lee et al. 1998), we did not observe an increase in the CRH
mRNA levels in adult animals treated with acute EtOH exposure. This
discrepancy is possibly due to differences in mRNA detection methods, as well
as timing. In our study, we measured CRH and AVP mRNA levels one hour
following the last EtOH injection. To our knowledge there are no other reports
that have measured CRH and AVP gene expression this early following EtOH
exposure. In this study, we show that this increased gene expression persists
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into adulthood regardless of subsequent EtOH exposure, although the molecular
mechanisms mediating these long-term changes remain to be elucidated.
Recent evidence suggests that acute alcohol exposure can interfere
directly with CRH promoter activity to alter CRH gene transcription (Li, Kang et
al. 2005). For example, Li et al., showed that alcohol decreased forskolin-induced
increase in CRH promoter activity possibly by interfering at the cAMP response
element (CRE) site in the NO108-15 cell line (Li, Kang et al. 2005). In addition,
recent evidence also suggests that EtOH can alter the DNA status (Pandey,
Ugale et al. 2008) or glucocorticoid response element (GRE):DNA binding in
different brain regions, including cortex and hippocampus, due to chromatin
remodelling (Roy, Mittal et al. 2002), raising the possibility that epigenetic
mechanisms might underlie the EtOH-induced long-term changes in CRH and
AVP gene expression. Histone deacetylases (HDAC) have the ability to remove
acetyl groups off the chromatin making DNA more dense and unavailable for
transcriptional machinery (Grunstein 1997). Interestingly, Pandey at al. showed
that HDAC activity was decreased following acute EtOH exposure (single 1g/kg
injection of EtOH), yet increased after chronic EtOH exposure (15 days of 9%
EtOH liquid diet) in adult animals (Pandey, Ugale et al. 2008). One possibility is
that binge-pattern EtOH exposure during puberty induces remodelling of the
chromatin surrounding the CRH and/or AVP genes thereby permanently altering
the access of transcriptional regulators for these gene promoters.
To my knowledge this is the first study showing the effects of adolescent
binge EtOH exposure on adult HPA axis reactivity, however other reports have
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demonstrated that pubertal EtOH exposure has long lasting effects on a variety
of other CNS systems and brain regions, including the mesolimbic dopaminergic
and glutaminergic system (Pascual, Boix et al. 2009), hippocampus, and
cerebellum (Pascual, Blanco et al. 2007). Such changes in the CNS are often
manifested by altered adult behaviour patterns (Maldonado-Devincci, Badanich
et al.; Pascual, Blanco et al. 2007; Pascual, Boix et al. 2009). For example,
Pascual et al. showed that 2 weeks of intermittent EtOH administration (single IP
injection of 3g/kg EtOH for two consecutive days, followed by 2 day rest, then
followed again by 2 days of EtOH injections) caused an increase in voluntary
EtOH consumption in adult animals (Pascual, Boix et al. 2009). In a different
study, they also showed that this intermittent pattern of EtOH administration
induced long lasting deficits in learning ability, as discerned by a decreased
number of correct choices in conditional discrimination learning task, and a
reduced ability to adapt to a challenging environment in adulthood in a narrow
beam task (Pascual, Blanco et al. 2007). Our data showing parallel effects of
peri-pubertal binge EtOH exposure to the effects of juvenile stressors on the
adult HPA axis (Avital and Richter-Levin 2005) or juvenile/early puberty EtOH
exposure on EtOH abuse in adulthood (Pascual, Boix et al. 2009) indicate that
during the peri-pubertal period the HPA axis is still immature and extremely
vulnerable to EtOH-induced insults (Zilberman, Tavares et al. 2003; McEvoy and
Shand 2008).
Physiological parameters of HPA axis, such as CORT and neuropeptide
levels, are markedly different in response to both acute and chronic stressors in
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juvenile compared with adult animals, suggesting that an extensive maturational
process occurs during the pubertal transition (Jankord, Solomon et al.; Romeo,
Lee et al. 2004; Romeo, Bellani et al. 2006; Romeo and McEwen 2006{Laroche,
2009 #190; McCormick and Mathews 2007; Evuarherhe, Leggett et al. 2009;
Evuarherhe, Leggett et al. 2009; Laroche, Gasbarro et al. 2009). Most striking is
the observation that corticosterone and ACTH levels take much longer to return
to baseline in juvenile compared to adult animals when subjected to a variety of
stressful stimuli (Vazquez and Akil 1993; Romeo, Bellani et al. 2006). Further,
juveniles have higher overall stress reactivity (Romeo, Bellani et al. 2006) and
chronic stress during puberty has been shown to result in an exaggerated stressinduced CORT response in adulthood (Jankord, Solomon et al.; Isgor, Cecchi et
al. 2003). My results are consistent with these observations, as our animals preexposed to binge-pattern EtOH had a similarly exaggerated response to a
subsequent EtOH stressor during adulthood. It is important to note that there are
some inconsistencies between studies depending on the type of stressor and the
specific paradigm (i.e. homotypic vs. heterotypic, chronic vs. acute).
Consequently, the effects of EtOH on the HPA axis during adolescence may not
necessarily be reflective of other types of stressors. Nevertheless, these data
contribute to the growing body of evidence that perturbations to the HPA axis
during this critical period of pubertal development can potentially have long
lasting consequences for the adult stress response.
We are confident that the effects observed here on the expression of the
AVP mRNA are specific to changes in the population of cells located in the
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pPVN, and not to the magnocellular region. First, our data are consistent with
our previous report showing no changes in the AVP mRNA expression in SON, a
region largely responsible for maintaining osmotic homeostasis (PrzybycienSzymanska, Rao et al. 2009). Second, our data are also consistent with other
reports showing that EtOH induced changes only in AVP-expressing neurons
located in the pPVN, and not mPVN (Silva, Paula-Barbosa et al. 2002). Finally,
the diuretic effects of EtOH are rapid and transient, making it unlikely to
contribute to long lasting changes in AVP expression in the PVN.
Binge alcohol consumption among adolescents is a fundamental problem
and mood disorders among both young and adult populations are increasing,
therefore elucidating the long lasting consequences of binge EtOH exposure
during adolescence is critical for understanding the aetiology of certain mood
disorders. In this study we have identified long lasting effects of binge pattern
EtOH exposure during peri-puberty on the central regulators of the HPA axis,
CRH and AVP, and on the adult stress response. We have shown that adults
who were exposed to a binge-pattern of alcohol during pubertal development
have increased stress responses after subsequent alcohol exposure.
Dysregulation of the HPA axis has been shown to be predictive of developing
mood disorders however more experiments, such as introducing a novel stressor
and measuring behavioural outcomes, are needed to determine if there is a
direct link between binge-pattern alcohol exposure and the development of mood
disorders. Overall, these data have identified yet another system and additional
molecular targets that are affected long term by adolescent alcohol exposure and
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may lead to better understanding of factors that regulate HPA axis maturation
during pubertal development.

Chapter Six
FINAL DISCUSSION
Summary
Our current understanding of how binge alcohol consumption affects the
developing adolescent brain is severely limited. To date, specific molecular and
neuroendocrine markers that are activated by alcohol during puberty and long
lasting consequences of this pattern of alcohol exposure during this critical time
period of development have not been identified. Elucidating the neurobiological
targets of EtOH resulting from a binge pattern of EtOH consumption during
adolescence is critical for understanding the long-term molecular and behavioral
consequences of binge EtOH exposure and potential mechanisms that may be
involved in development of mental health disorders. Therefore, the major goal of
studies presented herein was to investigate the long lasting effects of binge EtOH
exposure during puberty on the sensitivity of adult HPA axis to EtOH exposures
in adulthood, as well as short term effects of this pattern of EtOH exposure and
possible molecular mechanisms involved in these effects. In addition, in these
studies I sought to investigate potential mechanisms responsible for observed
sex differences in EtOH induced alteration of the HPA axis.
Based on my data, I can conclude that my hypothesis, that in males, binge
pattern EtOH exposure during pubertal development dysregulates functioning of
152
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adult HPA axis and that this effect is caused by long lasting changes in the PVN
expression of CRH and AVP during adolescence mediated by direct actions of
EtOH at the level of the CRH promoter, has been supported. (see Table 4 for
summary of major findings).
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SUMMARY OF MAJOR FINDINGS
Chapter 2. Effects of binge alcohol exposure in adolescence
Males (PND 37-44):
-

Binge EtOH INCREASED CRH and AVP mRNA in the PVN
Acute and Binge ETOH INCREASED plasma CORT levels,
habituation effect after binge

Females (PND 37-44)
-

NO CHANGES in the CRH and AVP mRNA in the PVN after EtOH
treatmnet
Acute and Binge EtOH INCREASED plasma CORT levels, habituation
effect after binge

Chapter 3. Molecular mechanisms behind alcohol effects
-

12.5 and 100 mM EtOH ↓ CRH promoter activity at 0.5 h
12.5 and 100 mM EtOH EtOH ↑ CRH promoter activity at 2.0 h
An increase in the promoter activity at 2.0 h is dependant on the
nGRE and CRE sites

Chapter 4. Mechanisms behind sex differences
Ch-treated females (PND 37-44)
-

Binge EtOH ↓ CRH and AVP mRNA in the PVN
Acute and binge EtOH ↑ plasma CORT levels, no habituation after
binge

E2-treated females (PND 37-44)
-

NO CHANGES in the CRH and AVP mRNA after EtOH treatmnet
habituation effect after binge EtOH exposure present

Chapter 5. Long lasting consequences of binge alcohol exposure during puberty
EtOH naïve males (PND 68-74)
-

NO CHANGES in CRH mRNA levels in the PVN due to EtOH
treatmnets
Acute and Binge EtOH ↑ plasma CORT levels, habituation effect after
binge EtOH exposure present
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SUMMARY OF MAJOR FINDINGS c.d.
EtOH pre-exposed males (PND 68-74)
-

Acute EtOH in adulthood ↑ CRH and AVP mRNA in the PVN (as
compared to EtOH naïve)
Pubertal binge EtOH exposure ↓ basal plasma CORT levels (as
compared to EtOH naïve)
Pubertal binge EtOH exposure resulted in ENHANCED ↑ in plasma
CORT after subsequent acute and binge EtOH exposures in adults
No habituation effect after subsequent binge EtOH in adults

Table 4. Summary of major findings. Data compared to saline treated controls. In EtOH
pre-exposed group data compared to EtOH naïve group.
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Data presented in this report clearly show that binge pattern EtOH
exposure during peri-pubertal development induces changes in CRH and AVP
gene expression in the PVN, the main brain region responsible for coordinating
stress responses, and circulating CORT levels. I showed that the effects of binge
EtOH exposure are sexually dimorphic and that these sex differences are
mediated by E2. In peri-pubertal females, E2 is responsible for maintaining basal
levels of CRH and AVP mRNA in the PVN even after binge EtOH exposure and
for the observed habituation effects after binge EtOH exposure. In addition, I
showed that EtOH-nGRE-CRH DNA interaction disrupt normal glucocorticoid
negative feedback exerted at the level of the CRH promoter in a PVN derived cell
line. Lastly, I showed that the changes observed during peri-puberty are long
lasting and result in dysregulation of functioning of adult HPA axis. Notably, in
peri-pubertal male rats binge EtOH exposure increased CRH and AVP mRNA in
the PVN in a permanent fashion and this permanent alteration in the HPA axis
resulted in dysregulation of the HPA axis in adulthood. Normal maturation of the
HPA axis that should occur during pubertal development was compromised by
binge EtOH exposure during peri-puberty because binge EtOH exposure during
this time period resulted in more sensitive/dysregulated HPA axis in adulthood.
Based on these data, I can speculate that this long lasting binge-EtOH-exposureinduced HPA axis dysregulation may result in mood disturbances in adulthood
and may lead to increased risk for developing mood disorders in adulthood.
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Final considerations
Binge alcohol exposure and magnocellular PVN and SON systems
Although it was not possible to separate the parvocellular and
magnocellular divisions of the PVN in my tissue microdissection sample
preparations, I am confident that the EtOH-induced changes in the AVP
expression in all experiments presented here, accurately reflect changes in the
AVP-expressing neurons associated with regulation of the HPA axis, and not in
those responsible for osmoregulation for the following reasons. First, I showed
that there were no changes in the expression of the AVP mRNA in the SON, a
region where AVP is primarily responsible for regulating fluid homeostasis, both
in adolescent male and female rats as well as in adult male rats. Second, there
was no effect of EtOH in either peri-pubertal or adult acute-treated groups and
since fluid homeostasis is an immediate and not cumulative physiological
response, any diuretic effect of EtOH would have been observed in the acutely
treated groups. Third, if the effects of EtOH on the AVP expression were due to
an osmoregulatory effect, I would have expected to see a significant increase in
the AVP mRNA in the PVN of peri-pubertal females, as well as peri-pubertal and
adult males. Fourth, the diuretic effects of EtOH are rapid and transient, making it
unlikely to contribute to any long lasting changes in AVP expression in the PVN
and finally, my data are in agreement with previous studies showing that there
were no changes in AVP expression in the magnocellular division of the PVN 3.0
h after an acute EtOH administration (Ogilvie, Lee et al. 1997).
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The only time when I observed binge EtOH exposure induced changes in
the AVP mRNA in the SON were in ovariectomized peri-pubertal females
replaced with Ch. In these females, binge EtOH exposure decreased the AVP
mRNA expression in the SON. This effect could be explained in two ways. First,
data showing decreased AVP mRNA in the SON is consistent with diuretic
effects of EtOH on the AVP as the AVP is mostly known as antiduretic hormone
(ADH). This explanation is highly unlikely because of the reasons described in
the previous paragraph. Second, based on previous reports, I can speculate that
EtOH induced changes in the PVN could influence gene expression in the SON.
EtOH could induce cell death in the PVN which would result in a decreased
expression of AVP mRNA in the SON. This explanation is consistent with
previous reports showing that the AVP mRNA in the SON is decreased following
EtOH exposure but only in rats bearing PVN lesions (Ogilvie, Lee et al. 1997)
and AVP is neuroprotective in a PVN derived neuronal cell line (H32) (Chen,
Volpi et al. 2008; Chen, Liu et al. 2009). Addition of the AVP to the media was
found to protect against serum starvation induced apoptotic cell death in these
neurons (Chen, Volpi et al. 2008; Chen, Liu et al. 2009). EtOH induced cell death
in the PVN could be responsible for a decrease in the AVP mRNA in the PVN in
Ch-treated females. It is likely that this decrease in the AVP mRNA in the PVN
resulted in a decrease in the AVP mRNA in the SON as the functions of these
two nuclei have been shown to be linked (Ogilvie, Lee et al. 1997). The
cooperation between both magnocellular and parvocellular AVP systems needs
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to be further investigated in order to support this hypothesis even though this
explanation at this moment seems to be most likely.
Overall, these data indicate that in intact peri-pubertal and adult animals
EtOH induced changes in the PVN are not due to diuretic effects of EtOH on the
magnocellular division of the PVN and are specific to regulation of the HPA axis.

Body weight changes after EtOH treatments.
In males treated with binge EtOH exposure during puberty and then again
in adulthood, data showed that pubertal binge-pattern EtOH exposure retarded
the rate of weight gain as compared to their saline treated counterparts. This
effect persisted into adulthood and resulted in adult animals that were
significantly smaller than controls. It is important to note that these animals did
not lose weight, but rather gained at a slower pace. Interestingly, this weight gap
persisted throughout the period of one month during which animals were
undisturbed and throughout adult EtOH treatments which had no further effects
on the growth rate of animals. This growth rate retardation could be explained by
following reasons. First, it is well known that both animals and humans undergo a
growth spurt during pubertal development marked by an increase in muscle and
bone mass (Gregory, Greene et al. 1992; Soliman, Khadir et al. 1995; Mauras,
Rogol et al. 1996; Schoenau 2006; Venken, Moverare-Skrtic et al. 2007;
Pradidarcheep and Showpittapornchai 2009) . In these experiments, binge EtOH
treatment occurred during puberty and possibly during the critical period for
weight gain. Alcohol is known to decrease bone and muscle mass (Callaci,
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Himes et al.; Elmali, Ertem et al. 2002; Lauing, Himes et al. 2008; Alvisa-Negrin,
Gonzalez-Reimers et al. 2009; Callaci, Himes et al. 2009), therefore it is possible
that if EtOH exposure occurred during pubertal maturation, it hindered muscle
mass and possibly bone gain and resulted in a permanent decrease in body
weight. This critical period hypothesis is consistent with the fact that in adult
animals, not undergoing growth spurt, binge EtOH exposure did not further cause
growth retardation. Second, it is also possible that EtOH effects on sex steroid
hormones were involved in the weight gain retardation observed. T levels
increase markedly during puberty (Huhtaniemi, Nevo et al. 1986; Delemarre-van
de Waal, van Coeverden et al. 2002; Evuarherhe, Leggett et al. 2009;
Pradidarcheep and Showpittapornchai 2009) and T increased muscle tone
contributes to the weight gain during pubertal development (Soliman, Khadir et
al. 1995; Schoenau 2006; Pradidarcheep and Showpittapornchai 2009). I
showed in peri-pubertal male rats that binge EtOH exposure decreased plasma T
levels (Przybycien-Szymanska, Rao et al. 2010). This EtOH-induced decrease in
plasma T levels could contribute to the slower weight gain in male rats that were
exposed to binge EtOH during puberty. This weight difference was not observed
in any of my previous studies most likely due to the shorter experimental time
period and a smaller number of animals per treatment group. Lastly, it is also
possible that in pubertal animals, binge-EtOH-exposure-induced elevated CORT
levels inhibited feeding behavior. It is well established that during stress, elevated
plasma CORT levels ingibit feeding behavior and cause muscle wasting (Tomas,
Munro et al. 1979; Sapolsky, Romero et al. 2000). Binge EtOH exposure by
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cousing elevation in plasma CORT levels could contribute to permanent
decrease in body weight possible due to decreased food intake and increased
muscle wasting during the growth spurt of animals. Together, these data support
the notion that puberty is extremely vulnerable to alcohol abuse and effects of
binge drinking during this developmental period can not only be manifested at the
level of the central nervous system, but also can potentially disrupt normal
homeostatic metabolic processes.

Additional notes about the binge EtOH exposure paradigm
This binge EtOH exposure paradigm employed in all of the studies
presented herein was very useful because it allowed us to distinguish the
pharmacological effects of EtOH from the effects of other nonspecific stressors,
such as handling and injections. A similar binge EtOH exposure paradigm has
been previously shown to be reliable for testing the effects of alcohol using an
exposure pattern that is typical for adolescents (Lauing, Himes et al. 2008) . In
addition, it has been show that the IP injection of EtOH, employed in my
paradigm, does not appear to result in significantly different BAC compared to
oral gavage in adolescent Wistar rats (Walker and Ehlers 2009), therefore the IP
route of administration has been chosen as the least stressful method.
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Future Directions
Data presented herein add a substantial amount to our knowledge of
consequences of alcohol exposure in adolescence, however, there are many
more questions that remain unanswered.
First, a direct link between binge EtOH exposure in adolescence,
dysregulation of the HPA axis in adulthood, and the development of mood
disorders in adulthood needs to be established. In studies presented herein, I
have identified long lasting effects of binge pattern EtOH exposure during peripuberty on the central regulators of the HPA axis, CRH and AVP, and on adult
stress response measured by plasma CORT levels. I have shown that adults
who were exposed to a binge-pattern of EtOH during pubertal development have
increased stress responses after subsequent EtOH exposure. Dysregulation of
the HPA axis has been shown to be predictive of developing mood disorders
however more experiments, such as introducing a novel stressor and measuring
behavioural outcomes, are needed to determine if there is this direct link between
binge-pattern EtOH exposure during puberty and the development of mood
disorders in adulthood. In the future, I would like to measure anxiety-like
behaviors in adult animals exposed to “binging” during puberty using a variety of
behavioral methods, including elevated plus maze, light-dark box and open field
test. I would also like to test whether animals pre-exposed to binge EtOH during
peri-puberty are more sensitive to other types of stressors, for example restraint
stress, by measuring their CORT responses and changes in CRH and AVP
mRNA expression after the stressor. These data would not only give me a direct
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and clear link between binge alcohol consumption in adolescence and increased
risk for developing mood disorders in adulthood, but would also strengthen my
argument that binge drinking during adolescence has detrimental consequences
for proper maturation of the HPA axis.
Binge EtOH exposure has sex specific effects on the pubertal HPA axis.
One very important question that still remains unanswered is whether females
are protected from long lasting detrimental effects of binge EtOH exposure
because they do not exhibit the same changes in gene expression as males or is
EtOH exposure during puberty more detrimental for females. In the future, I
would like to investigate the CRH and AVP mRNA expression in the PVN as well
as changes in circulating CORT levels in adult females pre-exposed to binge
EtOH during puberty and compare these changes with changes occurring in
males. If binge EtOH exposure in peri-pubertal females also induces long lasting
changes in functions of the HPA axis, the next step would be to investigate
anxiety-like behaviors and responses to heterotypic stressors in these females.
Results of these experiments would tell us if pubertal females are more
susceptible to the detrimental effects of alcohol and they could lead us to a better
understanding of the mechanisms behind these sex differences.
17β-estradiol is partially responsible for sex differences in the
responsiveness of pubertal HPA axis to binge EtOH exposure; however, it is not
the only factor involved. In ovariectomized females replaced with Ch, there was a
decrease in the CRH and AVP mRNA in the PVN and SON which is contrary to
what was observed in intact peri-pubertal males. Further studies in
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ovariectomized females replaced with other steroid hormones, for instance T or
its metabolites need to be performed in order to better understand the
mechanisms behind these sex differences. In these experiments, plasma CORT
levels and PVN expression of CRH and AVP mRNA would be measured in
ovariectomized females replaced with T or DHT and these effects would be
compared to ovariectomized females replaced with E2 or cholesterol. In addition
to these in vivo experiments, to better understand the interactions between EtOH
and sex steroid hormones, CRH promoter activity would also be measured after
EtOH treatment in the presence of androgen receptor agonists.
I showed that EtOH-GR signaling is responsible for the EtOH-induced
increase in CRH promoter activity and possibly CRH mRNA expression in the
PVN, although it is still not clear what causes a decrease in the promoter activity
at the 0.5 h time point, as GR antagonist treatment and deletion of specific GR
binding sites within nGRE site did not abolish this decrease. I would like to
investigate EtOH-induced changes in upstream signaling molecules and changes
in early response genes as these may be involved in this initial decrease in the
promoter activity. Some possible target molecules may be kinases that affect
cAMP signaling (PKA) or small ubiqitin-related modifiers (SUMO) that may affect
GR induced changes in the CRH promoter activity and gene transcription. For
example, it has been shown that SUMO-1 can increase the GR stability and
increase GR transcriptional activity (Le Drean, Mincheneau et al. 2002) therefore
the effects of EtOH on SUMO need to be investigated. We also need to
investigate the interaction of EtOH with GABA signaling using EtOH treatment in
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the presence of GABA receptor agonists and antagonists as GABAergic inputs to
the PVN are major inhibitory inputs to the PVN (Cole and Sawchenko 2002). It is
possible that at the 0.5 h time point, EtOH strengthens this GABA inhibition and
results in decreased CRH promoter activity. Another possibility is that AVP
mediates the decrease in CRH promoter activity at the 0.5 h time point. It has
been shown that a rapid and local release of AVP has an inhibitory tone on the
HPA axis and this effect is mediated through AVP R1 (Wotjak, Kubota et al.
1996). Therefore, it is possible that EtOH affects AVP receptors to inhibit CRH
promoter activity. I would like to investigate the effects of EtOH in the presence of
AVP, AVP receptors and AVP R agonist and antagonist to test for possible
interactions between AVP and EtOH on the CRH promoter.
To strengthen my hypothesis that EtOH interferes with GR:DNA binding, I
would also like to investigate these interactions in the presence and absence of
EtOH in vivo and in vitro using chromatin immunoprecipitation assay (ChIP).
Even though it has been shown in vivo, that EtOH decreases GR-DNA binding in
the hippocampus (Roy, Mittal et al. 2002), this effect needs to be confirmed in the
PVN derived cells. If there was a decrease in the GR-CRH DNA binding after
EtOH treatment in both in vitro and in vivo, this would confirm my hypothesis that
EtOH induced increase in CRH promoter activity is mediated by EtOH induced
decrease in GR-CRH DNA binding.
My in vitro data describe mechanisms involved in EtOH-induced changes
in the CRH promoter activity and potentially CRH mRNA. In addition to CRH, my
in vivo data identified yet another target of EtOH actions in the PVN, which is
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AVP. It would be important in the future to investigate molecular mechanisms
behind EtOH effects on this neuropeptide as they may be different from the
mechanisms described for CRH. Time course experiments would need to be
performed in order to investigate if EtOH can directly modulate AVP promoter
activity and if yes, it would be important to investigate effects of EtOH on AVP
promoter activity in AVP promoter lacking specific regulatory sites. It is possible
that mechanisms behind EtOH-induced changes in the AVP mRNA are different
from mechanisms responsible for changes in the CRH mRNA, however, it is
very likely that EtOH exerts similar effects on this promoter as the AVP promoter
also contains GRE site and CRE site and is regulated at these sites in the same
way as the CRH promoter (Iwasaki, Oiso et al. 1997; Kim, Summer et al. 2001;
Yoshida, Iwasaki et al. 2006).

Take Home Message
My data clearly show that binge EtOH exposure has detrimental
consequences for the adult HPA axis. Even though more experiments need to be
performed in order to support this conclusion, binge alcohol consumption in
adolescence may lead to increased risk for developing mood disorders in
adulthood.

CHAPTER SEVEN
GENERAL METHODS
Animals
Male and female Wistar rats were purchased from Charles River
Laboratories (Wilmington, MA) at weaning (post natal day (PND) 23) and allowed
to acclimate to the new environment for several days after arrival. Pre-pubertal
females on PND 26, were bilaterally ovariectomized and replaced with silastic
capsules containing either 17β-estradiol (E2) or cholesterol (Ch). On PND 30,
animals were handled 5 min/day for 7 days. EtOH treatments begun on PND 37.
Animals were housed on a 12 h light 12 h dark cycle with lights on at 07.00h.
Food and water were available ad libitum and all procedures were approved by
the Loyola University Medical Center Institutional Animal Care and Use
Committee (IACUC).

Binge Exposure Paradigm.
After one week of handling, animals were divided into one of 4 groups and
begun the following treatments: 1) UNTREATED 2) SALINE ONLY
(intraperitoneal (ip) saline injection once/day for 8 days), 3) ACUTE EtOH (saline
injection once/day for 7 days; one 3g/kg EtOH injection on day of sacrifice), 4)
BINGE EtOH (intraperitoneal (IP) 20% (v/v in saline) (Fig 2) EtOH injection every
morning at 10:00 AM for 3 consecutive days, followed by 2 days of saline
167
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injections, and then injected for additional 3 days with EtOH). A similar binge
exposure paradigm has been used previously to mimic the pattern of binge EtOH
consumption in adolescents (Lauing, Himes et al. 2008). It has been shown that
this route of EtOH administration does not yield statistically different BAC
compared to oral gavage (Walker and Ehlers 2009).
Importantly, the animals were given EtOH in the morning. Previous
studies showed that morning EtOH administration does not interfere with normal
feeding behaviour and does not result in body weight differences between EtOHtreated and control animals, thus eliminating the need for pair-fed controls
(Lauing, Himes et al. 2008; Przybycien-Szymanska, Rao et al. 2009). On the last
day of pubertal or adult treatments, one hour after the injection, animals were
sacrificed by decapitation under Halothane anesthesia and trunk blood and
brains were collected.

Blood alcohol concentration (BAC) measurements:
Trunk blood samples were collected into heparinised tubes, centrifuged at
3000 rpm for 10 min. at 4ºC; and plasma stored at -20ºC. Blood alcohol levels
were determined by measuring the change in absorbance at 340 nm following
enzymatic oxidation of EtOH to acetylaldehyde (Point Scientific Alcohol Reagent
Kit). Assay range is 0 to 400 mg/dl and intra and interassay CV = 8.9% and
7.86%, respectively.
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Hormone measurements:
Blood samples were collected into heparinized tubes, centrifuged at 3000
rpm for 10 min at 4ºC and plasma stored at -20ºC. For the testosterone (T) EIA
kit, the range of detection was between 3.9 – 500 pg/ml and for the estradiol (E2)
kit the range of detection was 8.6 – 4000 pg/ml.
In intact peri-pubertal males and females plasma levels of testosterone (T)
and E2 were measured using commercially available EIA kit (Cayman Chemical
Company, Ann Arbor, MI), respectively, according to manufacturer’s instructions.
In ovariectomized females replaced either with Ch or E2, plasma E2 levels were
measured by Endocrine Technology and Support Laboratory at the Oregon
National Primate Center at the Oregon Health Science University (Protland, OR)
where E2 Extraction-Chromatography-RIA was performed by Dr. K.-Y. Francis
Pau and colleagues. For E2 RIA reported intraassay and interassay CVs were
12% and 18%, respectively.
To measure CORT, 3I-CORT (PerkinElmer, Waltham, MA) and rabbit
CORT antiserum (MP Biomedicals, Solon, OH) were used to perform RIA. On
the first day of the procedure, a standard curve was prepared using CORTstandards (4-PREGNEN, 11b, 21-DIOL-3,20-DIONE-Steraloids, Inc). Appropriate
sample tubes were filled with 100 µl of a sample, 100 µl of antibody solution (in
0.1% gel PBS), and 100 µl diluted radioactive tracer (10-12000 cpm). Tubes
were incubated overnight at 4ºC. On the second day, all tubes were filled with
100 µl of 0.5% gel PBS, 1 ml Dextran-Coated Charcoal (DCC), and 1.0 ml 0.01
M PBS. Samples were centrifuged at 3000 rpm at 4ºC for 15 min and the
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supernatant was collected into scintillation vials. Radioactivity was measured in
each vial for 3 min. using Packard liquid scintillation counter. Levels of CORT in
unknown samples were interpolated based on the standard curve. Intra and
interassay CV were 4.96% and 7.93%, respectively.
To measure ACTH levels, 125I-ACTH (DIASORIN, Stillwater, MN), rabbit
IgG-ACTH-I primary antibody (Ig Corp, Nashville, TN ) and goat anti-rabbit Gglobulin secondary antibody (CalBiochem, San Diego, CA) were used to perform
RIA. On the first day of the procedure, a standard curve was prepared using
ACTH stock-human (1-39) obtained from BACHEM (Torrance, CA). Appropriate
sample tubes were filled with 90 or 50 µl of BSA Buffer (0.01M Phospate Buffer
Saline (PBS), 0.15 M NaCl, 1% BSA, 0.15% Triton-X-100, 250 KIU/ml Aprotinin,
pH7.6), 10 or 50 µl of sample for high and low hormone concentration
measurements, respectively and 100 µl of primary antibody solution (20 µl IgGACTH-I primary antibody in 100 ml of EDTA buffer (0.01 M PBS, 0.15 M NaCl,
0.05 M EDTA, 1% normal rabbit serum, 2.6 ml Aprotinin, pH7.6)). Tubes were
incubated for 24.0 h at 4ºC. On a second day, tubes were filled with 100 µl
diluted radioactive tracer (2000 cpm ± 10%), gently vortexed and incubated for
72.0 h at 4ºC. On the third day of the assay, 100 µl of goat anti-rabbit G-globulin
secondary antibody solution (1:20 dilution in 0.01 M PBS buffer (0.15 M NaCl, pH
7.6) was added to each tube, except for tubes containing tracer alone (total
radioactivity tubes) and incubated at 4ºC for 16.0 h. On the fourth day, 1.5 ml of
0.01 M PBS was added to each tube (except total radioactivity tubes) and tubes
were centrifuged for 40 min at 3000 rpms at 4ºC. Supernatant was decanted and
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radioactivity was counted for 5.0 min using gamma counter and levels of ACTH
in unknown samples were interpolated based on the standard curve. Intra and
interassay CV were 4.94% and.14.6 %, respectively.

Tissue collection and qRT-PCR:
After sacrifice, brains were rapidly collected and frozen using isopentane
and stored at -80ºC until further processing. Tissue collection and qRT-PCR were
performed as previously reported (Przybycien-Szymanska, Rao et al. 2009).
Briefly, frozen brains were sectioned at 200 µm on a freezing microtome and the
paraventricular (PVN) and supraoptic (SON) nuclei were microdissected using a
0.75 mm Palkovit’s brainpunch tool (Stoelting Co., Wood Dale, IL). The specificity
of the microdissected regions was confirmed using The Rat Bran in Stereotaxic
Coordinates, Fourth Edition Atlas (G. Paxinos and C. Watson). The PVN was
microdissected taking an 0.75 mm area on each side of the third ventricle
between 0.8 mm and 2.12 mm posterior to Bregma 8 mm below the top of the
brain (Smith, Gardiner et al. 2008) (see Fig 33 for schematic localization of the
PVN). The SON was microdissected taking a 0.4 mm area 9.5 mm below the top
of the brain between 0.8 mm and 3.14 mm posterior to Bregma. Total RNA
isolation was performed on sonicated tissue samples using Trizol reagent
(Invitrogen Inc., Carlsbad, CA) according to the manufacture’s directions.
Following RNA isolation, 0.5 µg total RNA was reverse transcribed using the First
Strand Synthesis SuperMix for qRT-PCR (Invitrogen Inc., Carlsbad, CA). Roche
FastStart SYBR Green Master Mix was added to intron-spanning AVP specific
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upper and lower AVP primer (0.25 µM final concentration; 5GGGCAGGTAGTTCTCCTCCT; 5-CACCTCTGCCTGCTACTTCC) and intronspanning CRH primer (0.25 µM final concentration; 5GAGAAAGGGGAAAGGCAAAG; 5-ATCAGAATCGGCTGAGGTTG). Then, 2 µL
cDNA templates were added to duplicate reactions performed in 96 well plates.
Quantification of the target gene expression was achieved by extrapolating from
standard curve of known concentrations of AVP or CRH run simultaneously in
the same plate. All samples were normalized to the hypoxanthine guanine
phosphoribosyl transferase 1 (HPRT) housekeeping gene, as it is not altered by
EtOH treatment (Przybycien-Szymanska, Rao et al. 2009).
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Fig 33. Representative diagram depicting the brain area microdissected (circle) for the
PVN. Scale Bar = 1mm. Adjusted from The Rat Bran in Stereotaxic Coordinates, Fourth
Edition Atlas (G. Paxinos and C. Watson).
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qRT-PCR for GR expression in IVB cells
GR gene expression levels were measured in IVB cells after EtOH
treatment. Cells were plated at the density of 200, 000 cells/well in clear 6-well
plate until they achieved final confluence of 90%. At that time (approximately
72.0 h later) cells were treated with 100 mM EtOH or vehicle for 0.5 or 2.0 h.
After appropriate treatment times, cells were washed 2 times with cold PBS and
1 ml of Trizol was added to each well. Total RNA isolation was performed on
sonicated samples using Trizol reagent (Invitrogen Inc., Carlsbad, CA) according
to the manufacture’s directions. Following RNA isolation, 0.5 µg total RNA was
reverse transcribed using the First Strand Synthesis SuperMix for qRT-PCR
(Invitrogen Inc., Carlsbad, CA). Roche FastStart SYBR Green Master Mix was
added to GR specific upper and lower primer (0.25 µM final concentration; 5AAACCTCAATAGGTCGACCAGCGT; 5-AGGTGCTTTGGTCTGTGGGATACA).
Then, 2 µL cDNA templates were added to duplicate reactions performed in 96
well plates. Quantification of the target gene expression was achieved by
extrapolating from standard curve of known concentrations of the hypoxanthine
guanine phosphoribosyl transferase 1 (HPRT) housekeeping gene ran
simultaneously in the same plate. All samples were normalized to the HPRT
housekeeping gene, as it is not altered by EtOH treatment (PrzybycienSzymanska, Rao et al. 2009).
Cell Culture
The IVB cell line, derived from the rat hypothalamic PVN, was used for all
transient transfections (generously provided by Dr. John Kaskow, University of
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Cincinnati) and was verified to be free of mycoplasma contamination (data not
shown, MycoSensor QPCR, Stratagene/Agilent Technologies). Cells were
maintained in DMEM containing 4.5% glucose and L-glutamine (HyClone
Labolatories, Logan, UT) supplemented with 10% fetal bovine serum. Cells were
grown to 90% confluence and all transient transfections were performed within
10 passages.

Reporter gene constructs and expression vectors
The full-length CRH promoter was generously provided and validated by
Dr. Audrey F. Seasholtz (University of Michigan, Ann Arbor, MI) and then
modified as follows. The full- length promoter fragment (-2125/+94) was excised
from the pUC18 vector by restriction enzyme digestion for EcoR1 (5’) and
HINDIII (3’) and subsequently subcloned into the promoterless luciferase vector
(pGL3 basic, Promega Corp., Madison, WI). The pRL-tk-luciferase reporter
vector (Promega Corp., Madison, WI) was used as an internal control for
calculating plasmid transfection efficiency.

Transient Transfections and Dual Luciferase Assay:
Cells were plated at the density of 20, 000 cells/well in opaque 96-well
plate for 24 hours prior to transfection to achieve a final confluence of 70-90%.
Transient transfections were performed in replicates of 6 wells/plate for each
construct/treatment and each assay was repeated minimum of 6 times (N=6).
Transfections were achieved using a lipid-mediated transfection reagent,
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Fugene6 (Roche Molecular Biomedical, Indianapolis, IN) according to
manufacturer’s instructions. Twenty-four hours following transfection, cells were
treated (see below) and then processed for luciferase assays (Dual Luciferase
Reporter (DLR) kit (Promega Inc., Madison, WI). Briefly, cells were lysed in 20 µl
of lysis buffer, incubated on a shaker for 20 min at room temperature and then
loaded into a multiple well plate reader (Synergy HT, Biotech). The plate reader
is equipped with dual injectors and automatically dispensed 100 µl firefly
luciferase substrate (LARII) followed by “stop-and glo” substrate for renilla
luciferase. Results were analyzed using Gen5 software (Biotech Inc., Winooski,
VT).
EtOH and Hormone Treatments
Twenty-four hours after transfection with the CRH promoter, cells were
incubated with varying concentrations of EtOH (12.5, 25.0, 50.0 or 100 mM)
diluted in 10% FBS media (vehicle) for 2.0 h (dose response), or they were
treated with 100 mM EtOH for either 0.5, 1.0, 2.0 or 4.0 h (time course). Cells
transfected with the mutated CRH promoter that lacked specific GR regulatory
regions were treated with 12.5 mM EtOH or vehicle for 2.0 h or, in control
experiments, they were treated with 25 µM Forskolin for 6.0 h. In another set of
experiments, 8.0 h after transfections with WT CRH promoter, cells were
incubated in 10 nM E2 or vehicle. 16.0 h after hormone treatments, cells were
treated with 10 nM E2 in the presence or absence of 100 mM EtOH for 2.0 h.
The glucocorticoid receptor (GR) antagonist, RU486, was used in cell
culture in the presence of EtOH in order to test if GRs are involved in EtOH
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effects on the CRH promoter. RU486 antagonistic properties are achieved by
corepressor recruitment to the GR-DNA complex and inhibition of gene
transctiption. It has been shown that in the presence of RU486 DNA binding to
GR still occurs but when RU486 is in a bound state, protein named nuclear
corepressor (NCoR) is recruited to the N terminus of the GR and the DNA
transcription is prevented. (Rajpert, Lemaigre et al. 1987; Schulz, Eggert et al.
2002). 8.0 h after transfections with WT CRH promoter, cells were incubated in
100nM RU or vehicle. 16.0 h after hormone treatments, cells were treated with
100nM RU486 in the presence or absence of 100 mM EtOH for 0.5, 1.0, 2.0 or
4.0 h.

Site-Directed Mutagenesis.
Scanning mutagenesis deletions were performed on the CRH promoter
using the QuickChange II XL kit according to manufacturer’s instructions
(Stratagene, LaJolla, CA). Briefly, forward and reverse primer sequences were
designed targeting the appropriate identified regions of the promoters (GR 1, (5’CTTGGATAATCTCATTCAAGAACAATGGACAAGTCATAAGAGC-3’; 5’GAACCTATTAGAGTAAGTTCTTGTTACCTGTTCAGTATTCTTCG-3’) GR 2 (5’CTCATTCAAGAATTTTTGTCAACAAGTCATAAGAAGCCCTTCCA-3’; 5’GAGTAAGTTCTTAAAAACAGTTGTTCAGTATTCTTCGGGAAGGR-3’), GR 3
(5’-TTTGTCAATGGACAAGTCAGCCCTTCCATTTTAGGG-3’; 5’AAACAGTTACCTGTTCAGTCGGGAAGGTAAAATCCC-3’), GR1 and 2 double
deletion (5’-GGATAATCTCATTCAAGAACAAAGTCATAAGAAGCCCTTCCA-3’;
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5’TGGAAGGGCTTCTTATGACTTTGTTCTTGAATGAGATTATCC-3’ or CRE
deletion (5’-CTTCCATTTTAGGGCTCGTTCCAAGGAGGCGATAA-3’; 5’TTATCGCCTCCTTGGAACGAGCCCTAAAATGGAAG-3’)). Sequences
contained deletions of 7, 4, 6, 11 or 7 bp, respectively sequentially from 5’ to 3’ in
these regions (Fig 12). A standard PCR reaction was performed on a thermal
cycler using mutated CRH-luciferase construct as a template. Following the
reaction, the parent plasmid was digested using the DpnI restriction enzyme and
the daughter plasmid, containing the desired mutation was transformed into XL10 Ultragold competent cells and amplified. The mutation was confirmed by DNA
sequencing using the in-house core sequencing facility (Loyola University
Chicago, Stritch School of Medicine).
In Vitro Toxicology Assay (MTT based)
Cell viability was measured using in vitro 3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide) MTT based Toxicology assay (Sigma-Aldrich)
according to manufacturer’s instructions. Briefly, following EtOH treatments cells
were washed once with sterile PBS and media was replaced with 250 µl of a 0.25
mg/ml solution of MTT in regular growth media without FBS and phenol red.
Cells were incubated in the MTT solutions for 1.5 h at 37º C; then MTT solution
was removed. MTT solubilization solution (200 µl of 0.04 M HCl in absolute
isopropanol) was added to each sample and transferred to 96-well plate.
Absorbance was read at 570 nm on a multimode multiplate reader (Biotech Inc.,
Wonooski, VT).
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Statistical Analysis
For most data, one-way ANOVA was used to test for differences between
specific treatment groups followed by Tukey post-hoc test if one-way achieved
significance. Student’s t-test was used in order to compare differences between
vehicle and EtOH treatment within each deletion mutation.
Two-way ANOVA was used to test for interactions between pubertal and
adult treatments and for main effects of these treatments in regards to following
dependent variables: plasma BAC, plasma CORT levels, CRH mRNA in the PVN
and AVP mRNA in the PVN and in the SON. Tukeys post hoc test was used if
ANOVA achieved significance. If ANOVA showed interactions between
treatments, students t-tests were used to asses significance between EtOH and
saline pre-exposed groups within specific adult EtOH treatments.
Two-way ANOVA was also used to test for interactions between Ch and
E2 treatments and for main effects of these treatments in regards to following
dependent variables: plasma BAC, plasma ACRH and CORT levels, CRH mRNA
in the PVN and AVP mRNA in the PVN and in the SON. Tukeys post hoc test
was used if ANOVA achieved significance. If ANOVA showed interactions
between treatments, students t-tests were used to asses significance between
Ch and E2 treatments within specific saline or EtOH treatments. All tests were
performed using SigmaStat Statistical Analysis Software. A p-value of less than
0.05 was considered to be significant.
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